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RESUME EN FRANÇAIS ET MOTS CLES FRANÇAIS
Des études présentées dans cette thèse ont permis de démontrer que le gène du
Groupe Polycomb (FcG,) Bnii-] est un déterminant génétique essentiel à l’activité
proliférative des cellules souches hérnatopoïétiques (CSHs) foetales et adultes.
Appuyant cette observation, l’hornozygotie pour un allèle nul du gène Bmi-1 conduit à
une anémie aplasique progressive et létale chez la souris. De plus, ce travail démontre
que la fonction du gène Bmi-] est maintenue au niveau des cellules souches leucémiques
(CSH-Ls). Cette importante observation renforce la notion d’une structure dans la
hiérarchie leucémique où Bmi-1 définit la “prirnitivité” et suggère que la fonction des
cellules souches (qu’elles soient normales ou leucémiques) est régulée par un groupe
commun de déterminants géniques. Il devient alors impératif de vérifier si la fonction de
Bmi-] s’étend aussi aux cellules souches normales et cancéreuses provenant d’autres
types tissulaires. Une étude d’expression détaillée de gènes de la famille Polvcomb
(FcG) dans des populations purifiées de cellules de moelles osseuses humaines a révélé
une curieuse dissociation entre le patron d’expression du gène Bmi-1 (restreint aux
cellules souches hématopoïétiques) et celui des autres protéines Potycoinb (PcG) avec
lesquelles Bmi-l interagit physiquement. Dans le but de définir la composition du
complexe contenant Bmi-1 au niveau des CSHs, nous avons utilisé une approche de
double-hybride chez la levure. Ceci a conduit à l’identification de huit nouveaux co
facteurs de Bmi-l spécifiques aux CSHs, incluant une molécule à doigts de zinc qui
semble représenter un médiateur clé de la fonction pro-proliférative de Bmi-1 au niveau
des CSHs. Par ailleurs, nous avons démontré que le gène Polycomb (PcG) eed possède
une activité antagoniste à Bmi-l dans la régulation de la prolifération des CSHs. Les
souris hétérozygotes pour un aflèle nul du gène eed (eed3354j développent des
anomalies myelo- et lyrnpho-prolifératives sévères, indiquant qu’Eed est impliqué dans
la régulation négative de la prolifération des progéniteurs de la moelle osseuse. En
conclusion, le travail présenté dans cette thèse démontre que l’activité proliférative de la
cellule souche hématopoïétique est régulée par la contribution relative d’un complexe
PcG contenant Bmi-l stimulant leur prolifération et d’un complexe contenant Eed,
réprimant cette activité.
Mots clés: Gènes du Groupe FoÏycomb (Pc, cellule souche hématopoïétique (CSH),
cellule souche leucémique (CSH-L), hématopoïèse, Bmi-1, eed.
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RESUME EN ANGLAIS ET MOTS CLES ANGLAIS
The studies presented in this thesis establish that the Folycomb Group (PcG,) gene
3m i-J is a key genetic determinant of the proliferative capacity of fetal and aduit
hemopoietic stem ceils (HSCs). Consistent with this, hornozygosity for a nuli allele of
3m i-J in mice leads to progressive and lethal aplastic anemia by early adulthood. This
work also shows that the function of Bmi-J is preserved in leukemic stem celis (L
HSCs), providing the first molecular basis for the concept that stem ceil function
(whether normal or neoplastic) is regulated by common regulatory genes. These findings
reinforce the notion of a structure in the leukemic hierarchy where 3m i-1 defines
“stemness”. Detennining whether this function of Bmi-J extends to other types of
normal and “neoplastic stem celis” is eagerly awaited. A detailed expression analysis of
selected members of the PcG gene family in purified subpopulations of hurnan bone
marrow ceils revealed a curious dissociation of the expression profile of Bmi-1 (mostly
restricted to the HSC cornpartrnent) and that of the other known PcG proteins which
physically interact with Bmi- 1. In an attempt to define the biochemical nature of the
Brni-1-containing complex in HSCs, a yeast-two-hybrid screen was performed using an
expression !ibrary enriched for primitive hernopoietic ceïls. This approach lcd to the
identification of eight novel stem ceil-specific co-factors of Bmi-l, including a zinc
finger molecule which appears to represent a key mediator of Brni-1 -induced HSC
proliferation. Conversely, it was established that the PcG gene eed performs an
antagonistic function to Bmi-J in the regulation ofHSC proliferation. Heterozygosity for
a nuil allele of eed (eed3354j leads to severe myelo- and lympho-proliferative defects
and lyrnphoid turnor development in mice, indicating that Eed is involved in the
negative regulation of the pool size of early bone manow progenitor celis. Together, the
work presented in this thesis reveals that the proliferative tone ofthe HSC is intrinsically
regulated by the relative contribution of a pro-proliferative (Bmi-Ï-containing) and an
anti-prou ferative (Eed-containing) PcG gene comp lex.
Key words: Polycomb Group (FcG) genes, hernopoietic stem ce!! (HSC), leukemic
stem ceil (L-HSC), hemopoiesis, Bini-], Eed.
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CHAPITRE 1
INTRODUCTION: SECTION 1
Molecular Genetics of Hemopoietic Stem Celis
7The present Ph.D. thesis, consisting of 7 chapters, describes the expression,
function and mechanisms of action of selected members of the PcG gene farnily in
normal and leukemic hernopoiesis.
Chapter 1 is a literature review which is subdivised into two sections. The first section
describes the genetic determinants of early hemopoiesis, the intrinsic and extrinsic
regulators of hemopoietic stem ccli (HSC) seif-renewai, and the rnechanisms regulating
stem celi homeostasis in model systems such as the DrosophiÏa germ une. The next
section summarizes the role of selected members of the Polycomb Group (PcG,) gene
farnily in the regulation of normal and teukernic hernopoiesis. A particular emphasis is
given to the epigenetic mechanisrns underlying Polycomb Group (PcG) gene function
across species. This last section bas been recently published as a review Article. It was
written by Julie Lessard under the supervision ofDr Guy Sauvageau.
31.1.1 Genetic determinants ofearly hemopoiesis
Hernatopoiesis is an ordered developmental program of differentiation and proliferation,
leading to the generation of mature blood celis of multiple distinctive lineages from
totipotent hernopoietic stem celis (HSCs). Regulation of this highly complex process
occurs at multiple levels, and can be simplistically viewed as the combined effects of
extemal influences (composed of boti; humoral factors and ceil-ceil or ceil-matrix
interactions) and intracellular signaling events, ensuring transcriptional factor regulation
and consequent changes in gene expression programs.
Until recently, very littie was known about the genetic mechanisrns that bring about the
intrinsic processes of lineage comrnitment and subsequent lineage-speci fie
differentiation of early hemopoietic celis. Accumulating evidence, from a number of
recent studies, is now pointing to transcription factors suc!; as ScL/tal-1 (stem celi
leukernia hemopoietic transcription factor), rbtn2/LMO2 (aiso known as ttg-2), AML-J
(aÏso Ïrnowit as RUNX1/3fA2 and PEBF2B), GATA-2 and Ikaros as key genetic
detenninants of early hemopoiesis. Depicted in figure 1 are the positions of essential
function for these transcription factors in the hernopoietic hierachy. The b-HLH domain
containing tal-l/SCL and the LIM domain-containing rbtn2/LMO2 proteins (which have
been shown to interact in vivo and form a heterocomplex) 1,2 act very ear!y in ontogeny,
as mice deficient for either ofthese gene products lack ail lineages ofboth primitive and
definitive hemopoiesis A role for the runt homology domain protein AML-1 in the
initiation of definitive hernopoiesis lias been demonstrated, as AML-1 miii mice present
normal primitive hernopoiesis but completely lack definitive hernopoiesis . The TEL
(transÏocaction-Ets-Ïeukemia or ETV6) gene was shown to be required specifically for
hemopoiesis of ail lineages in the bone maiow 6 Further studies will be necessary to
establish whether this reflects an inability of TEL HSC/progenitors to migrate to the
bone rnarrow or, more likely, to respond appropriately and/or survive within the bone
manow microenviromnent. Absence of the zinc finger protein GATA-2 in mice appears
to impair the proliferation capacity of early hemopoietic cells . Mice that lack
functional c-myb protein have a phenotype similar to that ofthe GATA-2 nuli mice, with
4the exception of the rnegakaryocyte lineage which appears to develop norrnally in the
absence of c-myb . Both GATA-2 and c-myb are nornially expressed in primitive
hemopoietic ceÏÏs and then down-reguÏated as these celis differentiate 9,10• forced
overexpression of GATA-2 and c-mvb in progenitor celis prornotes their proliferation and
blocks differentiation 10,1 1• Homozygous nuli mice for tue ets family member PU] lack
ceils of the granulocytic, monocytic and B celi lineages —the celis in which PU] is
norrnally expressed 12 Interestingly, a separate une of PU] nuli mice (derived using a
different targeting vector) has a more severe phenotype with additional defects in the T
and erythroid lineages . Finally, the Ikaros gene encodes six alternative transcripts that
are differentially expressed in lymphoid ceils and whose products regulate the
expression of a number of lineage specific genes ‘. Mice lacking Ikaros function
displayed a complete absence of ail celis of the lyrnphoid lineage (T, B and NX),
whereas both progenitor and mature celis of the myeloid and erythroid lineage where
increased 15
5Fig. 1.1 Schematic representation indicating the position of essential function of sorne
transcription factors known to be active in hemopoiesis. Positioning of each gene
product is based on the earliest block observed in hernopoiesis resulting from its
absence. Adapted from Shivdasani R A. and Orkin 5H. (1996) Blood 87: 4025-4039.
Other factors appear to be more lineage specific in action such as GATA-], EKLF, Nf
E2, Pax5 and E2A, as their absence affects onÏy one hernopoietic lineage 16-22 For
example, absence of GATA-1 blocks hemopoietic differentiation at the proerythroblast
stage followed by apoptosis of these celis, suggesting that the functional role of GATA
1 is to penriit survival and maturation of erythroid progenitor ceils by preventing
apoptosis 23
1.1.2 Self-renewal: a key property of the hemopoietic stem celi?
The hemopoietic stem ce!! (HSC) can be operationa!f y defined as a !ong-term
repopulating ce!! with both lyrnphoid (T and B) and rnye!oid potentia! 24 The first
evidence for the existence of sucli a ce!!-type cornes from experirnents by Ray Owen and
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6colleagues, in 1945, which showed that bovine fraternal twins, sharing a single placenta
and blood circulation, retained production of blood ceils genetically defined to be from
both throughout their Iife 25 Twenty years later, elegant experiments by Tili,
McCulloch, Wu, Becker, Sirnonovitch and colleagues demonstrated that aduit bone
marrow contained single celis that had the ability to forrn macroscopic nodules of
myeloerythroid celis on the spleen, $ to 12 days after intravenous injection into myelo
ablated recipients 26-28 These spleen-colony-forrning-units (CfU-S) were shown to be
clonaI 29 and, in rnany cases, couÏd generate similar colonies upon transplantation into
secondary recipients 28 As they shared several characteristics attributed to HSCs
(including high proliferative potentiaÏ, multipotentiality and seÏf-renewaÏ abiÏity), CFU-S
were initially considered to be HSCs 2$ The validity ofthe CFU-S assay to detect HSCs
with long-terni repopulating potential was questioned after the discovery that some of
these ceils were capable of only unilineage differentiation and/or lacked the ability to
self-renew (functional heterogeneity). Although most ofthe ceils possessed the ability to
differentiate into the erythrocyte and myeloid lineages, their lymphoid potential
rernained controversial 30-32 is now clear that most CFU-S cells in the aduit bone
rnarrow are cornmitted myeloid progenitors which can be physically separated from
more primitive cells with long-term lympho-rnyeloid repopulating potential
Although the CFU-S assay played a key role in the development of concepts of primitive
hemopoietic ccli organization and regulation, its inability to analyze pure stem ceils
meant that rnost oftheir functions were irnplied rather than directiy analyzed.
The first attempts at purifying the HSC came from the school ofTill and McCullogh 33,40
and Van Bekkum in the Netherlands 41 From this work, it lias becorne possible to
routinely identify and isolate highly purified murine and hurnan HSCs based mainly on
characteristic cell surface proteins that are either present (Sca-1 and c-kit) or absent
(using rnarkers of lineage cornrnitted cells such as CD38, Mac-l and CD8) (for review
42)
Despite the progress that has been made in identifying and obtaining enriched HSC
populations, analysis of the population dynamics and cdl cycle kinetics of HSCs
7remains difficuit. One of the most intriguing properties of aduit HSCs is a robust
maintenance of the dynamic equilibrium between seif-renewal and differentiation ‘n•
Under homeostatic conditions in vivo, most HSCs are quiescent, as demonstrated by
their relative resistance to killing by the cytotoxic dnig 5-fluorouracil (5-FU) when
compared to comrnitted progenitor celis When they enter cycle, HSCs can divide
asymrnetrically or symmetrically, resulting in different HSC fates. Stem ccli
maintenance divisions give rise to one daugbter HSC with essentially identical
biological properties (a process referred to as seif-renewal) and one committed daughter
ceil. The comrnitted daughter celi enters a transient state of rapid cellular proliferation
and, upon exhaustion of its proliferative potential, withdraws from the ce!! cycle and
progressively acquires the specialized characteristics of one of the 10 mature blood celi
lineages ta process known as differentiation). Although the relative influence of intrinsic
versus extrinsic factors on HSC seif-renewal remains to be detenriined, it bas been easier
to identify the environmental factors having a negative impact on this process than those
that enhance it. Thus, rnost in vivo culture conditions defined to date lead to depletion of
the HSC pool by favoring symmetric divisions (generation of two daughter
differentiated celis) and concomitant expansion ofcornmitted progenitor populations
Several sttidies using retroviral marking of HSCs have dernonstrated the ability ofHSCs
to undergo seif-renewa! divisions 46-49 A!though most of these studies failed to
accurately quantify the magnitude of seif-renewa! events, considerable evidence
suggests that this property is not unlimited. First, following bone marrow
transplantation, the HSC pool is flot found to regenerate to ievels higher than 10% of
normal pre-transplantation values, despite a complete regeneration of bone rnaiow
cellularity and progenitor ce!! numbers 5054 Some investigators have suggested the
involvement of negative feedback rnechanisrns irnposed in vivo by more mature ceils as
a possible mechanism that could prematurely inhibit HSC expansion following
transplantation . Alternatively, this loss of long-tenu repopulating ability may result
from damage to the recipient’s microenvironment inflicted by the conditioning regimen
(i.e. irradiation). However, experirnents performed in the anemic (WWV) recipient
mouse strain, which possess a normal microenvironment but poorly competitive
$hernopoietic celis due to a mutation in the c-kit ligand receptor 56, rather suggest that this
defect is intrinsic to the transplanted ceils themseives 51,57•
A major concem is that nearly ail HSC assays assessing seif-renewal rely on the
genel-ation of functionalÏy mature celÏs, and therefore provide a retrospective rather than
a current view of potential HSC attributes. In a transplantation setting, the accuiacy of
the HSC readout relies on the efficiency of the transplanted ceils to home and engraft to
the speciaiized niches of the bone marrow rnicroenvironment . The heterogeneity of
the HSC cornpartment further complicates the interpretation of such experimental
designs. Age-related and strain-specific 59,60 differences in HSC numbers and/or
competitive abilities have been reported (for review 61) Moreover, a functionai deciine
in the proliferative potential of FISCs derived from the fetal liver, umbilical cord (at
birth) and aduit bone marrow indicates ontogeny-related differences in HSC function
54,62-64 Whether this heterogeneity represents true intrinsic quantitative and/or qualitative
differences in HSC properties, or in the expression of this potentiai due to stochastic
events, remains unclear. So, a question remains: can HSCs tntly seif-renew or does cell
division impair their qualitative (biological) properties?
1.1.3 Intrinsic regulators of HSC seif-ren ewal
While the concept of “true HSC seifrenewai” remains controversial, genetic
programmes regulating the self-renewal and di fferentiati on outcomes of early
hemopoietic cell divisions have been described. Recent attention bas focused on
bemopoietic cytokines (see next section) 65-69 and cell intrinsic pathways whose
activation bas caused sorne HSC expansion ex vivo, with the ultimate goal of durable in
vivo engraftrnent. Enforced expression of the P glycoprotein purnp genes MDR] and
ABCG2 in murine bone marrow cells led to the expansion of side population cells with
retained in vivo repopulation ability 70• Activation of retinoic acid receptor signaling by
addition of all-trans retinoic acid resulted in retention of long-term repopulating activity
of cultured hemopoietic stem cells 71 Constitutive Notch signaling in purified Sca-l
Lin c-kit bone rnaiiow cells led to the immortalization of blast-like ceils that retained
9pluripotency and Ïong-terrn repopulating potential 72• In particular, retroviral
overexpression of HOXB4 in mouse bone marrow celis significantly enhanced the rate
of HSC seif-renewal (potentially tip to 1000-fold net increase of transduced HSCs) in
both prirnary and secondary recipients 0f note, this stem-ceil specific proliferative
effect of HOXB4 occurs without impairing normal differentiation or inducing cellular
transformation. A role for the Wnt signaling pathway in seif-renewal of HSCs has also
recently been demonstrated 76• Overexpression of activated 3-catenin expands the pool
of HSCs in long-terni cultures by both phenotype and ftmction. Ectopic expression of
axin or afrizzled ligand-binding domain, inhibitors of the Wnt signaling pathway, leads
to inhibition of HSC growth in vitro and reduced reconstitution in vivo. Furthermore,
activation ofWnt signaling in HSCs induces increased expression ofNotchl and Hoxb4,
suggesting a molecular hierarchy of regulation of HSC developrnent. Purified Wnt3a
protein also induces seif-renewal of repopulating celis (HSCs?), signifying its potential
role in tissue engineering Serial transplantation studies demonstrated a critical role for
the transcription-regulating/chrornatin modifying CREB-binding protein (CBP), but flot
its paralogous protein p300, in maintaining an adequate pool of murine HSCs through
seif-renewal 78• The cyclin-dependent kinase inhibitor (CKI) p21 also appears to be
an essential component of the molecular switch governing the entry of the hernopoietic
stem celis in cycle as in its absence, increased cdl cycling leads to stem ceil exhaustion
. Most importantly, the PoÏycoinb group gene Bmi-] is absolutely required for the
rnaintenance/self-renewal ofboth fetal and aduil HSCs (see below)80’81.
It was recently demonstrated that the horneoprotein Nanog is required for maintenance
of pluripotency in mouse epiblast and embryonic stem (ES) cells 82,83• Despite very
different genetic programs in vivo, tinder normal circtirnstances, both ernbryonic (ES)
and hemopoietic stem cells share fundamental common properties: rnultipotency and the
ability to self-renew. Insights into flic regulation of Nanog- as well as other regulators
of self-renewal/multipotency such as Oct4-, FoxD3-, Sox2- and Stat3-directed
transcription pathways and the network of crosstalk between these factors might
contribute to a better understanding of stem ceil behavior in other renewing tissues such
as blood. However, an important caveat is that ES celis truly self-renew whereas HSCs
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may not. This raises the hypothesis that distinct molecular programmes may be involved
in regulating this process.
1.1.4 Extrinsic regutators of HSC seif-renewal
1.1.4.1 Regulation of germ une stem celi (GSC) seif-renewal in Drosophita
Further defining the molecular mechanisms controlling stem ceil function is crucial to
the future use of stem celis in regenerative medicine as well as understanding the
processes of aging, turnor formation and degeneration. As mentioned above, a
ftindamental characteristic of adult stem ceils is their capacity to either divide
asyrnrnetrically or symmetrically. Thus, general mechanisrns may exist to balance self
renewal capacity with di fferentiation.
The Drosoph lia germ une represents an excellent system to study adult stem ceils at the
cellular and molecular level and their relation with their microenvironrnent. li the
female, at the anterior end of cadi ovariole of an ovary (or gennarium) rest two or three
gerrn-line stem celis (GSCs) that originate from primordial genn stem ceils (PGCs).
These primitive ceils are located in a niche which is composed of three differentiated
somatic ce!! types: terminal filament (TF) cells, cap celis and inner germarium sheath
(IGS) celis. This microenvironment is instrumental in regulating the expansion of tic
gemi une stem ceil pool. Anterior PGCs adjacent to Tf/cap celis give rise to two
daughters that both contact Tf/cap ceils and will eventually develop into GSCs
(symmetric division). The remaining PGCs (not in physical contact with Tf/cap ceils)
directly differentiate into mature oocytes (asymmetric division) 8490• In die male germ
une, PGCs are also selected to become GSCs based on their juxtaposition to a cluster of
somatid/support cells (called the hub) located at the apical tip of die testis. Upon ce!!
division, the daughter ccli maintaining contact with the hub retains stein ceil identity,
whereas the celi displayed away from the hub initiates differentiation into a gonialblast
91,92 Thus, the orientationlposition of genn line stem ceil divisions in the niche seems to
be critical in regulating tic expansion of tic germinal stem ccli pool (detenninistic fate).
In DrosophiÏa, the molecular rnechanisms regulating genn une stem ccli (GSC)
divisions are currently being unraveied. The Janus kinase-signal transducer and activator
of transcription (JAK-STAT) signal transduction pathway is an important intrinsic
regulator of GSC seif-renewal in the male gerrn une Similarly, piwi, the Drosoph lia
counterpart of human HIWI, is aiso required for the seif-renewal ability of G$Cs, but is
absolutely dispensabie for their differentiation into committed daughter celis
Decapentapiegic (Dpp,) (the Drosoph lia homoiog of human boue moiphogenetic protein
2/4), is expressed in anterior somatic ceils of the gonad and is essential for PGC
proliferation. PGCs mutant for thick veins, an essential dpp receptor, ate impaired in
their ability to clonally populate a niche, further suggesting that dpp is one of the
extrinsic mitotic signais that promote flic clonai expansion of GSCs in a niche 90• In the
male germ une, the asymmetric outcome of stem ceil divisions is specified, extrinsicaily,
through direct interaction with niche ceils expressing the ligand Unpaired (Upd) ‘°.
DE-cadherin-mediatcd ccii adhesion was aiso shown to be essential for anchoring
ovarian GCSs to their niches and stimulating their proliferation Loss of function of
the Drosoph lia Epidermal growth factor receptor (EGFR,) in sornatic ceils increases the
number of GSCs in the male genu une, suggesting that the EGFR gene is aiso an
extrinsic (but negative) reguiator of GSC proliferation 96•
1.1.4.2 Positional information and the regulation of stem celi seif-renewal: a
conserved mechanism?
Positionai cues from the microenvironrnent seem to be critical in regulating stem celi
fate decisions in severai other organisms and developmentai systems. In the C. elegans
gonadal ami, mitotic gerrn une stem ceils (GSCs) reside distaliy, while differentiating
gametes progressiveiy move towards the proximal end. Sornatic distal tip ceils (DTCs)
located at the extrernity of the gonad constitute a niche that is essential for promoting
GSC proliferation and preventing meiosis (for review 97)• In the developing brain,
mammaiian neural stem celis (NSCs) are known to be located in close contact with the
ventricular zone surface, whereas differentiated post-mitotic neurons progressively move
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towards the dorsal zone (for review, 9$)• Interestingly, it has been suggested that NSCs
dividing along the ventricular surface give rise to two stem celis, while the perpendicular
division generates one stem ceil and one differentiated neuronal celi . The small
intestine is cornposed of ciliated villi, each surrounded by crypts, embedded in the
intestinal wall for protection. Each crypt is composed of about 250 simple epithelial
ceils that include the stein ceil compartrnent for replenishing the villi. The multipotent
stem ceils are iocated near or at the base of each crypt To maintain horneostasis,
slow cycling stem celis are converted to rapidly but transiently proÏiferating celis that
move to the rnidsegment and subsequently differentiate into functionally mature and
specialized ceils (i.e. either absorptive enterocytes, mucus-secreting gobÏet or
enteroendocrine ceils). Similarly, the epidermis is composed of a single inner (basal)
layer of dividing sternlprogenitor celis, which periodically withdraw from the celi cycle,
commit to differentiate terminally, and move outward toward the skin surface ‘°‘.
The bone marrow aiso provides aduit HSCs with a rich, but complex, milieu (or niche)
composed of many ccli types including macrophages, adipocytes, fibrobiasts and
mesenchyrnal celis. Bone rnarrow strornal factors that positively impact on HSC
maintenance, propagation and homing include soluble and membrane-bound stem celi
factor (SCF), soluble Sonic Hedgehog, the fibrobiast growth factors fGf-1 and fGF-2,
the a-chemokine strornal-1 ccii derived factor-l (SDF-1) and a slew of extra ceilutar
matrix (ECM) moiecules, ail having the abiiity to specifically interact with various
receptors on the HSC surface (for review 102) On the other hand, purified primitive
(Sca-1 Lin c-kif’) bone rnarrow ceils are severely compromised in their short and long
term multilineage reconstituting ability when activated by TNF-alpha or through Fas 103
or when engineered to overexpress f1t3 104 providing molecular evidence for extrinsic
negative regulators of HS C seif-renewal.
Despite major efforts to characterize the bone rnarrow niche, in vitro studies indicate
that HSCs still survive better when cuitured with bone marrow strorna than when placed
in a defined medium supplernented with characterized bone manow components. This is
also true for epidermal keratinocyte progenitors which require coculturing with
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fibrob!asts to display their optimal survival and proliferative capacity 105 Thus, the
orientation of the stem ceil division plane in the niche rnight represent a general and
evolutionariÏy conserved mechanism invoÏved in regulating both germinal and somatic
stem celi horneostasis. Locating and analyzing the stem celi niches and identifying the
molecuÏes that orchestrate these environmental positional cues are of major importance
in stem ce!! biology.
1.1.5 Cellular organization of normal aiid leukemic hemopoiesis: a common
function for stem ceils
There is strong support for the idea that cancer is a stem-celI disease 106 The simi!arity
in the hierarchical organization of malignant and normal tissues is best characterized in
the hernopoietic system. Hurnan acute myeloid leukemia (AML) originates from a rare
population of primitive cel!s (CD34 CD38) high!y enriched in hemopoietic stem cells
(HSCs) 107 Most leukemic ceils (blasts) are limited in their proliferative capacity and
must be constant!y replenished by rare, se!f-renewing “leukemic stem ce!ls” (L-HSCs).
So, like the normal hemopoietic system, leukemia seems to be organized as a hierarchy
that originates from a stem-ce!! pool which rnost likely retains remnants of the nonrial
deve!oprnental program.
It has also been proposed that the initial, cancer-causing (“transforming”) niutations
occur in the seif-renewing stem ceil pool, rather than in a!ready committed precursors. In
this view, fewer mutations would be required to generate fu!!y malignant ce!!s if they
were to originate from already seif-renewing stem ce!!s, as opposed to cornmitted
progenitors with !ow pro!iferative potential. Thus, two important findings have recent!y
emerged from studies of stem ce!! biology and carcinogenesis: 1-) in the process of
neoplastic transformation, the genetic events responsible for di sease progression must
occur in a stem ce!!, un!ess one of the mutations would penriit se!f-renewal in a
downstream comrnitted progenitor; 2) within the cancer or leukemia, on!y a subset ofthe
cells that make up the tumor mass are tumorigenic —the “cancer stem celis” These
ideas predict similarities in the rno!ecular programmes of norma! and cancer/AML stem
ceils.
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The genetic rnechanisms regulating seif-renewal of the HSCs may be more generally
applicable to other regenerating tissue systems. Recent findings implicated the Notch
72,109,110 \Vnt and Shh 111-113 signaling pathways in prornoting stein ce!! seif-renewal in a
variety of different epithelia in addition to HSCs. 1nterestingly, mutations of these
pathways have been associated with a number of hurnan neoplasia, including colon
carcinoma and epidermal tumors 114,115 (Wnt), rnedulloblastoma and basal cali
carcinorna 116,117 (Shh), and T-ce!! leukernias 11$ (Notch).
As uncontrolled stem ce!l seif-renewal represents the basis of cancer, the identification
of stern-celÏ specific genes, especiaÏly those involved in the deregulation of their self
renewa! capacity is critical. The goal ofrny PhD thesis was specifically to identify such
a gene. To achieve this, I used a candidate gene approach and decided to focus rny
studies on the PoÏycomb (PcG,) fami!y of genes because: 1-) the PcG genes are upstream
transcriptional regulators of the homeotic (Hox, genes in skeletal precursor ce!!s 2-) the
Hox genes are important regu!ators of hemopoietic deveÏoprnent; 3-) HOXB4 is a critical
regulator ofHSC self-renewal; its retroviral overexpression in mouse bone marrow cells
leads to 1000-fo!d net increase of transduced HSCs in both primary and secondary
recipients N; 4-) in the rnid-90’s, expression of some FcG genes in hurnan and murine
hernopoietic ceil unes had already been reported; 5-) van Lohuizen and co!!eagues had
identified the Polycoinb Group (PcG,) gene Bmi-] as an essential regulator of the
proliferative activity of boue manow mye!oid and !ymphoid progenitors 119 suggesting
a putative roTe for this gene in the regu!ation of HSC behavior. The work presented in
this PhD thesis was intended at verifying whether selected members of the Polycomb
group (PcG) gene family 1-) were expressed in the hernopoietic tissue; and 2-) rnight be
involved in regulating critical aspects ofHSC function.
The next section xviii provide a detaiied overview of the Folycomb (FcG) group genes,
with special emphasis on their implication in the regulation of hernopoietic ce!!
developrnent.
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Abstract
Epigenetic modification of chromatin structure underlies the differentiation of
pluripotent hernopoietic stem ceils (HSCs) into their commited/differentiated progeny.
Compelling evidence indicates that Polycontb group (FcG,) genes play a key role in
normal and leukernic hemopoiesis through epigenetic regulation of HSC self
renewal/proliferation and commitment. The PcG proteins are constituents of
evolutionary highly conserved molecular pathways regulating celi fate in several other
tissues through diverse mechanisms including (1) regulation of self
renewal/proliferation; (2) regulation of senescence/imrnortalization; (3) interaction with
the initiation transcription machinery; (4) interaction with chromatin—condensation
proteins; (5) modification ofhistones; (6) inactivation ofpatemal X chromosome and (7)
regulation of celi death. It is therefore not surprising that PcG genes lead to pleiotropic
phenotypes when mutated and have been associated with malignancies in several
systems in both mice and humans. Although much remains to be Iearned regarding the
PcG mechanism(s) of action, advances in identifying the functional dornains and
enzymatic activities of these multimeric protein complexes have provided insights into
how PcG proteins accornplish such processes. Some of the new insights into a role for
the PcG cellular memory system in r-egulating normal and leukernic hemopoiesis are
reviewed here, with special emphasis on their potential involvement in epigenetic
regulation of gene expression through modification of chromatin structure.
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1.2.1 Definitïon, evolutionary conservation and organization of PcG proteins into
distinct multimeric complexes
In Drosophila metanogaster, the homeotic (HOIv!-C) genes are clustered in the
Antennapeclia (ANT-C) and Bithorax (BX-Ç) complexes. Parasegment ceil identity in the
somatic mesodermal tissue is achieved by differential temporal activation and spatial
distribution of the HOM-C gene products along the anterior-posterior (A/P) axis of the
developing ernbryo, in a manner that conelates with their position along the
chromosome (3’ to 5’) [1,2]. Loss- and gain-of-function of ANT-C and BX-C genes
resuit in horneotic transformations manifested by aberrant segmentation of the aduit
body [3-5]. Genetic screens in DrosophiÏa identified two distinct classes of regulatory
factors responsible for establishing and maintaining horneotic gene expression patterns.
Gap and pair-mie genes encode spatially restricted DNA-interacting factors that
establish homeotic gene expression pattems [6-8] by acting through specific cis
reguiatory chromosornal sequences named Maintenance Elements (MEs) [9-14].
However, these genes are transiently expressed during early embryogenesis, and
Trithorax Group (TrxÇ and Poiycomb Group ‘PcG,) genes are necessary to maintain
proper expression throughout the remainder of developrnent. TrxG proteins generaliy
maintain hoineobox gene transcription within previously estab lished boundaries,
whereas PcG proteins suppress previously siienced homeobox genes [15].
Genetic data in Drosoph lia revealed that the FcG genes consist of more than 30-40
members [16] (see table I). The various PcG naines originate from the ectopic
expression oforgans called sex cornbs on the second and third legs of male PcG mutants
[17]. li recent years, homologues have been found in several species such as C.eÏegans,
Zebrcfish, Xenopus, chicken, mouse, hurnan and plants (sec table I). The function of
PcG genes appears to be weil consen’ed throughout evolution. This is probably best
illustrated by the demonstration that M33, the mouse homologue of Drosoph lia Pc, can
largely rescue the phenotype of Pc mutant flics [18]. Drosophila PcG genes do not share
sequence homoiogy and their classification is based rnainly on the presence of
evolutionary conserved domains (sec table I).
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In Drosophita PcG mutants, the expression pattems of the HOM-C genes are correctly
initiated by the transiently expressed gap gene products, but afier their disappearance at
mid-gestation, [fox gene misexpression resuits in a dose-dependent change in the
identity of body segments to that ofmore posterior ones [19-21]. Similarly, mice mutant
for the Bmi-], Met-18, M33, RINGJ3 and Mphl/Rae-28 FcG genes show dose
dependent posterior homeotic transformations that correlate with the anterior shifts in
the expression boundaries of overlapping as well as distinct subsets of [fox genes [22-
26]. For example, in Bmi-1 mice, the anterior limit of expression of Hoxc5 is shifted
anteriorly by one segment, whereas the expression ofthis gene is not affected in Ivfel-]8
nuil mutants. On the contrary, Hoxc8 is shifted rostrally in both single mutant mice
[22,27]. Interestingiy, RinglA mutant mice show anterior homeotic transformations and
even though most skeletal defects are posterior in M33mice, anteriorisation of cervical
vertebrae identities (C2 into Cl) have been observed, suggesting an unusual sensitivity
to RinglA and M33 gene dosage in axial skeletai patteming [23,28]. Conversely,
transgenic mice overexpressing the 3m i_J gene present a dose-dependent anterior
skeletal transformation associated with posteriorisation of [fox gene expression [29].
Nullizygosity for the eed, Enx-] and YYJ alleles result in early embryonic lethality,
precluding analyses of any skeletal defects [3 0-32]. However, highly penetrant posterior
homeotic transformations, correlating with rostral shifts in [fox gene expression
boundaries, were observed in homozygous mice for a hypornorphic allele of ecU
(eed’989”989) [32,33]. The presence of several mammalian homologues for each
Drosophita FcG couterpart (see table I) Ïikely explains the weaker (and less penetrant)
phenotypes of mouse PcG mutants when cornpared to fly mutants (functional
redundancy). Accordingly, fly PcG mutants affect the regulation of ail HOM-C genes
whereas in mice, only subsets of [fox genes are ectopically expressed in a given PcG
mutant [21].
Evidence for strong dosage interactions between DrosophiÏa and mammalian PcG genes
is based on the synergism and increased penetrance of the horneotic defects observed
upon combining different PcG mutations [34,35]. In rnost double PcG mutant mice (i.e,
2$
Bmi-] x eed, Bmi-1 x Met-18 and Bmi-1 ï M33), exacerbation ofthe homeotic phenotype
correlates with enhanced shifts in Hox expression boundaries in the somatic mesodermal
tisstie ([36,37] and Schumacher et al., unpublished). For example, Bmi-1 and Met-18
double mutants die as early embryos (at —day 9.5 of gestation) with severely affected
Hox gene expression boundaries, whereas Bmi-Ï Mel-18’, 3mi-] Mel-18 and
3] Met-18 mutants display intermediate phenotypes [36]. The demonstrations
that double PcG mutants display Hox gene expression defects that are not observed in
the single mutants (eg. M33 Bnti-1) also suggests that PcG proteins can operate in
parallel/distinct molecular pathways [37].
The skeletaÏ defects observed in PcG gain- and Ïoss-of-function studies could lie caused
by alterations in proliferation rates ofbone precursor ceils, a process in which Hox genes
are clearly irnplicated. Although no loss-of-function mutations in human FcG genes
have been reported so far, deregulation of homeobox (Hox) gene expression lias been
observed in human congenital skeletal defects such as synpolydactyly [3$]. The fact that
only subsets of Hox genes are affected in PcG mutants might explain why only the axial
skeleton is affected in mutant embryos, whereas patteming ofthe lirnbs appears normal.
Recent observations by the Sheam laboratory, however, revealed that sorne members of
the PcG and TrxG groups (identified as Enhctneers of Trithorax anct Potycomb (ET?)),
exhibit the dual property of maintaining both activated and inactivated states of
homeotic gene expression. E(z), although classified as a Potvcomb Group (FcG,)
member, was shown to maintain activated Hox gene expression in vivo [39]. A screen
for enhancers of a TrxG member mutant, Ashl, identified several members of the PcG
farnily [40]. Accordingly, evidence indicates that TiaG and PcG members interact with
one another in the establishment of a functional regulatory complex of gene expression.
For example, Drosophila TrxG and PcG proteins where shown to colocalize at
Maintenance Elements (MEs) sites on polytene chromosomes [12,13,41,42] and genetic
interaction between the two groups has been reported in mice [43]. Finaïly, biochemical
studies showed that the PRC1 PcG complex (see below) can block chrornatin
29
remodeling by the TrxG-containing SWI/SNF complex, by occluding its access to the
nucleosomal template [44,45].
The function of the FcG/TrxG memory system is not lirnited to regulation of Hox gene
expression. TrxG and PcG proteins bind to more than $0-100 chromosomal sites in
addition to the ANT-C and BX-C complexes [41,46-50] and several nonhomeotic target
genes have been identified including the engrctiÏed and eveiz-sktped segmentation genes
[51-54]. In addition to homeotic transfomations, mutations in FcG and TrxG genes
were shown to confer pieiotropic phenotypes including: imaginai discs, hemopoietic,
cerebellar, cardiac, neural-crest, sex-reversal, srnooth muscle atrophy, and growth
retardation. In contrast to the ubiquitous expression of the fly genes, the expression
levels of mammalian PcG genes diffei- among different tissues and ccli types [55-6 1].
The heterogeneity in PcG complex composition due to tissue- and time-specific FcG
expression likely contributes to target gene specificity and explains the diversity of PcG
mutant phenotypes.
Several models have been proposed regarding the mechanism(s) ofPcG—mediated stable
gene repression. These include: (1) the establishment of a repressive chromatin structure
(through histone modifications, alteration of nucleosome positionlconformation,
interaction with chromatin condensation proteins and/or specific targeting of chromatin
remodeÏing complexes) [62-661 (2) inhibition ofchromatin-remodeling machineries [45]
(3) inhibition of the transcriptional initiation rnachinery [67-69] (4) recruitrnent of target
genes to repressive nuclear dornains [70] (5) inhibition of enhancer/prornoter
interactions due to DNA looping induced by the interaction between PcG complexes
bound at discrete chrornosomal sites [71].
The frequent co-localization of PcG proteins at distinct chromosomal loci on Drosophilci
polytene chromosomes reinforced the notion that PcG proteins act in concert to repress
gene expression [12,14,46,50,72,73]. Direct evidence for the existence of large
multimeric PcG protein complexes was obtained from imrn unoprecipitation, yeast-two
hybrid and size-fractionation experiments in flics and mammals [14,45,46,74-77].
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At least two distinct types of PcG complexes with different properties/functions can be
distinguished both in Drosophila and mammals [45,57,58,73,78-82]. The Extra Sex
Combs (Esc) and Enhancer of Zeste (E(z)) PcG proteins fonri the core of a 600 kDa
complex isolated from DrosopÏiiÏa ernbryo extracts [79,83] that includes the Rpd3
histone deacetylase, the PcG repressor Su(z)12 and p55/RbAp4s, a histone binding
protein also found in the chromatin rernodeling and chromatin assembly complexes
NURF and CAF1 [73,82,84]. The human counterpart of the DrosophiÏct Esc-E(z)
complex was recently purified from HeLa ceils and shown to contain EED, EZH2,
$U(Z)12, RbAp48 and AEBP2, a zinc finger transcriptional repressor [66]. These
complexes appear to be involved in making the “epigenetic mark” necessary for the
establishment and rnernoiy trace of the suent state and will therefore be referred to as
“PcGe” (see below). The Vav protein, a pan-hematopoietic rho family GTP/GDP
exchange factor (GEF) involved in lymphocyte selection and Antigen (Ag) receptor
mediated proliferation [$5-88] might also be included in the mammalian PcGe complex
because of its interaction with Enx-1/Ezh2 [89]. Finally, Esc/EED was shown to
physically associate with the DNA-interacting protein Pho/YY1, providing ftwther
insights into the molecular mechanisrns by which the Esc/EED-containing PcGe
complexes might be recruited to specific target genes [90,91].
The second type of PcG complexes appears to be required for stable maintenance
(PcGm) of gene silencing and is exernplified by Polycomb repressive complex 1
(PRC1), a -3 MDa complex purified from Drosophila embryos. This complex contains
the PcG proteins Pc, Ph and Psc at stoichiometric levels, and substoichiometric amounts
of Sex comb on midleg (5cm) [45,92]. The dernonstration that these proteins do not
obligatory colocalize on Drosophila polytene chromosomes [14,72] nor always co
immunoprecipitate [93] argues for the presence of multiple distincts PRC1-Ïike
complexes [14]. Biochemical studies indicate that the mammalian PcG proteins
M33/HPC1, BMI-1, MEL-18, HPHI, HPH2, HPH3, HPC2, HPC3, SCMH1, RING1A
and RING1B are constituents of heterogenous multimeric protein complex(es) (—1
MDa) that colocalize at distinct nuclear domains termed PcG bodies [56,70,77,94-98].
The DrosophiÏa sequence-speci fi c DNA-binding factors P ipsqueak, Zeste and GAGA
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coprecipitate with Pc-containing complexes and mediate their binding in vitro to ME
elements, suggesting that they may contribute to their recniitrnent in vivo [67,93,99-
101]. No mammalian homologues for these proteins have been identified so far, but
RYBP (RINGY- and YY1-binding protein), which does not seern to be present in
Drosophila, binds RING1A, RING1B, M33 and YY1, and represents a potential
targeting factor [102]. Sirnilarly, E2F6, a weak transcriptional repressor preferentially
expressed in human CD34 bone rnarrow progenitor cells [103], interacts with Bmi-1
and may be involved in recruiting the complex to relevant target genes, such as p]9’1’
[104,105]. The PLZF (prornyelocytic leukernia zinc finger) protein was shown to
mediate transcriptional repression of HoxD cluster genes through the recruitment of the
Bmi-1-containing PcGm complex [106]. Also associated with mammalian PcGm
complexes through direct interactions with the HPC2 and RING1B subunits are the C-
terminal binding protein (CtBP) co-repressor [107] and Mel-1$ and Brni-1-like RING
finger (MBLR) proteins, respectively [10$].
Evolutionary conservation of PcG complexes
The PcGe complex appears very “ancient” in evolution and is well conserved in lower
organisms where it fulfills an important role in maintaining gene silencing in the
germiine. In C. elegans, the Esc- and E(z) related proteins MES-6 and MES-2 forrn a
stable complex of approximately 255 kDa [109] which is required for germ-line
developrnent [110,111]. The conseiwed partnership extends to plants (Arabidopsis),
where proteins related to Esc, E(z) and Su(z)12 are cohort regulators in repressing seed
proliferation prior to fertilization [112]. The apparent absence of core PcGm
homologues in worms and plants implies that the Esc-E(z) PcGe complex can repress
gene expression independently of the PcGm complex. Further work in these systems will
address whether the Esc-E(z) complex-associated histone methyltransferase (HMTase)
activity represents an evolutionarily conserved “ancient” mechanisrn to mark chromatin
for heritable repression during developrnent.
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Synergy between ESC-E(Z) and PRC1 complexes
Despite biochemical and evolutionary distinctions between the Esc-E(z)/PcGe and
PcGm complexes, it is clear that they work together to repress gene expression in vivo.
As loss-of-function mutations in Esc, E(z), Pc or ph produce severe posteriorization
phenotypes on their own, removal of one PcG component from either complex is
sufficient to collapse the entire repression system [16]. Accordingly, E(z) function is
required for chromosome binding ofPc, Psc and Su(z)2 in DrosophiÏa embryos [72,113]
and in vivo repression by artificially tethered Pc or Esc depends upon endogenous PcG
components of both the PcGe and PcGm complexes [91,114-116]. This functional
interdependence between the two PcG complexes could be explained by a direct but
transient contact between Pc, Esc and E(z) specifically in extracts from preblastodemi
(O-3hrs) fly embryos [91] or, altematively, reftect an important function of E(z) in
modifying the template to allow stable binding or action of the PcGm complex (sec
Fig.1.1). Further work is needed to clearly establish whether PcG-mediated silencing
involves transient physical and/or functional interactions between the two PcG
complexes (sec Section 5).
PcGm
ÇM33 cl-I8
NURD /(Bfl1,
J iCi
i2 /
MAINTENANCE ELEMENT (ME) TATA
Fig. 1.2 Schernatic representation of the functional interaction between the PcGe and
PcGm complexes in regulating gene expression through epigenetic modification of
chrornatin structure. Ac, acetylated group; Me, rnethylated group; K27-H3, lysine 27 of
histone 3.
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1.2.2. PcG-mediated regulation of HSC!progenitor seif-renewal and proliferation
Hemopoietic stem ceils (HSCs) are characterized by their ability to generate, in a
controlled fashion, ail of the bÏood ceil lineages and maintain their original pooi through
seif-renewal. Prevailing moUds indicate that HSCs achieve this through a series of
binary decisions during which progressively restricted precursors commit to alternative
ceil fates. These developmental transitions -characterized by the acquisition and loss of
expression of lineage-specific genes- correlate with a decrease ability to reverse the
lineage choice and terminal differentiation to a specific blood ceil type. Aithougli much
progress has been made in identifying the cytokines and cell-adhesion molecules
controlling HSC lineage decisions/commitment, littie is known about the intrinsic
genetic/epigenetic mechanisms regulating the self-renewal/proliferation outcomes of the
H$Cs. Importantly, abnonnal regulation of HSC seif-renewal and/or proliferation
invariably leads to a variety of hernopoietic disorders, ranging from aplastic anemia to
leukemia.
Compelling evidence indicates that the PcG genes are involved in normal and leukernic
hemopoiesis, through epigenetic regulation of HS C/progenitor seif-renewal and
proliferation. We recently reported that Bini-] expression is restricted to primitive
human (CD34 CD45 CD7F) and mouse (Sca-1 Liiï) bone marrow celis [59,81].
Nuïlizygosity for the Bnti-] gene in mice leads to severe aplastic anemia due to a
progressive impainhient of HSC function [25,81,250,251]. Consequently, Bmi-] nuil
mutants surviving beyond the first week of birth suffer from pneumonia and infections
of the intestinal tract and die within 20 weeks of birth. Bone rnairow-derived progenitors
lacking Biiti-] are severely reduced in numbers and in their proliferative potential [25].
Furthennore, the number and proliferative capacity of primitive myeloid (LTC-IC) and
lymphoid (WW-IC) boue marrow progenitors in these mice are severely reduced to 4%
and 1% of wild-type levels, respectively [81]. The proliferative defect in progenitors
derived from Bini-i El4.5 fetal livers (FLs) is much less pronouuced than that
observed in the bone marrow, suggesting a progressive impainrient of the proliferative
potential of hemopoietic cells lacking this gene [25,81,250]. Retroviral expression of
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Bmi-] in Bmi-T’ fetal liver celis completely rescued the absolute numbers of high and
low proliferative potential myeloid colony-forniing celis (HPP- and LPP-CFC) to wild
type levels, indicating that Bmi-J is dispensable for the generation of FL-derived
rnyeloid progenitors, but absolutely essential for their full proliferative activity [250].
Sirnilarly, an experiment performed by our grotip confirrned the presence of normal
numbers of long-terni repopulating HSCs in Bnii-i’ fetal livers whose detection, at 16
weeks post-transplantation, vas strictly dependent on the retroviral expression of Bmi-]
[250]. Clarke and colleagues recently dernonstrated an inability of 3M and fL-derived
B,nj] celis to contribute to long-terrn hemopoiesis in reconstitution (fL and BM) as
well as competitive (FL) experiments, suggesting a ceil autonomous impairment of their
self-renewal/prohferation potential [251]. A detaiÏed structure to function study
describing the essential domains of Brni-1 for its function in FL-derived HSCs is
ongoing and should be reported shortly.
The PcGm-containing Mphl/Rae-28 protein also plays a key role in the regulation of
fetal liver-derived H$C function. This was first dernonstrated by a progressive
irnpairment in the numbers and proliferative potential of E14.5 FL-derived colony
forming-celis (CFC5) in Mph]/Rae-28 mutant ernbryos when compared to wild-type
littermates. The absolute number and proliferative potential of primitive myeloid long
term-culture—initiating ceils (LTC-ICs) and colony-forming units in spleen (CFU-S12)
are aÏso severely decreased (up to 20-fold) in A/fpÏll/Rcte-28 fetal livers when compared
to controls. Moreover, serial fL cell transplatation experirnents performed at limiting
dilution (LD) in sublethally irradiated congenic mice demonstrated a 15-20-fold
decrease in CRU content/proliferative activity in Mph1/Rae-28 embryos relative to
controls. These studies indicate a crucial role for Mphl/Rae-2$ in sustaining the activity
of HSCs during fetal hemopoiesis [117] and rnight explain the severe splenic/thyrnic
hypoplasia and perinatal lethality observed in Mplil/Rae-28’ neonates [24,1171.
In contrast to PcGm alleles, heterozygosity for a null allele of the ectocterm embiyonic
developnient gene (eed3354j in mice causes marked rnyelo- and lympho-proliferative
defects (3-fold increase in primitive (LTC-IC and WW-IC) and 19-fold increase in late
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(rnyeloid and pre-B CFC) bone marrow progenitor celi numbers on average), indicating
that the PcGe-containing Eed protein plays a crucial role in the negative regulation of
the proliferative capacity of both Ïymphoid and n;yeloid progenitor celis. This
antiproliferative function of Eed does not appear to be mediated by Hox genes or the
INK4a-ARf tumor suppressor locus, because expression of these genes was not affected
in eed mutants [81].
The studies described above indicate critical differences in the function of PcG proteins
belonging to the PcGe and PcGm complexes and point to an unexpected complexity of
PcG function in hemopoiesis. First, Eed (PcGe-containing) and Bmi-I (PcGm
containing) proteins represent functional antagonists in hernopoietic ceil proliferation.
Whereas Eed acts as a negative regulator of hemopoietic progenitor celi proliferation,
Bmi-I enhances the proliferative activity of primitive [$1] and more mature [25] bone
rnarrow progenitor celis. Intercross experiments between eed and 3mi] mutant mice
revealed that Bmi-1 is epistatic to eed in the control of primitive bone marrow ccli
proliferation. However, the genetic interaction between eed and Bmi-] is celi-type
specific, as the presence of one or two mutant alleles of eed trans-complernents the Bmi
J deficiency in pre-B bone rnarrow celis [81]. Thus, hernopoietic ceil proliferation in
mice seems to be regulated by an intricate equilibrium between enhancing (Bmi-1-
containing) and repressing (Eed-containing) PcG protein complexes.
Several observations also support a role for FcG genes in abnormal (leukernic)
hernopoiesis through the regulati on of HSC self-renewal/proliferation. Hypornorphic
alleles of the inulti sex combs (mxc) gene in Drosophila resuit in premature haemocyte
differentiation and tumourous overgrowth of the larvai hemopoietic organs [118,119].
Enx-1 directly associates with Vav, the product of a protooncogene that is required for
antigen receptor-mediated B- and T-lymphocyte proliferation [87,89]. Overexpression of
3,iii—J in the lymphocyte compartmnent in mice (using the immuiiogÏobin heavy chain
enhancer (Ezt)) leads to the development of B and T celi lymphoma [120,121]. The
human 3h-] gene has been located on chromosome i0pi3, a region involved in
chrornosornal transiocations in infant leukernias [122], rearranged in adult malignant T
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celi lymphomas [123] and amplified in occasional non-Hodgkin’s lymphomas (NHLs)
[124,125]. li particular, it lias been proposed that 3h-] gene alterations may contribute
to the pathogenesis of malignant 1y’mphomas of the mantie cell type (MCL) [126] and
amplification of the 3h-] gene bas been reported in a specific subset of MCLs with
blastoid transformation [124]. The human HPC3 protein interacts witli ENL and AF9,
two common fusion partners of the human TrxG protein MLL in 1 1q23 translocations
that are associated with highly aggressive acute leukemias in infants, suggesting a direct
role for PcG proteins in MLL-associated chuldhood leukernias [127,128]. Although no
direct tumorigenic properties for EZH2 have been found, its location at 7q35 suggests
that it might be involved in 7q35-q36 aberrations in human myeloid leukemia [129].
Finafly, HPHJ/Rae-28 is Ïocated on chromosome Ï2pl3, a region that is frequentÏy
involved in chromosome abnormalities and loss of heterozygosity (LOH) in a variety of
malignant hemopoietic diseases, including ALL [130,131].
An emerging concept in the field of cancer biotogy is that a rare population of “turnor
stem cells” exists amongst the heterogeneous group of ceils which constitutes a tumor.
These “turnor stem ceils” have mostly been characterized in human leukemias whose
transplantability (self-renewal capacity) depends on the rare “leukernia stem celi” which
shares common phenotypical characteristics (e.g., CD34CD3 $) with normal
hemopoietic stem celis. These biological and phenotypical sirnilarities between normal
and leukemic stem celis raise the possibility that the stem ceÏl function (whether normal
or neoplastic) is defined by a common set of critical genes. Evidence that Bmi-] might
be such a common regulator includes: (j) Bmi-] expression is restricted to primitive bone
mairow celis in both humans and mice [59] but is also expressed in all myeloid
leukemias analyzed to date [59,250] and (ii) Bmi-1 is essential for adult-derived
hernopoietic stem cell function (see above). Our recent studies demonstrated that Bmi-]
is dispensable for the generation of hemopoietic stem celis and for their transformation
into leukemic stem ceils (L-HSCs). However, 3mi] is essential for the full proliferative
activity of both normal and leukemic stem and progenitor cells. In 3nii-1 leukemias,
both groups of cells eventually undergo proliferation alTest and manifest signs of
differentiation and apoptosis, leading to transplant failure of the leukernias in syngenic
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hosts. Complementation studies indicate that Bmi-1 can cornpletely rescue the
proliferative defect of both normal and leukemic Bnii-] stem ceils [250]. These
findings clearly integrate Bmi-1 in a growing family of genes (also inciuding MeisÏ, N.
Copeland, personal communication) required for fetal hemopoietic stem ce!! function,
but dispensabie for their generation. Moreover, they also provided molecular evidence
for the emerging concept that the molecular machinery regulating normal hemopoietic
stem celi activity is critical for the maintenance of the leukemic phenotype in vivo. The
apparent difficuities of bypassing the requirernent for Bmi- 1 in leukemic
stem/progenitor celis in vivo suggests that adroit rnolecular targeting of Bmi-1 in
leukemic stem/progenitor celis may have potent and specific therapeutic effects.
Although Hox genes are best known for their role in the specification of the antero
posterior (A/P) axis, it is now becoming clear that Hox genes also play a part in
determining celi fate in several other tissues, including blood [132-134]. By anaiogy to
their role in skeletal developrnent, some evidence indicates that PcG genes rnight be
invoived in hemopoiesis through the regulation of Hox gene expression. In sharp
contrast to the expression of HoxA and B ciuster genes which is highest in the most
primitive bone rnanow cells [135], differentiation of primary human bone maow celis
is accornpanied by a rnarked up-regulation in PcG gene expression leveis inciuding
M33, MEL-]8, HPHi and ENX-i/EZH2 [59]. Only BMI-i exhibits a different patteni of
expression with high levels in primitive CD34 ceils and very low levels in mature
CD34 celis (see above) [59]. These data are consistent with a role for PcG proteins in
regulating differentiation and/or proliferation of human hemopoietic celis by silencing
Hox gene expression. Similarly, the MeÏ-i8, Bmi-], M33 ctnd Mphl/Rae-28 PcG genes
were shown to be rapidly activated upon antigenic stimulation of lymphoid B ceils and
are considered as immediate eariy genes [136]. This contrasts with the ubiquitous
expression of the PcG genes in Drosophita syncytial blastodenits [137] and thus point to
an important mechanism for regulating PcG gene functions in differentiating bone
marrow celis [59]. Interestingly however, no evidence for Hox gene misexpression in the
hemopoietic tissue of PcG mutant mice has been reported yet, even though such a foie
bas been suspected [81,117]. Extensive analyses ofHox gene expression levels in highly
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purified subpopuÏations ofhemopoietic ceils isolated from FcG mutant mice is awaited
in order to resolve this issue.
1.2.3. Regulation ofsenescence: the PcG and INK4a/ARF connection
The murine 3m i-J gene was first isolated as an oncogene that cooperates with c-myc in
the generation of mouse B and T celI lymphomas [120,138,139]. The synergisrn in
lymphomagenesis bas been confirmed by the generation of Bmi-1/c-myc double
transgenic mice that die from massive leukernia as newborns [120]. It was later
established that the INK4a-ARf tumor suppressor locus is a critical in vivo target of
Brni-1 [140] and that the ability ofBmi-Ï to collaborate with c-myc in lymphomagenesis
relies on the inhibition of c-rnyc-induced apopotosis through the INK4a-ARF pathway
[141]. This connection is of considerable interest since this locus encodes the main
regulators of the imrnortalizationlsenescence checkpo int in rodent and human primary
celis (reviewed in [142]). The INK4a-ARf pathway functions as part of a fail safe
mechanism that is triggered by inappropriate mitogenic signaling, stress invoked by
unnatural in vitro culture conditions or as primary ceils approach their maximum
number of ceil divisions. The early work of Hayftick dernonstrated that prirnary ceils in
culture have a finite replicative potential [143]. Once such ceil populations have
progressed through a certain number of dociblings, they stop growing, a process terrned
senescence [144,145]. In cultures of human fibroblasts, the senescence checkpoint can
be circurnvented by disabling the Rb and p53 tumor suppressor pathways, thus enabling
the celis to continue proliferating for additional generations, until they enter a second
state termed crisis. The crisis state is characterized by massive ceil death, karyotypic
disarray associated with end-to-end fusion of chromosomes, and the occasional
ernergence ofvariants (lin ceils) that have acquired the ability to multiply without
limit, a trait termed immortalization [146]. The INK4a-ARF-encoded 161NK4a and
19ARF tumor suppressor proteins are known to impair CDK4 and CDK6-induced
phosphorylation of Rb and prevent the functional inactivation of p53 by binding to
Mdm2, respectively [147-151]. In absence of Bmi-1, primary motise embryonic
fibroblasts (MEFs) are impaired in progression into the S phase of the ceil cycle and
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undergo premature senescence [140]. In these flbroblasts and in Bmi-]-deficient
lymphocytes, the expression of the turnor suppressors 16INK4a and p19’ is raised
markedly. Conversely, overexpression of 3m i-1 in MEFs was found to down-regulate
the expression of 16INK4a and 19F, delay replicative senescence and facilitate
immortalisation [140]. Similarly, overexpression of 3mi1 in prirnary hurnan fibroblasts
was shown to extend their replicative life-span (via its RING finger and helix-tum-helix
domains) by suppressing the p16i4adependent senescence pathway [152]. ftnportantly,
epigenetic and genetic abrogation of CDKN2A (pl6INK4a) and CDKN2B (p19) are
common lesions associated with poor prognosis in several human leukernias and mouse
leukemia models [153-157].
Recent evidence indicated that H$C homeostasis/quiescence is maintained by a
dominant antiproÏiferative tone mediated by critical molecular checkpoints in the celi
cycle machinery and excessive HSC cycling may lead to stem ceIl exhaustion [158,159].
The deleterious effects of excessive HSC cycling may resuit from accelerating the
rnechanisms that cause normal aging in a manner analogous to the Hayftick ceiling
identified for proliferation of untransforrned fibroblasts (MEFs) [143]. Although not
investigated in HSCs, inactivation of the INK4a-ARf pathway drarnatically reduced the
hernopoietic ceil proliferation defects of Bmi-1 null mutants, indicating that INK4a/ARf
is a critical in vivo downstream target for Bmi-1 in the regulation of hemopoietic ceil
proliferation [140]. This change in defects vas evident in CD4CD8 double positive T
+ +
ceils as well as in mature 3220 sIgM B celis [140]. In Bmz-1 E14.5 total FL celis,
j94RF expression was undetectable but j6h1hi’4a ÏeveÏs were cÏearly elevated (Clarke et
al., submitted). Interestingly, p16”4 and p191’ levels appeared normal in total E14.5
fetal liver ceils isolated from Mph]/Rae-28 nuil mice when compared to that of control
littermates [117]. These studies underscore the importance to investigate a putative role
for the INK4a-ARf pathway (and other CKIs) in the proliferative impairment of the
HSCs deficient for the Bmi-1 anct MpÏil-Rae28 gene products [81,117,250,251].
Irnportantly, the aging of prirnary human fibroblasts is accornpanied by decreased 3mi]
expression (both at the RNA and protein level) [152,160] and accumulation ofpl6l4a
and 19ARF [161]. It xviii thus be of interest to verify whether the Brni-1-containing
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PcGm complex is part of an evolutionary conserved ‘c1ock” rnechanism that counts
primitive HSC divisions.
The observation that MeÏ-18 MEfs also express elevated levels ofp16”4” raises the
possibility that the INK4a-ARf locus represents a more general target ofPcG function.
Importantly however, the INK4a-ARf locus does not account for ail of the hernopoietic
and neuroÏogical defects observed in Bmi-1 nuli mutants [140] and the horneotic
phenotype of Bmi-] mutants rernains unaffected by genetic deletion of the INK4a-ARf
pathway, indicating that additional cell-context-dependent targets of the Bmi- 1-
containing PcGm complex remain to be identified. Interestingly, expression ofthe T-box
protein TBX-2 cati bypass the senescence arrest of Bini-] primary fibroblasts (MEF5)
by down-reguiating 19ARF expression levels [162] and overexpression of the anti
apoptotic Bd-2 oncogene in Bmi-1 deficient mice (using a Eu-bct2-36SV transgene)
partially rescued the hemopoietic defecis, indicating that increased apoptosis may
contribute to the Bini-]’ phenotype [141].
1.2.4. PcG-mediated repression: a llnk with the basal transcription and chromatin
assembly/condensation at mitosis?
Recent evidence suggests that PcG-mediated gene silencing is linked to general
chromatin condensation during celi cycle progression and that perturbation of this
regulatory system leads to genome instability and cancer. Mutations in the Drosophikt
centrosonzal anci chromosoniat factor (‘ccJ) gene, which encode a protein required for
normal chromosome condensation during mitosis, enhance Pc, ph, and E(’z) phenotypes
and Ccf colocalizes to some Psc binding sites on polytene chromosomes [163].
Similarly, it has been demonstrated that ME function depends partly on the Barren and
Topoisomerase II proteins required for proper chromatin condensation at mitosis [62].
Barren and Topo II colocalize with PcG proteins at MEs in the bitIiorcc complex and
specificaily immunoprecipitate with Ph. Mutations in bctrren Iead to de-repression of the
Fab-7 ME in vivo and en]iancement of a homeotic phenotype [62]. Aithough the
repression mechanisrn is still iiot ciear, a role for condensins in interphase geïie
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repression has ample precedent in C. etegctns dosage compensation (reviewed in [164]).
Intriguingly, ph and barr mutant embryos display similar chromosome segregation
defects, suggesting that the Ph-Barren interaction somehow contributes to genome
stability [62,165]. Detemiining if this level of epigenetic regulation is rnisregulated in
leukernia and solid cancer will be a priority of future work.
Recent studies also stiggested that FcG-mediated silencing might involve inhibition of
general transcription factor (GTF)-mediated transcriptional activation. PRC1 was found
to associate with stoichiometric amounts of 6 TBP (TATA-binding-protein)- associated
factors (dTAfs) that are components of the general transcription factor TFIID in fty
embryo extracts [67]. Analysis of cross-linked chromatin detects colocalization of Pc
and Ph with TBP, TFIIB and TFIIF on Hox prornoters in cultured fly celis [69]. Two of
the six TAFs found in PRC1 are histone-fold proteins that could aÏso assist PRCÏ-DNA
contact. These resuits suggest that maintenance ofthe silenced state by PcGm complexes
might involve inhibition of GTf-mcdi ated transcriptional activation.
Similarly, Xenopus Eed (Xeed) directly interacts with TAF1132 [6$], a component ofthe
general transcription factor TFIID complex [166]. It has been proposed that this
interaction rnight impair gene activation by inhibiting the assernbly of the transcription
initiation complex at promoters or occluding its interaction with co-activator proteins
[68]. Intriguinly, a region of MLL (the hurnan homologue of DrosophiÏa Trithorax, also
referred to as ALL-1 and HRX) that is required for its transcriptional activation function,
binds specifically to human TAF1131 [167] and the co-activator CBP [168,169].
Therefore, Esc/EED may antagonize MLL function by inhibiting its association with
TAF5 and/or CBP proteins bound at prornoters. Validation ofthese possibilities requires
further investigation.
Relevance to hemopoiesis and cancer
Some evidence indicates that PcG genes are involved in leukernogenesis and the
development of solid tumors through an epigenetic silencing mechanisrn involving
interactions with the general transcription machinery and/or co-activator/co-repressor
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molecules. First, dE(z) physically interacts with the dSAP1$ protein, a component ofthe
Sin3 -HDAC co-repressor complex [170]. Furthermore, mice with monoallelic
inactivation of the co-activator C’BP gene develop highly penetrant, multi-Ïineage
defects in hemopoietic differentiation and, with advancing age, an increase incidence of
hematologic malignancies. The latter are characterized, at least in some cases, by loss of
heterozygosity (LOH) at the (‘3F iocus, suggesting that CBP has tumor-suppressing
activity [171]. The association of dCBP with TrxG proteins has been implicated in the
maintenance of Hox gene expression pattems [172,173]. Chrornatin-related properties of
CBP fused by the t(11;16)(q23;p13) transiocation to MLL generate a myelodysplastic
like syndrome that evolves into rnyeloid leukemia in mice [174] and is associated with
cases oftherapy-reÏated acute leukernia and myelodysplasia in humans [175-178].
Overexpression of the SET domain-containing EZH2 PcGe-containing protein was
recently dernonstrated in honnone-refractory, metastatic prostate cancer and EZH2
protein levels correlated with adverse prognosis. Ectopic expression ofEZH2 in prostate
ceils induces transcriptional repression of a large cohort of genes, (whereas no genes
appeared to be activated with the exception ofEZH2 itselO, consistent with a functional
role for EZH2 as a general transcriptional repressor in tumor celis. Gene silencing by
EZH2 seerns to involve an epigenetic mechanism since it requires the HMTase SET
domain and is attenuated by inhibiting histone deacetylase activity. These observations
suggest that epigenetic gene silencing caused by dysregulation of EZH2 expression may
be associated with prostate cancer progression [179].
The rnyeloid- and lyrnpho-proliferative defects obseiwed in eecÏ mutant animais (see
above) together with the increased susceptibility of these mice to develop hemopoietic
tumors [$1] would suggest that the Eed PcGe-containing protein complex bas tumor
suppressive activity. Accordingly, it has been demonstrated that heterozygous and
homozygous mice for a viable hypomorphic eed1989 allele have an increased incidence
and decreased latency of N-rnethyl-N-nitrosourea (IvINU) [180] and y-rays (J.L and
G.S., unpublished results)-induced B and T ccii lymphoma when compared to wild-type
Ïitten-nates. The requirement for exposure to genotoxic agents and the relativeiy long
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latency before tumor deveioprnent indicate that additional genetic events are required for
the “full transformation” of iyrnphoid ceils lacking a functional eed gene. Because point
mutations at the eecl gene locus that account for the hypornorphic (‘eed’989,) and nuil
(eed3354,) aileles were shown to disrupt its interaction with Enx, it will be interesting to
detennine whether Enx-1/EZH2 and/or Enx-2/EZH] mutant animais aiso deveiop
turnors, thereby ascribing the turnor-suppressor function to the Eed-Enx PcGe complex.
Furthemiore, the recent finding that the Eux-1 /EZH2 -histone methyltransferase
(HMTase) activity towards lysine 27 (Lys27) of histone 3 (H3) is Esc/Eed-dependent
[66] suggests epigenetic chromatin modification as the underlying mechanism
responsibie for increased turnor susceptibiiity in eed mutant animais (Lessard et ai.,
ongoing studies).
1.2.5. Epigenetic modifications of histone tails by PcG proteins convey stable
inheritance of the silenced state: a role in hemopoiesis?
Modification of the histone taiis by acetylation, phosphoryiation and methylation is
beÏieved to generate a histone code, which may regulate gene expression by controliing
the organization of the chromatin fiber into higher order structures [181,182]. Histones
codes that are frequently found in inactive and suent genetic loci- and that are enriched
in heterochromatin- include histone deacetylation, acetylation on lysine 12 (Lys 12) of
histone H4 and methylation on Lys9 of H3. Histone codes that correlate with gene
activity inciude H3 acetyiation on Lys9 and Lys 14, H3 (poiy)-methyiation on Lys4, H4
acetylation on Lys5 and H4 methyiation on arginine 3 (Arg3) [182]. There are strong
indications that PcG complexes suppress gene activity through such epigenetic
modifications. The apparent dissociation of PcG complexes from chromatin during
mitosis implies that an epigenetic rnechanism is used to “mark” suent loci for
refonnation of the appropriate PcG complexes after mitosis [183-185]. The
dernonstration that ectopic expression of horneotic genes caused by removal of Psc and
its homologue Su(z)2 can be reversed if the depleted protein is supplied within a few ceil
generations, provides further evidence for an heritable mark for PcG-mediated
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repression that can persist, at least for a few generations, on genes that are de-repressed
[186].
Methylation
The SET domain is an evolutionarily conserved sequence motif initially identified in the
Drosophila position effect variegation (PEV) suppressor Su(var)3-9 [187] (not a PcG
member), die PcG protein E(z) [188] and the IrxG protein Trithorax [189]. In
eukaryotic celis, the histone methylase SuV39H1 and the methyl-lysine binding protein
HP1 functionally interact to repress transcription at heterochromatic sites. SuV39HI
methylates Lys9 of histone H3 (through its SET dornain and its two adjacent cysteine
rich regions) [190] creating a binding site for the chromodornain of HPÏ [191,192].
Although HPI is not a PcG member, the sirnilarity of its chromodomain with that of
Polycomb (Pc) itself originally led to the proposaI that PcG proteins might alter
chromatin structure at target loci [193].
In addition to heterochromatin silencing, recent studies indicate that HP1 is involved in
silencing of specific genes in euchromatin. It was found that Rb (through its pocket
dornain) associates with SuV39HI and HP1 in vivo to regulate expression ofthe cyclin E
gene [194]. The observation that histone H3 methylation and HP1 binding is
significantÏy reduced at the cyclin E promoter in the absence of Rb suggests that
deacetylation of histone H3 at Lys9 by Rb-associated deacetylase activity (HDAC) is
required as a preceding step to SuV39HY-mediated methylation at euchrornatic sites.
Accordingly, methylation by SuV39H1 cannot take place on an already acetylated lysine
[190]. It wilI be interesting to unravel the rnechanism(s) by which this Rb-mediated
repressive effect at the cvcÏiii E locus can be re-established at every ceil cycle event. 0f
interest, HP] genes (such as HP]”5° HP]”5 and HP]”S’?), like most PcG genes, are
also preferentially expressed in mature subpopulations of human bone rnaiow cells,
suggesting that they might be involved in epigenetic regulation of progenitor cell
proliferationldifferentiation [59].
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Furthermore, evidence suggests that histone H3-K9 methylation may also contribute to
chromosomal targeting of components of the PcGm complex. HPC2, Brni-1 and
M31/HPI (but flot M33/mPcI) were shown to physically associate with SuV39H1 in
vivo. Overexpression Su V39H1 (but not an enzymatically inactive mutant) induces
selective nuclear localization ofHPC2, Bmi-1, RING1 and HPH1/2 (but flot EED/EZH2
and HPC1) PcG proteins to large pericentromeric heterochromatin domains at position
1q12 on human chromosome 1 that show increased H3-K9 methylation [195].
Interestingly, these domains are also observed in the osteosarcoma celi irne U2OS and
are remarkably similar to the PcG domains observed in HT-1080 ceils [57,70,94,95].
These observations may suggest a rote for the SuV39H1 HMTase and histone H3-K9
methylation in the targeting of human PcGm proteins to modified chromatin structures
[195].
The presence of a SET domain in the Drosophila E(z) and its human counterpart EZH2
[196] raised the possibility that the Esc-E(z) and EED/EZH2 PcGe complexes rnight
also have histone methyltransferase (HMTase) activity. A Drosophikt Esc-E(z) complex
containing the histone binding proteins RbAp46/RbAp48 and the PcG repressor Su(z)12
was recently reported to display HMTase activity towards Lys27 (K27) and Lys9 (K9)
ofhistone H3 [78]. Mutations in the SET dornain ofE(Z) dismpted the HMTase activity
ofthe complex, leading to Hox gene misexpression in vivo. Importantly, methylation on
H3-K27 faciÏitated the binding of Polycomb (Pc), a component of the PRCÏ (PcGrn)
complex, through its chrornodomain [66]. Depletion of Esc (using the RNA interference
(RNAi) system) resulted in greatly reduced ME binding by E(z), Ïoss of H3-K27
methylation, and concomitant loss of Pc binding [66]. Recruitment of PRC 1, in turn, is
known to prevent the access of micleosome remodeling factors, such as SWI!SNF
[44,45], leading to the formation of a repressive chromatin state. A second Drosophita
Esc-E(z) complex containing the same subunits, in addition to the histone deacetylase
Rpd3 protein, was also purified by Pirotta and colleagues and shown to methylate H3-
K27 as well as trimethylate H3-K9. Irnportantly, the methyl H3-K27 rnoiety was shown
to make the major contribution to Pc affinity for histone H3. Since the MTase activity of
recombinant E(Z) was stiictly dependent on the presence of the Esc and RbAp48
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subunits in vitro, these two WD4O domain-containing proteins likeiy mediate the
interaction with histone H3, while the E(z) SET domain is responsible for the catalytic
activity [84]. Similarly, a human EED/EZH2 complex was recently purified from HeLa
ceils and shown to specifically methylate nucleosomal histone H3-K27 [66]. A recent
report presented evidence that Ezh2-mediated methylation of H3-K27 is required foi
normal Igli rearrangement in pro-3 celis and thus terminal B celi differentiation [197].
Although the K27 rnoiety of histone H3 appears to be the major site of methylation by
E(z) [66,82,84], some studies also reported E(z)-mediated H3-K9 methylation [78,84].
One possibility is that methylation of H3-K9 by E(z) is nonspecific due to relaxation of
substrate specificity under in vitro experimental conditions. Altematively, E(z)
interacting factors and/or specific histone modifications within the nucleosome (specific
histone code) rnight modulate the affinity of E(z) towards either residue. Nevertheless,
these observations identify E(Z) and EZH2 as PcG proteins with HMTase activity and
clearly in;pÏicate E(Z)\EZH2 methylation ofhistone H3 in PcG silencing.
Although the studies described above indicate that methylation of H3-K9 and K27
functions as a repressive mark, not ail lysine methylation appears to be a signal for
repression of transcription. It was shown recently that methylation of histones H3 (Lys4
and Lys9) and H4 (Lys2O) by the DrosophiÏa epigenetic activator Ashi serves as a
binding surface for a chiomatin-remodeÏing complex containing the epigenetic activator
Brahrna (Brrn) [198]. Another study reported that the S. cerevisiae Seti protein catalyses
di- and tri- methylation of H3-K4 and activates gene expression [199]. Sirnilarly,
Drosophila Trx and its mammalian counterpart MLL/ALL-11HRX were shown to
possess HMTase activity toward H3-K4 via their SET domain [84], leading to
transcriptional activation at Hox gene promoters [200,20 1]. This antagonism between
H3-K9 (negative) and H3-K4 (positive) HMTases on chromatin modulation is beeing
unraveled at the biochernical level: whereas H3-K9 methylation generates a binding
affinity for “repressive” HP1 proteins (see above), H3-K4 methylation prevents
association of the negatively acting nucleosome remodeling and histone deacetylation
(NuRD) complex [202,203]. Furthermore, H3-K4 methylation is hown to impair H3-
K9 substrate recognition by the “repressive” Suv39hl HMTase [202]. It is thus likely
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that PcG and TrxG complexes containing the SET-dornain proteins E(z), ASH-1 and
MLL/ALL-1/HRX use the methylation H3-K9/H3-K4 antagonism to transduce their
opposing epigenetic signais at target loci during embryonic deveiopment.
Histone deacetylation
Besides hi stone methylation, genetic and biochernical tests associ ate histone
deacetylation to PcG-mediated repression [63,73,92] and hyperacetylation to TrxG
dependent active states [173,204]. First, some evidence link the Drosophila Esc-E(z)
and mammalian EED/EZH2 complexes to histone deacetylases (HDACs)
[63,73,78,84,170]. However, the data gathered to date suggests that the interaction with
HDACs may be transient or that biochernically distincts ESC/E(Z) complexes may exist
[66,78,82]. Second, Drosophita dMi-2 (a Hunchback-(Hb) interacting protein)
genetically interacts with PcG members in enhancing horneotic transformations [65].
Similarly, mammalian Mi-2 and Hunchback-like proteins are part of a complex with
histone H3 and H4 deacetylase and ATP-dependent nucleosome remodeling activities
(NuRD) [205-207]. As direct evidence for a physical interaction between Mi-2 and PcG
proteins is still lacking, it has been proposed that the NuRD complex may induce local
chromatin change (such as histone deacetylation) that allow and facilitate the
recruitment of PcG proteins. Third, current evidence for the involvement of histone
deacetylation in FcG silencing in vivo came from the demonstration that HDAC1 is
recrujted to chromosome sites that harbor ectopic MEs [92]. HDAC1 was shown to
cofractionate with the Drosophila PRC1 complex [67,92], although further studies are
needed to address whether the purified complex tnily possesses histone deacetylase
activity [67,92]. literestingly, although Hox tepression does flot appear compromised by
HDAC] mutations alone, enhanced homeotic phenotypes were observed in HDACJ/FcG
dotible mutants [92]. Further evidence of a role for HDACs in PcG function in vivo
arises from studies of mitotic inheritance of the fAB-7 ME showing that its activation,
by transient expression of GAL4 early in embryogenesis, is accompanied by an increase
in histone H4 acetylation [204].
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We conclude that a combination of histone marks could be a major factor in the
establishment of stable pattems of horneotic gene expression and constitute the
molecular basis of the PcG/TrxG ceÏÏuÏar mernory system. Moreover, as histone
modifications can be synergistic or antagonistic to each other, it will be important to test
for regulatory interactions, or crosstalk, among the various tau modifications (reviewed
in [20$]). For example, phosphorylation of serine (Ser) 10 on histone H3 is
synergistica]ly coupled to the acetylation of Lys9 and/or Lysl4 but antagonizes the
methylation of Lys9 on the saine histone [209]. Likewise, interplay between phospho
H3-S2$ and methyl-H3-K27 could resemble the inhibitory crosstalk between phospho
H3-Sl0 and rnethyl-H3-K9 [190]. In this view, kinases and phosphatases would be
expected to provide regulatory imputs to the PcG/TrxG system. To date, no histone
dernethylase lias been identified suggesting tliat histone metliylation bas a more long
lasting impact on the chrornatin structure than acetylation [210]. Interestingly, H3-K9
metliylation bas been shown to trigger DNA CpG methylation in lower organisms
[211,212]. This is consistent with other “chromatin-driven” models of gene regulation
wliere plant mutants for the Swi/Snf-like component ddm] [213] or the E(z) homologue
curlv leaf [214] were shown to affect DNA CpG methylation. It will also be important to
detennine whether additional PcG/TrxG proteins possess and/or interact with histone
rnodifying activities and to define the histone modification states on PcG-repressed and
TrxG-activated genes in vivo. Finally, detennining if this level of epigenetic regulation is
rnisregulated in cancer will be a priority of future work [215]. Unlike mutagenic events,
epigenetic events in cancer can be reversed to restore the function of key control
pathways in malignant and pre-malignant celis.
1.2.6. Role ofEed/Enxl in paternal X chromosome inactivation in trophoblast stem
ceils: an epigenetic phenomenon
In mammals, dosage compensation of X-linked genes is achieved by the transcriptional
silencing of one X chromosome in the fernale [216]. This process, called X inactivation,
is usually random in the ernbryo proper. In marsupials and tlie extra-embryonic region of
the mouse, however, X inactivation is imprinted: the paternal X chromosome is
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preferentially inactivated whereas the maternai X is aiways active. Having more than
one active X chromosome is deleterious to extra-embryonic development in the mouse
(217]. The Eed nuil mutation was shown to affect the stable maintenance (but not
initiation) of irnprinted paternal X inactivation in extra-ernbryonic tissties, resulting in
two active X chromosomes in females [21$]. A second study showed that Eed and Enxl
are directly localized to the inactive X chromosome in XX trophoblast stem (TS) ceils
and that this association of Eed/Enxl is rnitotically stable [219]. Several epigenetic
iyiodifications are associated with the inactivation of the X chrorriosome, including
coating by the cis-acting Xist rnRNA, late replication, histone hypoacetylation and
methylation of CpG residues in the prornoter regions of inactivated genes [216,220].
Based on the recent finding that Eed interacts with histone deacetylases, the authors
propose a model in which the early Xist-induced repressed state of genes on the inactive
X chromosome in the extra-embryonic tissues provides a signai for the local assembly of
the Eed/HDAC complex, causing deacetylation and the formation of higher chromatin
structure to secure gene silencing. Once established, Xist is no longer required for
maintaining the repressed state (221] and these complexes can be self-propagated
through the ceil cycle to maintain long-terni inactivation of the inactive X chromosome
[222]. Recent evidence has shown that H3-K9 methylation occurs rapidly at the onset of
random X inactivation, although the enzyme responsible for this activity is
uncharacterized [223-226]. It will be important to verify whether the HMTase activity of
EZH2 is responsible for paternal X chromosome inactivation in trophectoderm ceils.
Moreover, a second murine K9-specific HMT, termed SuV39H2 (not a PcG gene), with
59% identity to the murine SuV39HI was recently identified [227]. Although Suv39hl
and Suv39h2 display overlapping expression profiles during mouse embryogenesis, the
latter is uniquely expressed in the testis of adult mice. Because SuV39H2 specifically
accumulates on the sex chromosomes (XY body) which undergo transcriptional
silencing during the first rneiotic prophase, the HMT activity of SuV39H2 was proposed
to be involved in organizing meiotic heterochromatin and genornic imprinting of the
male gerrn line [227]. In this regard, it would be interesting to investigate whether
SuV39H2 is involved in paternal X chromosome inactivation in trophoblast stem cells.
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1.2.7. PcG genes in regulation of Iymplioid ceil proliferation ami differentiation
In peripheral lymphoid organs such as lymph noUes and tonsils, antigen tAg)- specific
immune responses are generated by a highly dynarnic process of lymphoid B ceil
differentiation and proliferation. Germinal centers (GCs) form after the activation of
naïve B ceils by antigens (Ag) and serve to amplify the number of Ag-specific B celis.
As they consist of B celis at various stages of differentiation and proliferation, GCs
represent a unique system to study the expression of PcG genes during Ag-specific B
celi responses. GCs consist of a follicle containing a dark zone (with centroblasts and
centrocytes) and a light zone (that contains mainly centrocytes and a follicular network
of Ag-presenting dendritic ceils) that is smTounded by a mantie zone (MZ) of resting
naïve B celis. During the GC reaction, founder Ag-primed B celis from the mantie zone
enter the follicle where they begin to divide rapidly to form clonally related 1g
centroblasts. These celis alter their Ag-receptor specificity by sornatic hypermutation
and ultimately give rise to resting 1gt centrocytes that are subjected to selection. Meijer
and colleagues recently demonstrated that expression of the two PcG complexes,
reflected by detection of BMI-l/RINGÏ (PcGm), and EZH2/EED (PcGe), is mutually
exclusive at different B ceil differentiation stages in germinal centers (GCs) [601.
Resting mantie celis and follicular centrocytes preferentially express the PcGm
containing BMI-1 and RTNG proteins. By contrast, rapidly dividing centroblasts are
BMI- 1 and RiNG negative and express the PcGe complex-containing EZH2 and EED
proteins. Expression of EZH2 in proliferating centroblasts coincides with the detection
ofMib-1/Ki-67, a rnarker for proliferation. By contrast, resting BMI-lmant1e celis and
centrocytes are Mib-F. Together, these studies revealed that the transition of resting
rnantle B cells to rapidly dividing Mib-1 follicular centroblasts coincides with loss of
BMI-1 and RNGY Pc-Grn protein detection and appearance of ENX and EED PcGe
protein expression. By contrast, differentiation of centroblasts into resting centrocytes
correlates with reappearance of BMI-1/RTNG1 and loss of ENX/EED and Mib-l
expression. These resuits show that expression ofFcG genes is strictly regulated during
follicular B cell development and suggest a distinct role for the two types ofPcG protein
complexes in the GC ccli reaction.
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Similar to follicular B ceils, Meijer et al recently dernonstrated that expression ofBMI-1
and EZH2 in mature T ceils is mutually exclusive. The majority of resting Mib—ï mature
peripÏ;eral T ceils expresses BMI-1, whereas dividing Mib-1 T blasts are EZH2. The
absence ofBMI-1 in cycling ceils is probably related to the observation that chrornatin
association of the BMI-1-containing PcGm complex is regulated through the celi cycle
[184]. However, the mutually exclusive expression pattem of BMI-1 and EZH2 in
peripheral mature T celis is not irnmediately established in differentiating T ce!!
precursors. Subcapsular immature double-negative (DN) (CD4 CD$) T ceils in the
thymus onïy express BMI-1 and are Mib-ï, or coexpress BMI-l and EZH2 and are Mib
1. Their descendants, the double-positive (CD4 CD8) cortical thymocytes, express
oniy EZH2 and are also Mib-1. Maturation of D? cortical thymocytes to SP (CD4
CD8 or CD4 CD$) medullar thyrnocytes correlates with decreased detectability of
EZH2 and continued relative absence ofBMI-1. Together, these data show that BMI-1
and EZH2 expression in mature peripheral T celis is rnutually exclusive and linked to
proliferation status [61]. This may suggest that normal regulation of lymphocytic celi
division depends on a balance between the BMI-1- and EZH2-containing PcG
complexes. Given the well-established role of PcG proteins in regulating gene
expression and ccli fate, these nnitually exclusive pattems potentially reflect
stabilization ofcell type-specific gene expression and irreversibility of lineage choice.
Meijer and colleagues recentÏy reported coexpression of BMI-1, EZH2 and the
proliferative marker Mib-1/Ki-67 in Reed-Sternberg ceÏls of Hodgkin’s disease (HRS).
As the expression ofthese two PcG proteins is mutually exclusive at different stages of
B ce!! differentiation in germinal centers (GCs) from which the HRS cells originate (see
above), these observations suggest that Hodgkin’s disease is associated with the
coexpression ofBMI-1 and EZH2 [228]. Sirnilarly, coexpression ofBMI-1 and EZH2 is
associated with enhanced proliferation and degree of malignancy in B-cell non-Hodgkin
lymphorna (i.e., small lymphocytic lymphoma, follicular lymphoma, large B-cell
lymphoma, mantie ccli lyrnphorna, and Burkitt lymphoma). In contrast to the mutually
exclusive pattern of BMI-1 and EZH2 in reactive follicles, the neoplastic cells in B-
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NHLs of intermediate- and high-grade rnalignancy are Mib-1 and show strong
coexpression ofBmi-1 and EZH2. Large Mib-1 neoplastic ceils in low-grade B-NHL
show weak coexpression ofEZH2 and BMI-1. By contrast, small neoplastic ceils in low
grade B-NHL show reduced BMI-1 expression in the absence of EZH2 or Mib-1.
Together, these findings suggest that the co-expression of BMI-1 and EZH2 in B
lymphocytes is an early event in the developrnent of Hodgkin and non-Hodgkin
lymphoma in humans.
Sirnilarly to Bmi-1 mutants, mice lacking the PcGm-containing Mel-18 protein die at
about 4 weeks of age and present spienic and thymic hypopiasia that coincide with
severe combined irnrnunodeficiency [22,229]. Nakayama and cou. recentÏy
demonstrated decreased antigen and bacterial-induced Th2-dependent immune responses
in Mel-18 deficient mice, suggesting a crucial role foi- Mei-18 in the Th2 celi
differentiation process [230]. In Mel-18’ mature peripheral T ceils, the production ofthe
Th2 cytokines IL-4, IL-5 and IL-13 is significantly reduced, which conelates with
decreased leveis in dernethylation ofthe IL-4 gene and reduced GATA3 induction [230].
Although anti-TCRICD3-induced proliferative responses appear normal in Mel-] 8 nuil
mutants [230], a study recentiy described Mci-18 as a negative regulator of B ccli
receptor (BCR)- induced proliferation of mature B celis through the down-regulation a
c-myc/cdc25 cascade [231]. This phenotype was rescued in Mel-18/c-myc double
transgenic mice, indicating that c-Myc locates downstream ofMeÏ-18 in the pathway. In
Mel-18 transgenic mice, the irnpaired B ceil proliferative response observed upon BCR
stimulation correlates with downregulation of cyclins D2 and E; CK4, -6 and-7; and
CDC25A protein levels and hypophosphorylation of the retinoblastoma (Rb) protein. In
contrast, the upregulation of c-Myc, CDC25 and CDC2/CDK2 kinase activities in meÏ
18 deficient mature B ceils results in acceleration of proliferation, even without any
stimulation [231]. These resuits contrast with previous studies showing an impaired
mitotic response of MeÏ-18” immature B and T celis upon IL-7 stimulation [229] and
suggest that Mci-18 differentiaily regulates distinct signal transduction pathways
invofved in controlling lymphocyte proliferation. In this view, Mci-18 wouid function as
a positive regulator of proliferation mediated by cytokine receptors (IL-7k) and their
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downstrearn molecules such as JAK3/STAT5. However, MeÏ-18 wouÏd negatively
regulate proliferation triggered by antigen receptors (BCR/TCR) and their downstream
molecuies such as lyn, fyn, icklras, MAPK!Rel and NF-kB. In conclusion, the irnpaired
Th2 ccli differentiation [230] and the BCR- and IL-7-dependent B and T celi
proliferation defects [229] observed in MeÏ-]8 deficient mice suggest a clear
invoivement for the Mel-18 gene product in criticai deveiopmental aspects of the
immune system. However, further studies are clearly needed to unravel the precise
molecular mechanisrn(s) by which Mci-18 controls lymphocyte proliferation.
1.2.8. Deregulated expression of PcG genes in sotid tumors
SCMH1, the human homologue of Drosophila sex cornbs on rnidieg (scm) that shares
dornains with the tumor suppressor Ïethal(3)malignant brain tumor (l(3)mbt) protein,
maps to chromosome lp34, a region of LOH in cases of well-differentiated gastric
cancer and colon cancer [97,232,233]. BAil-] overexpression was recently reported in
several cases of human high-grade osteosarcomas and 58% of resectable non-srnall ccli
lung cancer (NSCLC) [234]. Although BMI-] overexpression (and not amplification) in
NSCLC could not be associated with tumor characteristics and patient outcomes, a
significant inverse correlation between BMT-l and INK4a expression levels was found.
Severai breast cancer ccli lines as weii as irnmortaiized rnamrnary epitheiial celis
(MECs) were also shown to overexpress BMI-] [160]. DNA amplifications and gains of
the region encompassing the human 3h-] gene iocus (lOpl3) have also been observed
in severai cases of head and neck carcinomas and other soiid turnors [125]. The
synoviai-sarcoma-specific chirnaeric protein SYT-SSX, the product ofthe chromosomai
transiocation t(X;18)(pl l.2;ql 1.2), was shown to co-localize with the human PcG
proteins BMI-1 and RfNGY at specific nuclear domains, suggesting a possible
involvement ofPcG function in synovial cancer [235].
Severai observations support a role for Mel-1 8 as having tumor suppressive activity.
Diminution of the Mci-18 protein in NIH 3T3 fibroblasts by expression of antisense
RNA leads to the acquisition of tumorigenic activity in nude mice [236]. Interestingiy,
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the human MEL-18 gene is located at 17q, a region with putative candidate tumor
suppressor genes for breast cancer. Mutations in the MEL-18 gene are very rare in
human sporadic and familial breast cancers. However, decreased MEL-]8 expression bas
been observed in several human breast cancer ccli unes, supporting a role for MEL-18
haploinsufficiency in breast carcinogenesis. Accordingly, mice haplo-insufficient for
met-18 are susceptible for the deveiopment of mamrnary gland turnors [237].
Overexpression ofHPc2 (encoding a protein belonging to the PcGm compiex) in mouse
rnarnmary epitheliai (MEC) and human ccli limes (U2OS and C57MG) caused decrease
c-rnyc expression whereas interference with HPC2 function (using a dorninant-negative
HPC2 mutant lacking the conserved C-terminal transcriptional repression domain) in
these ceils resuited in enhanced expression of c-myc and c-fos and celiular
transformation. Sirnilarly, the overexpression of RINGJA in these cells (encoding
another PcGrn-containing protein), caused anchorage-independent growth, cellular
transformation and metastatic activity in nude mice [76]. This was accompanied by
strong enhancernent of the expression levels of the oncogenes c-jun and c-fos but not of
c-myc. Together, these resuits argue that HPC2 acts as a turnor suppressor gene whereas
RING 1 behaves as an oncogene. How these observations can be rnechanisticaiiy
explained at the molectilar level is unclear and the in vivo relevance of these findings
rernains to be shown.
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Table 1
PoÏycoinb (PcG,) and Enhancers of Trithorax and Polycomb (ET?,) Groups of Genes
Drosophita Mouse (Human) Domain(s); Complex
Potycomb Grottp (PcG) Genes
Polycomb (Pc) [193] M33(M33/HPCI], inPc2(HPC2,), Carboxy-terminal domain,
(HPC3.) chromodomain; PRC1
Polyhomeotic (ph) [238] MphI/rae28(HPHJ), SPM dornain*, zinc finger;
Mph2(HPH2), (HPH3) PRC1
dRING Ring/Ringla (RINGI) RINGfinger; PRCJ
Diug/Ringlb (‘RING2,)
Extra sex combs (esc,) [239] eed(EED,) WD4O repeats t; PRC2
Super sex combs (sxc,.) [240]
A’fulti sex combs (mxc) [118]
Potycomb-like PcJ) [241] M96 PHD fingers
Cramped (cpt) [242]
Pleihomeotic (‘pho,.) [243] Y)’I(YYJ) Zinc fingers
Sex comb extra (‘Sce) [244]
Suppressor of SU(Z,,112 orYJAZI Zinc finger;VEfS-box
zeste 12 (Su(z)12) [245]
Enhancers of Trithorax and Pot)’Conzb (ETP)
A dditional sex AsxIl (‘ASXL]), Asxl2 (ASXL2)
Combs (Asx) [246]
Enhancer of Epcl(EPCI), Epc2(EPC’2,) Yeast hornolog present in NuA4
Potycomb (E(Pc)) [247] HAT complex
Enhancer ofzeste (E(z» [196] EnxJ/Ez/i2(EZH2), SET domain ; PRC2
Enx2/Ezh I (EZHI)
Posteriorsex combs (Psc,) t248] bnu-](BMI-1), mel-18(MEL-18,) RING (zinc finger), PRC1
helix-turn-helix; PRC 1
Se.r comb on midÏeg (‘5cm) [233] Scmhl(SCMHI),(CA’fH2), SPM dornain ; PRCI
5cm il (SCML 1), Scml2(’SCML2,) (substoichiometric
amounts)
Suppressor of b,ni-1(’BMI-l), ineÏ-18(MEL-]8,) HR region (shared with Psc)
zeste 2 (Su(z)2) [249]
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* SPM dornain refers to the presence of this motif in Scrn, Ph and MBT proteins; WD4O repeat is a
conserved domain that usually ends with TrpAsp (WD); VEFS-box is a conserved motif found in the
VRN2-EMF2-FIS2-Su(z)12 proteins; SETdomain refers to its presence in the Su(var)3-9, E(z) and Trx
proteins.
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Chapter 2 is a co-authored work which describes the expression pattem of selected
members of the PoÏycomb Group (‘PcG) gene farnily in ptwified subpopulations of
human bone marrow ceils. This work was the first to dernonstrate the expression of the
PcG genes in prirnary human bone rnarrow ceÏÏs and lead to the identification of several
novel members of the PoÏycomb (Pç) subfamily of PcG genes in hernopoietic ceils.
Most irnportantly, this study provided to first insights for a role of the PcG genes in
regulating normal hemopoiesi s through the transcriptional repression of the homeotic
(Hox) genes.
Soheyl Baban, a technical assistant in the Iaboratory at that time, contributed to this
work by providing technical support with the sequencing of the chromoboxes of genes
ofthe Pc subfamily ofPcG genes presented in Table III. The paper was written by Julie
Lessard under the supervision ofDr Guy Sauvageau.
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Abstract
Mammalian PoÏycomb group (Pc-G) genes, constituting some 5 subfamilies based on
their identity to the Drosophila genes Pc, Psc, ph, esc, and E(z), appear to play critical
roles in maintaining the transcriptional repression state of Hox/HOM-C genes during
development. Despite increasing evidence of the important role of Hox genes in both
normal hematopoiesis and leukemic transformation, littie is known abotit the expression
and possible function played by Pc-G genes in hematopoietic cells. To address this, we
first exarnined the expression of Pc genes in purified CD34 human bone marrow celis
by reverse transcriptase-polymerase chain reacti on (RT-PCR), using degenerate prirners
that specifically ampïify the majority of Pc genes. This analysis showed the expression
+ Hsa flsy
of 8 different Pc genes in CD34 bone marrow celis, mcludmg HP] , HP] , the
heterochromatin p25 protein, the human homologue of the murine M32 gene, and 4
novel members of this family. To assess whether Pc-G rnRNA levels change during
differentiation ofbone marrow ceils, a quantitative RT-PCR method was used to amplify
the total cDNA originating from three purified subpopulations of CD34 bone marrow
celis known to differ in their ability to grow in long-terrn or sernisolid cultures. In sharp
contrast to Hox gene expression, which is highest in the most primitive bone marrow
ceils, these studies show that the expression level of $ of the 9 Pc-G genes studied (je,
HP]’, HP1”’, M3], M32, M33, Mel-]8, Mph]/Rae-28, and ENX-]) rnarkedly
increases with differentiation of bone rnanow ceils. InterestingÏy, 3h-] exhibits a
strikingly different pattem of expression, with high expression levels in primitive ceils
and very little expression in mature CD34 cells. Together, these resuÏts document for
the first time that differentiation of human bone marrow celis is accompanied by
profound changes in Pc-G gene expression levels.
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Introduction
In Drosophila, the homeotic (NOM-C) genes ofthe ANT-C and BX-C complexes encode
highly conserved transcription factors involved in celi fate deteniiination.’ During
embryogenesis, the spatial and temporal expression of these genes is collinear relative to
their 3 ‘—*5’ position on the chromosome. Although this unique expression pattern is
established by segmentation genes of the pair-rule (activators) and gap (repressors)
farnilies, the maintenance of NOM-C gene expression during later stages ofdeveloprnent
is dependent on the tritÏiorax (‘ti-G,,) and Poiyco,nb group (Pc-G,) gene products
(reviewed in Simon et ai2). For the Pc-G genes, this repressive function appears to be
achieved initially by direct interaction with the transiently expressed gap proteins and,
later, by contributing to the formation and stable transmission ofheterochromatin.
The Drosophila PoÏycomb (Pc,) gene was one of the first members of the Pc-G family to
be identified based on its ability to maintain segment-specific expression ofthe NOM-C
genes.3 At least 12 other mutations leading to a phenotype similar to Pc (or to its
enhancement) have been described. These include: Posterior sex combs (Psc,) 4;
polyhomeotic (‘ph) 5; Polyconibiike (Pci) 6; exti-a sex combs (esc) 7; Additionai sex conibs
(Asx) 4; Enhancer oJzeste [E(z)J, also known as poivcombeotic (pco) 9; i(4,)lO2Efc,1°
recently renamed pieihomeotic’ , Sex combs extra (Sce,.) 12; Sex combs on midieg (5cm) 4;
super sex combs (sxc) 13; muiti sex contbs (mxc) 14; and Enhancer ofPolycomb [E(Pc,)J.
15 These various Pc-G names originate from the ectopic expression of organs called sex
combs on the second and third legs of male mutants.16
Recent studies have provided evidence for the existence of mammalian Pc-G genes and
their invoivement in repressing the transcription of homeotic (Hox) genes.17 M31, M32,
M33 (murine), the heterochromatin p25 protein (the human homologue ofM3l), NP]”,
and HPl”’ (human) are ail homologues of the Drosophila Pc gene’8; bmi-1 and mci-18
are both murine and hurnan homologues of the Drosophiia Posterior sex combs (Psc,)
gene’9; Enx-1 (human and mouse), ceci and Mph]/Rae-28 (mouse), and NPNJ and
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HPH2 (hurnan) ÏikeÏy represent the mammaïian counterparts ofthe DrosopÏtiÏa E(z,), esc,
andph genes, respectively.20,21
An important due to Pc-G gene function in contributing to the formation of
heterochrornatin carne from the finding that a conserved region called the
chrornodomain (for chromatin organizer domain) is shared between Pc and the
heterochromatin-associated protein HP 1.22 Furthennore, it has been recently shown that
both Drosophila and mammalian Pc-G proteins interact with chrornatin as
heterogeneous multimeric complexes.20’23’24 The exact mechanisrns by which these
complexes repress transcription of their target genes are not yet fully understood. The
chrornatin accessibility model predicts that the cooperative interaction of Pc-G protein
complexes interacting with Pc-G response elements (PREs) regionally compacts the
chrornatin structure, thus eliminating the accessibility of DNA to transcriptional
regulators.2529 However, several pieces ofevidence suggest that the mechanisrn of Pc-G
gene-mediated silencing may not be solely achieved by the general inaccessibility of
regulatory sequences. For example, it was shown that Pc proteins can inhibit Gal-4- but
not T7-dependent transcription in Drosoph lia ernbryos.3° Thus, other models by which
Pc-G genes might be acting have been proposed. For example, Pc-G genes could act as
transcriptional repressors 6,31-35 , they could interact with specific molecules required for
pol II transcription, or, alternatively, they could block looping interactions between
promoters and enhancers.36
The pleiotropic phenotypes observed in rnany Pc-G mutants indicate their participation
in nurnerous cellular processes such as anterio-posterior segmentation, dorso-ventral
patterning, neural development, oogenesis, and hematopoiesis.1 1-13,37-40 In support of the
importance of Pc-G genes in hematopoiesis, severe hypornorphic alleles ofthe mttiti sex
comb (mxc,) gene in Drosophiia were shown to result in premature hemocyte
differentiation and tLtmorous overgrowth of the larval hematopoietic organs. 14,41,42
Recent studies in mice also support a critical role for Pc-G genes in hematopoiesis. B
and T celi populations in M33 mice exhibit a decreased proliferative response to plant
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agglutinin.23 Mice lacking bmi-] display a progressive aplastic disease characterized by
replacernent of bone marrow space by adipocytes, as well as a smaller spleen and
thymus than control littermates. Although ail thymocyte populations are initially normal
in newborn bmi-]’ mice, a progressive loss of CD4CD8 celis is observed such that
aduit thymi contain more than 90% CD4CD8 cells. 3-ceil development is also
abnormal, with bone rnarrow pro-3 and pre-B celis being rnost affected. h addition,
bone marrow macrophage colony-stirnulating factor (M-CSF) and interleukin-7 (IL-7),
but not IL-3, responsive clonogenic progenitors are decreased in numbers. hterestingly,
erythropoiesis does not appear to be altered in these mice. Together, these data suggest
that bmi-1 function in hernatopoietic celis is lineage- and stage-specific, displaying a
redundant role during embryogenesis but being essential for proliferation of certain adult
hematopoietic lineages.43 Sirnilarly, targeted disniption of the other mammalian Psc
gene, mel-18, leads to B- and T-cell developmental defects caused by an insufficient
response to IL-7 stimulation ofthe lymphoid precursors.2° An additionai line of evidence
further suggesting a role for Pc-G proteins in hematopoietic celi function is provided by
the finding of a direct interaction between the Pc-G protein Enx- 1 and Vav, a proto
oncogene expressed predominantly in hematopoietic cells.44
Interestingly, perturbation in expression levels of certain Pc-G and Hox genes produce
comparable phenotypes in hematopoietic cells. Sirnilarly to what has been observed in
bmi-1 and meÏ-18 mice, retroviral overexpression of HOX4]O or HOXB3 in murine
bone marrow ceils causes a block in differentiation of early B and T cells,
respectively.45’46 These observations underscore the importance of preserving the
downregulation of Hox gene expression that occurs during normal differentiation of
primitive hematopoietic cells47 and suggest that Pc-G gene products play a key role in
assurning this function. furtherrnore, inactivation of Pc-G genes may lead to leukemic
growth as a consequence ofHox gene overexpression.45’435’
In this work, we have investigated the expression of mammalian Pc-G genes in purified
subpopulations of hurnan bone rnarrow ceils and in ieukemic celi lines. We document
the existence of a highly regulated program of Pc-G gene expression with mature bone
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rnarrow subpopulations showing much higher Pc-G gene mRNA levels relative to less
differentiated precursors. These resuits contrast with previously documented Hox gene
expression profiles and thus suggest a role for Pc-G proteins in regulating differentiation
and/or proliferation ofhurnan hematopoietic cells by silencing Hox gene expression.
Materïals and methods
PCR amplification ofttie chromodornaïns of thePotyconib (Pc) subfamily of Pc-G
genes
A set of degenerate oligonucleotides was designed to match ail the different sequences
of the conserved 5’-end [5’-CAT-GAA-TTC-(GATC)GA-(GA)AA-(GA)AA-(GA)G-
T(GATC) (TC)-T(GATC)GA-(TC)(AC)G-3’] and 3’-end [5-TCT-AGA-TCT-(TC)T-
C(GATC)G-G(TC)T-CCC-A(GATC)GT-(GA)T-T-3’] of the chrornodomains of most
members (from Drosoph lia to mammals; see Table II) of the PoÏyconib (Pc,) subfamily
of Pc-G genes. These primers were used to polyrnerase chain reaction (PCR)-amplify
the conserved chromodomain of Pc genes from a phage cDNA library made from
purified CD34 hurnan bone marrow cells originating from a single donor.46 Briefly,
phage DNA was obtained by 2 successive phenol-chloroform extractions and
approximately 0.1 p.g of this DNA introduced in a PCR mixture containing 200 pmol of
each degenerate primer (see above), 250 tmol of each four deoxyribonucleotides
(dNTP; Phannacia, Uppsala, Sweden), 1.5 rnrnol of MgCI2, 10 rnmoi of Tris-HCY, pH
8.9, 50 mmol of KC1, 5 U of Taq polyrnerase (Life Technology, Burlington, Ontario,
Canada), and water to 50 tL. Parameters for PCR amplification were 30 seconds at
94°C, 2 minutes at 50°C, and 2 minutes at 72°C for 35 cycles. A unique 115-bp
fragment was obtained and subcloned into the EcoRV site of Bluescript KS (Stratagene,
La Jolla, CA) as described.47
DNA sequencing and sequence analysis
DNA sequencing was perfonned by the dideoxy chain termination rnethod using [33S]
dATP and a T7 sequencing kit (Pharmacia) according to the manufacturer’s
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recommendations. Either the universal, reverse, T3, or T7 primers complernentary to
sequences within the cloning vector were used. Nonredundant nucleotide sequence
databases (GenBank, EMBL) were screened for homologous sequences using the search
algorithms BLAST and fastA ofthe GCG program (Genetic Computer Group, Madison,
WI). The BestFit program was used to obtain the sirnilarities and identities of the Pc-G
genes ofthe Pc subfamily.
Purification of CD34 human bone marrow ceil subpopulations
Low-density ceils (<1.077 g/mL) obtained from 3 different healthy boue rnanow (BM
no. 1, 2, and 3) donors were isolated by centrifugation on Ficoil-Paque (Pharmacia LKB,
Uppsala, Sweden) and kept frozen in Iscove’s medium containing 10% fetal caif serum
(FCS) and 7.5% dirnethyl sulfoxide. For fluorescence-activated ceil sorting (FACS)
experiments, ceils were thawed in the presence of DNase I (Sigma, St Louis, MO) to
avoid clogging; stained with a series of directly conjugated fluorescent antibodies to
CD34 (8G12-Cy5), CD45RA (8d2-R-phycoerythrin), and CD71 (OKT9-fluorescein
isothiocyanate); and washed twice (propidium iodide at 1 j.ig/rnL was included in the last
wash [Sigma]) before sorting on a FACStarplus (Becton Dickinson Immunocytometry,
San Jose, CA) as described.47 Celis were sorted in three phenotypically and functionally
distinct subpopulations: subpopulation I (CD3 4CD45RKCD7 1 ), 11M
(CD34+CD45+CD71I0), and 111E (CD34+CD45RKCD71h), as characterized before.47
Ceils from boue marrows were also stained with 8G12-Cy5 alone and separated into
total CD34 and CD34 subpopulations. Aliquots from each subpopulation were
analyzed and found to be greater than 98% pure.
cDNA generation and amplification
A previously described method for generating representative amplified total cDNA from
small numbers of liematopoietic celis tising an oligodT-based primer and polyA tailing
strategy was used, with modifications designed to improve cDNA yield of even rare
transcripts and to provide amplified sequences extending up to 2 kb 5’ of the
polyadenylation site.47 In brief, 1,500 to 10,000 celis of each subpopulation were
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pelleted and then lysed in a 5 rnol/L guanidium isothiocyanate solution containing 20
mmol/L dithiothreitol. Nucleic acids were precipitated by adding 25 jiL of 7.5 moÏ/L
ammonium acetate, 20 ig of glycogen as a carrier, and 2 vol of 95% ethanol. The
washed pellets were dried at room temperature and resuspended in 9.5 pi of a solution
containing 6.1 tL of diethyl pyrocarbonate-treated water, 2 tL of 5x RT buffer (Life
Technology), 1 tL of 0.1 mol/L dithiothreitol, 0.2 pi of 25 rnmol/L dNTPs
(Pharmacia), 0.2 tL ofa special 60-mer oligo(dT) primer [1 jig/jiL; 5’-CAT-GTC-GTC-
CAG-GCC-GCT-CTG-GAC-AAA-ATA-TGA-ATT-CT(24)3 ], and 0.5 tL of Moloney
murine leukernia virus (MMLV) $uperScript II reverse transcriptase (200 U/pL; Life
Technology). The samples were left at 40°C for 1 hour, heated to 75°C for 10 minutes,
and ethanol-precipitated with ammonium acetate and a linear polyacrylamide carrier, as
described.47 The pellet was washed once; resuspended in 5 iL of a tailing solution
containing 1 iL of 5 x terminal deoxynucleotidyl transferase (TdT) buffer (Life
Technology), 0.5 tL of 100 mmol/L dATP (Pharmacia), 3.5 iL ofwater, and 0.5 pi of
TdT enzyme (15 U/jiL; Life Technology), and incubated for 15 minutes at 37°C. Afier
heat inactivation (75°C for 10 minutes), this solution was directly added to a PCR
amplification mixture consisting of 25 pi ofa 2x buffer (20 mmol/L Tris, pH 8.8, 100
mmol/L KCI, 9 mmol/L MgC12), 4 pi of the 60-mer primer (same as described above),
0.5 pi of nuclease-free bovine serum albumin (10 mg/mL; Sigma), 5.25 iL of water,
and 2 pi of d(GCT) deoxynucleotides adjusted at 25 mmol/L each. Four micrograms of
gene 32 protein (Pharmacia) and 5 U of Taq polymerase (Life Technology) were added
to each tube and total cDNA was arnplified with an Ericomp thermal cycÏer (Ericornp,
San Diego, CA) using the following parameters: 94°C for Y minute; 55°C for 2 minutes
except for the first cycle, which was performed at 3 7°C; and 72°C for 10 minutes for 44
cycles.
Southern blot analysis of total amplified cDNA
One-fifth of the total amplified cDNA prepared from each purified subpopulation or ceil
line was electrophoresed in a 1% agarose gel and transfelTed to an ionic nylon
membrane (Zeta-probe; Bio-Rad, Hercules, CA). Probes were labeled with 32P-dCTP by
random priming and purified on Sephadex-G50 columns (Pharn-iacia). Blots were
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prehybridized and hybridized at 65°C in 44x SSC, 7.4% formamide, 0.74% sodium
dodecyl sulfate (SDS), 1.5 mmol/L EDTA, 0.74% skirn rnilk, 370 tg/mL salmon sperm
DNA, and 7.5% dextran suiphate. Membranes were washed three times for 30 minutes
at 65°C in 0.3% SSC, 0.1% SDS, and 1 mg/mL sodium pyrophosphate and exposed to
Kodak BioMax MS films (Interscience mc, Markham, Ontario, Canada). Blots were
stripped in a 1% SDS solution at 95°C for 30 minutes and tested for the absence of
signals by overnight exposure to Kodak BioMax MS films (Eastman Kodak, Rochester,
NY) using appropriate intensifying screens (Interscience mc).
Most probes used in these studies were generated by PCR amplification of cDNA or
genomic DNA obtained from various sources and were ah sequenced as described
above. These probes included (1) a 264-bp fragment of the hurnan HF]’° gene
(nucleotides 4 16-679; accession no. S62077; 5’ primer
CTCAAACAGTGCCGATGACA and 3’ primer TCCGCATCCTCAGGATATGC)
located downstream of the chromodomain; (2) a 222-hp fragment of the human HPl’
gene (or p25 heterociiromatin gene) also located downstream of the conserved
chromodomain (nucleotides 558-779; accession no. U35451; 5’ primer
GAAAGCTGGCGGGCACTAT and 3’ primer GAGCGTTAGTTCTTGTCATC); (3) a
326-hp fragment corresponding to the untranslated exon 7 of the 3’ UTR of the murine
M3] gene (nucleotides 68-393; accession no. X95397; 5’ primer
TGTCTTGACACCATAGAGGT and 3’ primer CTACACACATGCTAGGCTGT); (4) a
268-5p fragment of the murine M32 gene located downstream of the chromodomain
(nucleotides 252-5 19; accession no. X566$3; 5’ primer ATCTGACAGTGAATCTGAT
and 3’ primer TTGTGCTTCATCT TCAGGAC); (5) a 322-hp fragment of the murine
M33 gene located downstrearn of the chromodomain (nucleotides 1346-1667; accession
no. X62537; 5’ primer AGCTGACTTGCAAGGCAACG and 3’ primer
GACTCCTTCACGGTGACAGT); (6) a 329-hp fragment of the human BMI-] gene
located in the 3’ UTR (nucheotides 193$-2248; accession no. L13689; 5’ primer
GATGAATTCGTCACTGTGAATAACGATTT and 3’ primer
TCTAGATCTACAATCATTTCTGAATGCAT); (7) a 287-hp fragment of the human
Mci-18 gene located downstream of the RING finger domain (nucleotides 876-1168;
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accession no. D13969; 5’ primer CAAGTACCGTGTCCAGCCAG and 3’ primer
TCTGCAGGCAGTTCAAGCTA); (8) a 228-hp fragment of the hurnan ENX-1 gene
located downstream to the SET domain (nucleotides 2338-2565; accession no. U52965;
5’ primer CTGAAGTATGTCGGCATCGA and Y primer
ACACTTTGCAGCTGGTGAGA); and (9) a 251 -bp fragment of the murine Mph]/Rae
28 gene located in the Y UTR (nucleotides 3 190-3440; accession no. U63386; 5’ primer
GTGCTACATGGTGACAGCTT and Y primer AGCTAGGAAAGCTGACCTCT).
Probes for HP]”, Hp]Hsfl and ENX-] were isolated from cDNA obtained from CD34
human bone rnarrow celis; M3] and M32 were obtained from a pool of total RNA
extracted from the BaJF3, 32D, FEL, and FDC-P1 murine hematopoietic ccli unes; M33
and Mph]/Rae-28 were obtained from murine genomic DNA; and BMI-1 and MeÏ-18
were obtained from human genomic DNA isolated from K562 ceils. Probe for the full
length human HP]’ coding cDNA (519 bp) was isolated as a BamHIJEcoRI fragment
ofpGEX-2T (kindly provided by Dr H.J. Worman, College ofPhysicians & Surgeons of
Columbia University, New York, NY). Probes for fi-actin, hurnan CD34, MuÏti-Drug
Resistance (MDR,), and ,6-gÏobin were isoÏated as described.47
After database searches, probes were designed to minimize any cross-hybridization
between the various Pc-G genes and other related sequences. To determine whether
these probes recognized single copy gene, Southem blot analysis was performed on
genornic DNA isolated from mouse thymus and human leukemic cdl unes (1(562, HL
60) using the same hybridization conditions as described above. A single band was
detected with the foilowing probes: M3], M33, MeÏ-]8, BMI-], Mph]/Rae-28, and ENX
1. However, M32 and HP1h1s3 hybridized to 5 to 10 different DNA fragments digested
with either of the following restriction enzymes: EcoRI, HindIII, BglII, KpnI, BamHI,
and J7îoI. The probe used to detect HP] also showed a single hand. However, by
using a different probe, it has been shown that this gene is part of a larger farniÏy18 and
highly similar sequences to HP]” are found in different EST databases.
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Ce!! unes
Hernatopoietic ccli unes used in this study were obtained from the Arnerican Type
Culture Collection (ATCC; Rockville, MD), unless specified otherwise. They included
the HL-60 ceils derived from a patient suffering from acute rnyeloid leukemia, the K562
ceils obtained from pleural effusion of a patient suffering from blast phase chronic
myelogeneous leukemia, the MOLT-4 celis established from the peripheral blood of a
patient suffering from acute T-ce!! lyrnphoblastic leukernia, the KG-la celis obtained
from a patient suffering from acute rnyeloid leukernia, the TF-l hurnan erythroleukemic
ccli une, the 32D murine mast celi une, the FDC-Pl myeloid ce!! une derived from long-
terni boue rnarrow cultures of DBA-2 mice, the BalF3 murine celi une (a gift from A.
Miyajirna, DNAX Research Institute, Palo Alto, CA), the FEL-745 Friend murine
erythroleukernic ce!! une, and the murine Rat-1 fibroblasts. Ail ce!! unes were
maintained in RPMI 10% FCS (GIBCO/BRL) except for FDC-P1, 32D, and Ba1F3,
which grow in the presence of 5 ng/rnL of mIL-3 and TF-l celis that were maintained in
the presence of 5 ng/mL of hurnan granulocyte-macrophage colony-stimulating factor
(hGM-CSF). Ail growth factors were used as diluted COS-celi supernatants produced at
Institut de Recherches Cliniques de Montréal (IRCM).
Northern blot analysis
Total cellular RNA from 1 x l0 cells ofthe murine FEL, FDC-Pl, 32D, and BaJF3 and
human K562, HL-60, TF-l, MOLT-4, and KG-la hematopoietic ce!! unes was isolated
with TRIzol (Life Technology). Approxirnately 5 jig of each sampie was size
fractionated by electrophoresis on a 1% agarose gel containing 1 x Na-MOPS and 5%
deionized formaldehyde and transferred to Zeta-probe nylon membranes. Blots were
prehybridized and hybridized at 45°C in 42% deionized formamide, 4.8% SDS, 480
mmol/L phosphate buffer Na2HPO4/NaH2PO4, pH 7), 960 jig/mL of nuciease-free
bovine serum alburnin, and 400 tg/rnL of salmon sperrn DNA. Membranes were washed
twice in 0.2x SSC, 0.1% SDS and once in 0.lx SSC, 0.1% SDS for 30 minutes at 55°C.
Total RNA loading was verified by hybridization of membranes with radiolabeled
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oligonucleotides (5 ‘-ACG-GTA-TCT-GAT-CGT-CTT-CGA-ACC-3’) specific to 18 S
ribosomal RNA.
Resuits
Expression of known and novel Pc genes in CD34 human bone marrow celis
To obtain an initial indication of the range and expression pattem of known and
potentially novel Pc genes that might be expressed in human bone marrow celis, a set of
degenerate oligonucleotides spanning a region of the conserved chromodornain of most
Pc genes was synthesized (Table II) and used to PCR-arnpïify cDNA isolated from a
CD34 human bone marrow cDNA library. A PCR fragment of 115 bp presurnably
containing several different chromobox sequences was subcloned and the nucleotide
sequences of 73 independent clones were cornpared with known Pc-G genes.
The resuits from this analysis showed that at least 8 different Pc genes are expressed in
hurnan bone rnaiow cells (Table III). The HPl” and HPl” genes were most
represented, with 31 (42%) and 15 (21%) of the 73 clones corresponding to these 2
genes. Three Pc subfamily members having a chrornobox highly sirnilar to that of
Hp]Hsa were identified in 2 independent PCR reactions, suggesting that they represent
novel Pc genes. They were named HPÏ’-1ike A, B, and C. DNA and protein sequence
comparison ofthese clones to HP]H5a is shown in Table III.
Three additional sequences were identical to the hurnan heterochromatin p25 protein
and one clone, refen-ed to as p25-like, xvas rnost sirnilar to p25 but contained 3
mismatches (Table III). Two clones, each obtained from independent PCR reactions, had
a single mismatch to the murine ?v132 gene and likely represent its human homologue.
Finally, seven additional sequences containing a single nucleotide mismatch to either
HPJH5a or HPÏ were identified. It is impossible at this point to ascertain whether any
ofthese represent distinct genes or reflect PCR artifacts.
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Together, the data obtained with this approach show the presence of at least 8 different
Pc genes in human bone rnanow celïs, 4 ofwhich are potentially novel genes, and one is
the human homologue ofthe murine M32 gene.
Table II
Alignment of the chrornodomains of the Pc genes and generation of a consensus
sequence to design the degenerate oligonucleotides used in these studies.
Pc Genes Cliroinodomoin Conserved SeqLIeflrs
HP? (D) ‘ivvEKVLDRRVRKGKvEYYLKWKGYPETENr’wE PENN*
HPJ° (H) YAVEKIIORRWKGQVEYLLKWKGFSEETWEPEKN
HP 1’t (H) FVVEKVLDRRVVNGKVEYFLKWKGFTDADNT’WEPEEN
M3 1 (M) YVVEKVLDRRVVKGKVEYLLKWKGFSDEDNIWEFEEN
M32 (M) FWEKVLDRRVVNGKVEYFLKWKGFTDADNTWE PEEU
p25 (H) t YVVEKYLDRRWKGKVEYLLKWKGFSDEDNTWE PEEN
Consensus VVEKVLDRRWKGKVEYYLKWKGFPETDNTWE PENN
FA II RNQ F YSDEH K
L TAE E
Abbreviation: D, Drosephila; H, hurnan: M. mouse.
Lottots in bold ropresunt tho amino acid sequenco usod to con
strLlct the 2 degenetate priniers usod in these studios.
tHurnan heterochroinatin p25 prot&n is also reforred to as HSMI or
HP7”J and is the huinan homologue ofthe mouse M37 gene.
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Table III
Pc gene sequences obtained from cDNA isolated from purified CD34 hurnan bone
marrow ceils with degenerate oligonucleotides designed based on conserved sequences
of Pc genes.
t’J _r t
P: cDNA S ncs E tyu Dcjonnrat. Oliqos (and TinsItioii) SiIisnnI
R V V K G Q V E Y L L K W K G F S E E H
1. HP1’°- G CCC GTG CII G GGA C GTG GAA TAT CIA CCC AAC CCC AAA CGC ITT TCI GAG GAG CAC 311
H
2. HP1”’ -hkeA G G 3
E
3. HP1” -liko B 41
F
4. HPI”-IiknC 31
R V V H G K V E Y F L K W K G F T D A D
5. HP1” A CCI CTA GTG AAT CGG AAA GTG CAA TAT TIC CIG AAC TGG .C CGA III ACA GAT GCI GAC 151
R V V K G K V E Y L L K W K G F S D E D
6. p25 T CGA GTG GIA ?C GGC AAÂ GIC GAG TAC dc CIA AAC TGG AAG GCA lIC ICA GAI GAG GAC 3
D E
7. p25-liko T 1
R V V U G K V E Y F L K W K G F T D A D
8. M32 (homologun) T CAT GTA GTG AAT GGG AAG GTG GAG TAT rrc C0 AAG 1CC AAG GGG TIC ACA GAI GCT GAI 21
9. Sov€ral HP 1’” -liko with s singlo mutation (considoroci as potontial PCR-inducod mutations) 6
10. Ono HP111’_Iiko with u singlo mutation 1
Four additional clonos wom unrolatod to Pc-G gonos.
‘tsoqcinnccs obtainnd from 2 indopondont PCR roactians.
Quantitative analysis of Pc-G gene expression in functionally distinct
subpopulations ofliuman bone mari-0w ceils
We next assessed the variation in expression levels of Pc-G genes during differentiation
of bone rnarrow celis. This was performed by generating PCR-amplified total cDNA
from functionally and phenotypicaÏly distinct FACS-purified hurnan bone rnarrow
subpopulations, using antibodies directed against CD34, CD45RA, and CD71 surface
antigens (Fig. 2.1). In total, 5 different subpopulations were purified from 3 healthy bone
rnarrow donors: (1) total CD34 cells, which phenotypically represent 1% to 5% ofbone
rnarrow ceils and contain ail types of progenitors; (2) CD34’CD45CD7F ceils
(subpopulation I), which are highly enriched for very primitive long-terni culture
initiating ceils (LTC-IC); (3) CD34+CD45CD71h1, which are enriched in erythroid (je,
burst-forniing unit-erythroid [BFU-E]) clonogenic progenitors (subpopulati on 111E); (4)
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CD34+CD45+CD71I0 celis, which are highly enriched in granulocyte-macrophage
progenitors (colony-fonning unit-granulocyte-macrophage [CfU-GM]; subpopulation
11M); and (5) total CD34 subpopulation, which contains mature bone maiow celis with
no progenitor activity. Detailed functional characterization of each ofthese
purified populations has been described elsewhere.47’52
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Fig. 2.1 FACS profiles of the CD34 subpopuÏations isolated from donor no. 1:
subpopulation I, CD34CD45RACD7F (highly enriched in LTC-IC); subpopulation
11M, CD34CD45RACD7 110 (highly enriched in CFU-GM); subpopulation 111E,
CD34+CD45RKCD7111 (highly enriched in BFU-E ). FITC, fluorescein isothiocyanate;
PE, phycoerythiin.
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Total cDNA isolated from each purified subpopulation was PCR-amplified using a
method previously shown to preserve quantitative differences in mRNA abundance
using lirnited celi numbers.47’53 To assess both the sensitivity and the abiïity of this
procedure to measure quantitative diffei-ences of Pc-G messages in hernatopoietic ceils,
various numbers of the human K562 ceils, which express HP1”’, were rnixed with Rat
1 fibroblasts that do not express this gene. Total cDNA arnplified from each cellular
preparation was blotted and hybridized with a probe specific for HP1’ and showed
linearity of expression in a range between 40 and 20,000 K562 celis (Fig. 22).
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Fig. 2.2 Representative amplification of mRNA by quantitative RT-PCR. Expression of
HP1’’ in total ampÏified cDNA obtained from various cellular preparations of K562
(which express HP]””) and Rat-1 ceils (HPl’ negative) by Southern blot analysis.
Exposure tirnes are as indicated.
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Total amplified cDNA from each of die 5 purified subpopulations obtained from one
bone marrow donor was analyzed for the expression of the rnajority of mammalian Pc,
Psc, ph, and E(z,.) genes characterized to date (Fig. 2.3). Probes were carefully designed
to minimize the presence of conserved or repetitive domains within the various Pc-G
genes. Ail Pc-G genes anaiyzed to date are expressed at sorne levels in at least one ofthe
purified subpopulations shown in Fig. 2.3. Interestingly, and in contrast to Hox gene
expression, which is predominantly observed in primitive subpopulations of CD34
human bone marrow cells,47 the expression of most Pc-G genes is higher in celis lacking
the CD34 surface antigen (compare the signais shown in lane 3 [CD34 celis] with those
in lane 2 {CD34j; Fig. 2.3). The detaiÏed analysis ofthese resuits suggests a progressive
increase in Pc-G gene expression with bone marrow ce!! differentiation (Fig. 2.3). Some
important variations in expression levels were observed within each subfamily. For the
Pc subfamily, M31, M32, and M33 had a sirniÏar pattem of expression, with very high
expression levels in CD34 ceils, moderate leve!s in subpopuiations 11M and 111E, and
litt!e (M31) or no detectab!e expression (M32, M33) in the rnost primitive subpopu!ation
I. The expression pattern of HP11’’ differed significantly from the other Pc genes with
simi!ar abundance in CD34 and CD34 ceils (Fig. 2.3) Expression also differed between
die two known members of the Psc family BMI-1 and Mel-18. Whereas Mci-18
expression was rnost prominent in mature ceils (CD34 and subpopuiation 11M), that of
BIvfI-1 was highest in the most primitive subpopuiation and minimal in CD34 celis. The
expression of ENX-1 [a mammalian E(z) gene] was similar to that of HP]’ and the
expression of Mphl/Rae-28 (a ph gene) paralleled that of Met-18. Interesting!y,
Mph]/Rae-28 expression was not observed in the 3 ce!i unes shown in Fig. 2.3, whereas
Met-18 expression was detected oniy in human K562 and murine Rat-Ï celis.
Severai control probes were hybridized to the membranes containing the arnpiified
cDNA obtained from each subpopuÏation. Actin showed comparable loading in each of
the 9 lanes, except for lane 4, which was moderately under!oaded, and lane 5
(subpopulation 11M), in which a clear distinct signa! could be detected on!y upon
pro!onged exposure (flot shown). Expression ofCD34 in these subpopulations corre!ated
with the expression of this antigen as detennined by FACS analysis, with a progressive
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decrease in expression levels from subpopulation I to 11M and 111E (data flot shown and
Sauvageau et ai47). Expression of CD34 could flot be detected in the CD34 cDNA even
upon prolonged exposure (Fig. 2.3). As might be expected, fi-gÏobin expression was oniy
detected in populations containing mature red b!ood ce!! precursors (total unseparated
bone marrow and CD34 ce!!s). Fina!iy, consistent with the findings of our previous
studies,47 the expression of the muÏticÏrug resistance gene (MDR-]) was highest in
subpopu!ation I and was aiso abundant in K562 cel!s (data not shown).
The reproducibi!ity of these data was examined in identica! bone maiow subpopulations
isolated from 2 additionai donors. Probes for HP]”’, p]Hs and ENX-] were
hybridized to membranes containing total amplified cDNA, and the resuits from these
experirnents were superimposable to those shown in Fig. 2.3 (data not shown). Together,
these data high!ight the cornplexity of the regulation of Pc-G gene expression during
differentiation of human bone manow ce!!s and suggest the existence of diverse Pc-G
protein complexes during hernatopoietic cel! di fferentiation.
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Fig. 2.3 Expression of mammalian Pc-G genes in purified bone rnarrow CD34
subpopulations. Five to ten thousand celis were isolated from cadi subpopulation
(>98% purity upon reanalysis) and their total RNA was revcrse-transcribed and PCR
amplifled as described in the Materials and Methods. From primitive to mature
subpopulations: subpopulation I, CD34CD45RKCD7F; subpopulation 11M,
CD34CD45RACD71’°; subpopulation 111E, CD34±CD45RKCD71I11 and CD34 ceils.
Exposure tirnes (ail at -70°C unless specified) were as follows: HP]”°, 6.5 hours at
room temperature; HPl, 1.2 hours; M31, 6 days; M32, 27 hours; M33, 26 hours; Met-
18, 24 hours; 3h-1, 8 days; Mph-]/Rae-28, 3 days; ENX-1, 4.5 hours; /3-globin, 5
minutes; and ,8-actin and cD34, 5 hours each.
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Several Pc-G genes are expressed as multiple alternative transcripts in primary
celis and in leukemic ceil lines.
Previous studies have shown that one of the hallrnarks of Pc-G genes is their expression
as severai alternative transcripts. To evaluate whether hematopoietic ceils also express
multiple Pc-G gene transcripts, total RNA isolated from 5 different human (K562, HL
60, MOLT-4, TF-1, and KG1-a) and 4 murine (FEL, FDC-P1, 32D, and BaJF3)
hematopoietic ccli unes, representing different lineages and stages of differentiation,
was assessed for Pc-G gene expression by Northern blot (Fig. 2.4).
This analysis showed the presence of multiple transcripts for 3 of the 5 Pc-G genes
exarnined. These include HPJIJ5a, which had a hurnan and a mouse-specific transcript of
9.9 and 8.7 kb, respectively, and shared a transcript of 1.2 kb in ail ccli unes examined
(Fig. 2.4). Different transcripts of the M3] gene were detected in hurnan versus murine
ccli hues, the former expressing transcripts of 10.7 and 2.4 kb aud the latter expressing
transcripts of 2.4 and 1.1 kb. The probe for HP] also detected 2 distinct species (2.1
and 1.1 kb) in human ccli unes, whereas murine ceils only expressed a transcript of 2.1
kb.
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Fig. 2.4 Northern blot analysis showing the expression of selected members ofthe ?c-G
family in human and murine hematopoietic ceil unes. Five micrograms of total RNA
isolated from each ceil line was hybridized to probes specific to HF]11 (14 hours of
exposure), HPl’ (5.5 hours), Ivf3] (96 hours), M32 (6 days), 3h-] (14 hours), and
1$S rRNA (4 minutes).
Two ofthe 5 genes exarnined expressed a single transcript. These include the M32 gene,
whose expression could only be detected in ceil unes of murine origin (Fig. 2.4). The
lack of expression of M32 in human ceil unes contrasts with its relative abundance in
primary bone maiow cells (Fig. 2.3), suggesting either the presence of different
transcripts specifically recognized by our probe in primary ceils or its complete absence
in the irnrnortalized unes examined here. Simiiarly, M33 and Mph]/Rae-28 expression
could not be detected in any hematopoietic ccli une exarnined, although both were easily
t t n
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detectable in the purified subpopulations shown in Fig. 2.3. finally, although MeÏ-18
expression could not be detected by Northern blot analysis of total RNA (data flot
shown), RT-PCR analysis showed its presence at low levels in K562 but not in HL-60
celis (Fig. 2.3). These resuits were confirmed using polyA rnRNA isolated from the
same ceil unes. Two different transcripts forMel-18 (1.8 and 3.4 kb) were detected in ail
the celi unes examined, except in HL-60 ceils (data not shown).
To test whether the transcripts identified in the hurnan ceil unes reflect those present in
primary isolates, mononuclear celis were isolated from 2 different human bone marrow
specimens and total RNA hybridized to probes specific for the HP1’ and HP1’’
genes. In both cases, the transcripts obseiwed in primary ceils conesponded to those
found in human cell unes, except for the 1.2-kb transcript of HP111 whose presence in
prirnary celis remains unclear (data flot shown). Together, these data suggest that
alternative transcription pattems for the majority of Pc-G genes represent an additional
level for regulation ofthe Pc-G gene action during hematopoietic celi differentiation.
Discussion
These studies report the expression of at least 13 different Pc-G genes in human boue
rnaow ceils, including 4 potentially novel homologues of the Drosophilct Pc gene.
Moreover, our data suggest the existence of a highly defined program of Pc-G gene
expression in phenotypically distinct subpopulations of human bone marrow celis
representing various stages of differentiation. In contrast to the preferential expression of
Hox genes in the eaily hematopoietic cells,47 our study showed that the expression levels
of $ of the 9 Pc-G genes studied is much higher in the more mature bone marrow ceils
than in the primitive subpopulations. For sorne of the Pc-G genes, such as ENX-1, M3],
HPl”, and HP]’’, this upregulation seems to appear in the earliest stages of
hematopoietic differentiation, whereas for others (ie, M32, M33, Mci-18, and Mphl/Rae
28), increase in their expression levels coincides with later stages of differentiation
(summarized in Fig. 2.5). This suggests that Pc-G protein complexes present in primitive
hematopoietic celis (ie, population I) differ from those found in mature bone manow
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ceils. These resuits document, for the first tirne, changes in Pc-G gene expression levels
with cellular differentiation. This contrasts with their ubiquitous expression in
Drosophila syncytial blastoderms24 and thus point to an additional level for regulating
Pc-G gene functions in mammalian ceils.
Using degenerate primers, 4 novel chromobox sequences similar to that of the
previously described Pc genes (refelTed to as HP]”-Ïike A, B, and C and p25-Ïike) were
identified. In most cases, these sequences were obtained in 2 independent PCR reactions,
suggesting that they may represent novel human Pc members. Because the bone manow
used for this part ofthe work originated from a single donor, it is impossible to nue out
that one of these sequences (eg, clone no. 4, Table III) represents polyrnorphism.
However, this is unlikely, because each novel sequence contains at least one mutation
that affects the primary sequence of the highly conserved chromodornain. In support of
the existence of several uncharacterized HP1’ members, several HP]” sequences
have been found in EST databases. Hybridization of mouse and human genornic DNA
with a probe for HP1F have also shown several bands.’8 Lmportantly, the other HPlJm_
related sequences identified by Saunders et al’8 were not detected by the probe used in
our studies. Together, these data indicate that our knowÏedge of the full complernent of
Pc-G genes expressed in hernatopoietic cells has not been resolved yet.
The ability of each probe to hybridize to specific sequences is shown in Fig. 2.3 by the
absence ofa signal in at least one ofthe ceil une controls (HP]’, M32, M33, Mel-18,
Mphl/Rae-28, and ENX-1) or one of the purified subpopuÏations analyzed (HP1 and
M31). Except for M32 and HP]’, ail Pc-G gene probes used in these studies only
detected one DNA fragment, as shown by Southem blot analysis of human and rnouse
genomic DNA (data not shown). Therefore, M32 and HP]” probes possibly cross
hybridized with other Pc genes whose expression would also be prorninent in mature
bone marrow cells (fig. 2.3), further supporting our observation that Pc gene expression
is higher in more mature bone rnarrow cells.
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Further insight into Pc-G gene expression was provided by Northern biot analysis,
which showed multiple Pc-G gene signais in several human and murine hematopoietic
ceils. Because our probe for M32 and HP] may recognize more than one gene, some
of the signais detected by Northern Not analysis may be derived from related genes.
However, the signais observed with the probes specific for HP11’, M31, and Met-18
represent alternative transcripts. It would be interesting to investigate whether sorne of
these transcripts are hematopoietic-specific, lineage-specific, or encode proteins with
altered function (eg, dominant negative, etc). Interestingly, the iow to undetectable
expression levels ofthe M32, M33, and Mphl/Rae-28 genes in ail cell unes (Figs. 2.3
and 2.4) contrast with their reiativeiy high expression levels in differentiated primary
hematopoietic celis (Fig. 2.3), raising the possibiÏity that these proteins normally
perfonn antiproliferative functions in mature bone marrow ceils. Indeed, a colTelation
can be made between the expression pattem of BMI-1 and Met-18 (the 2 known
mammaÏian Psc genes) and their ability to control ceiiuÏar proiiferation. BMI-], a known
proto-oncogene, is preferentially expressed in bone maiow cells displaying a high
proliferative potential (ie, subpopulation I; Fig. 2.3), whereas Mei-]8, a gene recently
shown to exhibit tumor suppressive activity,54 is oniy expressed in mature and
nonproiiferating CD34 ceils.
Together, our results show a progressive upregulation of most Pc-G genes concomitant
with differentiation of human bone marrow ceils and support a complex-constitution
model. hi this model, newly expressed Pc-G gene products would progressively interact
with existing Pc-G protein complexes, favoring novel interactions with target sequences.
This, in tum, would allow a progressive packaging ofDNA into an heterochrornatin-like
structure and, for the Hox genes, a progressive 3’ to 5’ closure of the clusters, allowing
proper differentiation of the hematopoietic stem celis. This is rnost interesting in the
view that Hox gene expression decreases 3’ to 5’ during differentiation of hematopoietic
cells47 and overexpression of Hox genes in hematopoietic ceils profoundiy alters their
differenti ation and proliferation.45’46’55
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Fig. 2.5 Sumrnary of Pc-G gene expression pattems observed in different purified
subpopulations ofhurnan bone rnarrow ceils.
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Chapter 3 is a multi-authored work which presents a detailed characterization of the
hernopoietic phenotype ofthe loss-of-function ofBmi-1 and eed, two PcG gene products
belonging to biochernically distinct PcG complexes. The resuits presented in this study
are consistent with an antagonistic function of eed and Bmi-] in hernopoietic ceil
proliferation.
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mice used in these studies and to the writing of the manuscript. Dr Unnur
Thorsteinsdottir helped with the analysis of some of the eed and eed/bmi-] double
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respectively. The paper was written by Julie Lessard under the supervision of Dr Guy
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Abstract
The murine FoÏycomb-Group (PcG) proteins Eed and Bmi 1 govem axial pattenhing
during embryonic developrnent by segrnent-specific repression of Hox gene expression.
The two proteins engage in distinct multimeric complexes that are thought to enhploy a
common molecular rnechanisrn to render the regulatory regions of Hox and other
downstrearn target genes inaccessible to transcriptional activators. Beyond axial
patterning, Bmi] is also involved in hernopoiesis since a loss-of-function allele causes a
profound decrease in bone rnairow progenitor ceils. Here, evidence is presented that is
consistent with an antagonistic function of eed and Bmi] in hemopoietic cell
proliferation. Heterozygosity for an eed null allele causes marked myelo- and lympho
proliferative defects, indicating that eed is involved in the negative regulation of the pool
size of lymphoid and myeloid progenitor cells. This anti-proliferative function of eed
does flot appear to 5e mediated by Hox genes or the tumor suppressor locus
j6INK4a/jARf
since expression of these genes was flot altered in eed mutants. Inter
cross experiments between eed and Bini] mutant mice revealed that Bini] is epistatic to
eed in the control of primitive bone rnanow ceil proliferation. However, the genetic
interaction between the two genes is cell-type specific as the presence of one or two
mutant alleles of eecÏ trans-complements the Bmi]-deficiency in pre-B bone manow
cells. These studies thus suggest that hemopoietic ceil proliferation is regulated by the
relative contribution of repressive (Eed-containing) and enhancing (Bmi 1 -containing)
PcG gene complexes.
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Introduction
The murine Polycomb (FcG) and trithorax (‘trxG,) Group of genes are constituents of an
evolutionary highly conserved epigenetic pathway(s) goveming metameric patterning of
the axial skeleton by regulation of Hox gene expression (for review, see Schumacher and
Magnuson, 1997; Gould, 1997; van Lohuizen, 1998). PcG and trxG gene products are
thought to modify higher-order chrornatin structures to maintain a repressed and de
repressed state of Hox gene expression, respectively. Consistent with their role as
upstrearn regulators of Hox genes, loss offunction ofFcG and trxG genes in mice alters
Hox gene expression causing skeletal transformations. For example, dosage-sensitive
posterior homeotic transformations have been observed in mutant alleles of the murine
PcG genes Bmi] (B cetl-spectfic liO-MLV integration site I) and eed t’embrvonic
ectoderin deveÏopment,.) (van der Lugt et al., 1994; Schumacher et al., 1996).
Beyond axial patterning by control of Hox gene expression, several studies also support
a role for PcG genes in regulating hernopoiesis. For example, differentiation ofprimary
boue marrow ceils is generally accompanied by an up-regulation of PcG gene
expression levels (Lessard et al., 199$). Only Bmi] exhibits a different pattem of
expression with high levels in primitive CD34 celis and very low levels in mature
CD34 ceils (Lessard et al., 199$). Likewise, the Hox gene expression levels are highest
in the most primitive bone marrow celis (Sauvageau et al., 1994). These data are
consistent with a down-regulation of Hox gene expression by PcG proteins as primary
bone marrow ceils differentiate. Furthenriore, by virtue of their transcriptional activation
upon stimulation of lyrnphoid B celis, PcG genes also act as immediate early genes
(Hasegawa et aI., 1998).
Further insight into the function of PcG genes in hemopoiesis can be derived from
mutant analysis. Mice lacking Bntil display a progressive replacement of bone maiow
hemopoietic celis by adipocytes along with an irnpaired proliferative response of the
bone man-ow progenitors to mitogens (van der Lugt et al., 1994). Similarly, targeted
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disniption of mel]8, Mph]/Rae28 and M33 in mice ieads to hypo-proliferation and/or
atrophy ofvarious hernopoietic organs (Akasaka et al., 1996; Takihara et al., 1997; Core
et ai., 1997). Therefore, in ail FcG mutants analyzed thus far, the hemopoietic
compartment rnostly affected correlates with the preferential expression domain, i.e.
stem/progenitor ceils in case of Bmi] and mature ceils in case of inel]8, M33 and
Mphl/Rae28 (Lessard et al., 199$). Recent!y, the first downstream mediator of FcG
rnediated ce!! proliferation was identified. Remova! of the ink4a locus, which encodes
the tumor suppressors j6h1’4a and y94Rf al!eviated the proliferative defects caused by
!oss offunction ofBmi] (Jacobs et al., 1999).
Murine PcG proteins engage in two distinct muitimeric complexes: One complex
includes Eed, Enxl/EzH2 and Enx2/EzH1 (Sewait et ai., 199$; van Lohuizen et al.,
199$; Denisenko et aÏ., 1998) and the other Bmil, Me!1$, Mphl/Rae28, and M33
(Gunster et al., 1997; Aikema et al., 1997; Satijn et al., 1997; Satijn and Otte, 1999). For
simp!icity, the Bmil- and Eed-containing comp!ex is herein referred to as ‘cornp!ex A’
and ‘compiex B’, respectively. Based on the phenotypic similarities arnong complex A
and complex B FcG mutants, axial patteming of the primary body axis is likely to
involve a common regu!atory effect on Hox gene expression. Consistent with this
hypothesis, Bmil/1vf33 double mutants show synergistic interactions resulting in
enhanced axial phenotypes (Bel et ai., 1998). Likewise, the penetrance of homeotic
transformations in eed/Bmi] double mutant animais is significant!y increased as
cornpared with the single mutant phenotypes (A. Schumacher and T. Magnuson,
unpubl.). In the hemopoietic iineages, complex A PcG genes exert a positive regulatory
effect on celi proliferation. The function of complex B genes in hemopoiesis is
unknown. However, by analogy to the rather uniform PcG function in axial patteming,
compiex B genes are predicted to act as positive regulators of hemopoietic ceil
proliferation with synergizing effects in double mutant combinations with complex A
alieles.
Here, the hemopoietic phenotype of mutant a!!eies of the complex B gene eed is
described. Surprisingly, eed acts as a negative regulator of myeloid and !ymphoid
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progenitor celi proliferation in the bone rnanow. This reflects a functional antagonism
between the complex A gene Bmil and the complex B gene eed, which act as positive
and negative regulators of bone manow progenitor ceil proliferation, respectively.
Hyperproliferation of eed mutant ceils is not associated with altered expression of Hox
genes and the ink4a locus and, therefore, involves as yet unknown downstream
mediators. Inter-cross experirnents revealed an epistasis of3inil to eed in the control of
bone rnarrow stem celi proliferation because the eed/Bmi] double mutant phenotype is
identical to the Bmil single mutant phenotype. However, genetic interaction between the
two genes is celi-type specific as the presence of one or two mutant eed alleles trans
complements the Bmi]-deficiency in pre-B bone marrow ceils. These resuits reveal an
unexpected complexity in PcG function in murine hemopoiesis.
Resuits
Expression of eed and Bmil in bone marrow celis
Bmi] is preferentially expressed in primitive subpopulations of human bone maiow
celis (Lessard et al., 199$). In contrast, eec! is expressed at about equal levels in both
primitive and mature human hemopoietic celis (J. Lessard and G. Sauvageau, unpubl.).
The expression of these two genes was similarly determined in mouse primary bone
marrow cells representing functionally distinct stem/progenitor (Sca Liiï) and mature
(Sca Lin) ceil compartments (Fig. 3.1A). In agreement with the human data, only the
Sca Lin subpopulation displayed an elevated expression level of mouse Bmi] (Fig.
3.1A, upper panel) whereas eec! expression was consistently high in all subpopulations
(Fig. 3.1A, middle panel).
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Fig. 3.1 Expression of eed and Bmil PcG genes in purified subpopulations of murine
bone marrow ceils and hemopoietic ccli unes. (A) five to ten thousand celis were
isolated from each subpopulation (>98% purity upon reanalysis), and their total RNA
was reverse-transcribed and PCR-arnplified as described in Material and Methods.
Cocktail of lineage-specific (Lin) monoclonal antibodies (MoAbs) contained B220 (B
lymphocytes), Gr- 1 (granulocytes), and Mac-1 (granulocyte-macrophages). From
primitive to mature subpopuiations: Sca+ Lin- subpopulation (lane 2); Sca- Lin+
subpopulation (lane 3). Exposure times (alI at -70°C) are as follows: BmiÏ, $3 hr (except
all hemopoietic cdl lines, 20-hr exposure); eed, 4.5 hr, and -Actin, 25 min (except $2
Drosophila ccii line, 75-min exposure). (B) Schematic representation of complexes A
and B PcG gene expression pattems in purified subpopulations of primary bone marrow
ceils (this paper; Lessard et al., 1998; Sauvageau et ai., 1994).
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eed ïs a negative regulator of boue marrow progenitor ceJi proliferation
The ubiquitous expression of human and mouse eed in bone maiiow ceils suggests that
this gene may function in both primitive and mature hemopoietic celis. To test this
hypothesis, the proliferation and differentiation of primitive and mature bone marrow
celis was assessed in eed mutants. Hemopoietic ceils were derived from animais
carrying one or two copies of a viable hypomorphic allele of eed, 17Rii5’989 (herein
1989/+ 1989/1989 335488refeiTed to as eecl and eecl ) or one copy of an eed nulÏ ailele, l7Rn5
(herein referred to as eed3354j (Schumacher et al., 1996). Homozygosity for the eed3354
allele is lethai at gastrulation (Faust et aI., 1995) and, thus, exciudes analysis of
hemopoietic celis.
When compared to control littermates, the boue manow, spleen, thymus and peripheral
blood counts were normal in ail young eed mutants analyzed, that is, animais of <4
rnonths of age (n> 5 per group). Moreover, cytologicai and cytofluorometric analysis
showed that myeÏoid (Mac+, Gr-1+), B (B220+CD43+; B220+IgM+) and T
(CD4+CD8+; CD4-CD$-; CD4+ and CD8±) ccli populations derived from eed’989,
eed’98971989 and eed3354 mutant mice were simiiar to that of sibling control animais (data
not shown). However, there was a 2- and 3.5-fold increase in the frequency of mature
3354/+myeloid and pre-B Iyrnphoid progenitors, respectively, in the boue marrow of eed
animais (Fig. 3.2B) when compared to control littenriates. Moreover, eed3354 pre-B
progenitor-derived colonies were on average four times larger than those derived from
controi animais (data not shown). Morphological analysis and immunophenotyping
conflrmed that these colonies contained mostly B lymphocytes, indicating that eed
mutant cells undergo increased proliferation prior to becoming terminally differentiated
(data flot shown).
To ascertain whether the precursors of the mature myeloid and lymphoid colony
forming celis (CFCs) were affected in eecl mutant animais, the frequency of the mostly
quiescent primitive boue marrow myeloid long-terni culture-initiating ceils (LTC-ICs)
and lyrnphoid Whitlock-Witte-initiating cells (WW-ICs) were measured by limiting
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dilution analysis. The resuits presented in Fig. 3.2B indicate that LTC-IC frequencies are
comparable between the controls (n3) and the eed mutant mice (n=6 total for eed’°89
and eed’989’989 and n=2 for eed3354j. The WW-IC, which was only evaluated in the
eed’989 mice, was also flot significantly different from the controls.
Thus, the significant increase in the number ofthe more mature myeloid and pre-B bone
3354/+ . .
rnairow progemtors in young eed mutant mice is consistent w;th eed actmg as a
negative regulator of ceil proliferation in mature bone maiow progenitors.
A
LTC-IC HPP-CFC myeloid-CFC mature celis
(Z’ © diftntiatiori
WW-IC pre B-CFC
B-lympboid
differentiation
primitive mature
B
Absolute numbers (per femur) ofprimitive and more mature myeloid and iymphoid progenitor
cells in bone marriw of eed mutant mice
B-lymphoid lineage Myeloid ineage
Mce No. ofWAN-IC Pre-B-CFC No. ofLTC-IC Myeloid-CFC HPP-CFC
/femur ifemut fxlø’) Ifemur Ifemur (x1D) tfemur (x103)
Controlb 1386±147 2 ±0.4 575 ±220 99 ±18 25±5
eed 2255±807 4 ±1 785 ±272 82 ±19 19±5
eed334 n.a. 7 ±1 795 ±142 187 ±22 42±8
Fig. 3.2 Eed is a negative regulator of the proliferative activity of bone rnairow
myeloid and lyrnphoid progenitor cells. (A) Schematic representation of the myeloid
and B-lyrnphoid differentiation pathways. (B) Absolute numbers of primitive myeloid
(LTC-IC), primitive lyrnphoid (WW-IC), and colony-fonning celis (CFC) per femoral
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bone of 12- to 16-week-old eecÏ mutant mice. Resuits are expressed as mean ± SD.
(HPP-CFC) High proliferative potential co]ony-forming ceils; (pre-B) B ce!! precursors;
(n.a.) not available. a lic1udes both co!ony-forniing-unit-granulocyte-rnacrophage
(CfU-GM) and co!ony-fonning-unit-granu!ocyte-erythroid-rnonocyte-rnegakaryocyte
(CFU-GEMM) (>1000 ce!ls); b CFC (n=9), LTC-IC and WW-IC (n=3); C includes both
eec1’989 and eecl’98911989 mutant mice, CfC (n9), LTC-IC (n=6), and WW—IC (n=2); U
CFC (n=5), LTC-IC (n=2).
Lymphoid and myeloid hyper-proliferation in older eed mutant mice
To investigate the long-tenn effect of decreased Eed activity in hemopoietic cel!s, nine
eed3354/+ mice were analyzed between 7 to 18 rnonths of age. 0f these, five had
developed Iympho-proliferation (LP) (group 3; Figs. 3.3 and 3.4), three mice suffered
from a severe rnyelo-proliferative disease (MPD) (group C; figs. 3.3 and 3.4) and one
was stiil relative!y normal (group D; fig. 3.3) although it had a noticeable increase in
bone rnarrow pre-B progenitors (fig. 3.4A).
The Ïympho-proliferative defect observed in eed3354 mice (group B) was ciaracterized
by a 35-fold increase in the frequency of lymphoid (pre-B) bone rnarrow progenitor ceils
with highly increased pro!iferative activity when cornpared to control litterrnates (group
A, Fig. 3.4A). Morphological and cytofluorornetric analyses confirrned that these celis
were of B lineage origin (data not shown). A smaller but significant increase in the
frequency of immature !yrnphoid (WW-IC) and rnye!oid (LTC-IC) bone rnanow
progenitor ceils was also found in eed3354 mice when cornpared to control !ittermates
(3.5-fold and 2—fold increase, respectively; Fig. 3.43). Furtheniiore, as evaluated by the
number of B ceils produced per WW-IC at lirniting dilution, the prof iferative potential of
individual eed3354 group B immature WW-IC !yrnphoid progenitors was increased by
12-fo!d as compared with control anima! s (Fig. 3.4C). This provides a possible
exp!anation for the increase in pre-B CFC in these mice.
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Despite as much as a 35—fold increase in the frequency of pre-B-ce!l population in
eed3354 mice, there were no significant changes in the absolute numbers of more mature
B ceils in the bone rnarrow and peripheral hemopoietic organs of these mice when
compared with controls (Fig. 3.3A,B). These observations suggest that a cornpensatory
mechanisrn must operate to maintain normal numbers of mature ceils in eed3354
animais. One possibility is that pi-e-B CFC detected in vitro would not survive in vivo
under lirniting cytokine (e.g. IL-7) conditions. Therefore, survival assays were
perforrned in which IL-7 was added following an initial culture period of 0, 24, 48 or 72
hr. $uch delayed addition of IL-7 did not resuit in a significant decrease in colony
3354/+ . .formation in eecÏ cultures with respect to that of control littermates, mdicatmg that
eed3354 group B lymphoid precursors (pre-B) are not more sensitive to cytokine
deprivation than control ceiis (data not shown). This suggests that B-ce!! homeostasis in
these mice might be dependent on ‘periphera! regu!ators’ of B-ce!! numbers.
A severe MPD also developed in some ofthe o!der eed3354 mice (group C, 7-18 months
of age; Fig. 3.3), which showed genera! signs of i!!ness and severe weight !oss. When
sacrificed, they were athyrnic and showed splenomegaiy and !yrnphadenopathy.
Bacteriology, parasito!ogy, and viro!ogy testing of plasma and severai tissues isolated
from these animals excluded pathogen infections (data not shown). These mice
displayed higli peripheral white blood cel! counts, representing almost exc!usively
segrnented neutrophils (Fig. 3.3A). Cytofluornetric ana!ysis of ce!ls derived from the
bone marrow, spleen, thymus, and lyrnph nodes of these mice showed a profound
increase in the frequency of a mye!oid population of celis coexpressing the Mac-1f and
Gr-1 surface markers (up to 91% and 57% of total bone marrow ce!!s and splenocytes
coexpressed Mac-1f and Gr-1, respective!y; Fig. 3.3B). These mice a!so exhibited a
marked decrease in the number ofbone rnarrow B22OE’igM immature B cells (<1% of
wiid-type !evels) and mature IgMIgD B ce!!s (44% of wild-type levels; Fig. 3.3B) in
secondary lymphatic organs, !ike!y reflecting infiltration and disp!acement by the
expanding myeioid population. In the on!y mouse presenting an invoiuted thymus, the
ratio of CD4 to CD8 T cells was normal (data flot shown). Despite a 2-fold reduction
in bone maiow ce!!u!arity, myeloid bone marrow progenitors were increased 2.5-fold
133
and consisted predominantly of granulocyte and/or macrophage colony-forming celis (G
and/or M-CfCs) (Fig. 3.4A; data iiot shown). Consistent with the cytofluorornetric
studies, the absolute numbers of pre-B and immature Iymphoid B-(WW-IC) cd
populations in these mice were reduced to 1 .6% and 37% of wild-type levels,
respectively (Fig. 3.4A,3).
Importantly, the myelo-proliferative disorders were observed only in eed3354 mice that
derived from the double mutant crosses with Bmi], suggesting that this phenotype may
5e rnodulated by the presence of a modifier gene(s) in the FVB/N background
(C3Hf/101 vs. C3Hf/101 x FVB/N; fig. 3.3).
The hyperproliferative effects observed mostly in the lyrnphoid 3-ceil lineage of
C3Hf/101 eed mutant mice would suggest that eed may be another member of the
growing farnily of tumor suppressor genes. To test for this possibility, a larger cohoiÏ of
eed mutant mice (including 12 homozygous eed’989’989 and 2$ heterozygous eed’989
mutant mice) were monitored for tumor formation for up to 2 years, of which a single
case was observed in a 3-rnonth-old eed’989’989 mouse. Morphological, cytological, and
DNA analyses confinned that the tumor was a monoclonal B-cell lymphorna [see
histology and 3-celi receptor (BCR) rearrangement in Fig. 3.5J. Interestingly, the
exposure of eecÏ’989 and eed3354 mice to a genotoxic agent, methylnitrosourea (MNU),
led to lymphoid tumor formation in 100% of these mice in a timeframe where no tumors
would develop in control animals (E. Richie, A. Schumacher and T. Magnuson,
unpubl.).
Together, these data indicate that eect perfonns important antiproliferative activity on a
subset of early (WW-IC) and late (myeloid and pre-B CFC) bone marrow progenitors
and that ultimately, its absence may lead to tumor formation. These data contrast with
previous studies of mutant complex A PcG genes (including Bmil) where
hypoproliferation of hemopoietic precursors vas observed (van der Lugt, 1994;
Akasaka, 1996; Core, 1997; Takihara, 1997).
eed — (7—18 months fiuioiv—up)
Group C (MFD
(n3)
Fig. 3.3 Cytopathological (A) and cytofluorometric (B) analyses of hernatopoietic celis
isolated from older control and eecÏ3354 mutant mice. (A) Wright staining ofperipheral
blood srnears (P3), bone manow (3M) cytospins, and touch preparations’ of spleen
(SPL) from representative control, eed3354 group B (LP), eed3354 group C (MPD) and
eecÏ3354 group D mutant mice (also described in Fig. 3.4). Note the infiltration by
neutrophils (n) in ail tissues of eed3354 group C (MPD) mutant mice. Magnification,
lOOx for ail, except for peripheral blood, 40x. Note that absolute number of bone
marrow cells per fernur is reduced about twofold and absolute number ofnucleated ceils
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(n5)
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per spleen is increased about fourfold in eecÏ3354 group C (MPD) mutant mice. For B,
resuits are expressed as mean ± SD. (LP) lyrnphoproliferation; (MPD)
myeloproliferative disease. a Absolute numbers of bone manow ceils per femur:
Control group A 3.2 x i07 ± 0.2, eed3354 group B (LP) 2.9 x i0 ±0.3, eed3354 group C
(MPD) 1.5 x i0 ±0.5., eed3354 group D 2.1 x io; b Absolute numbers of nucleated
S 3354/+ 8celis per spleen: Control group A 1.8 x 10 ±0.5, eed group B (LP) 1.4 xlO ±0.1,
eed3354 group C (MPD) 7.8 x 108 ±1.6., eed3354 group D 2.4 x 108. (*), Only one
mouse analyzed.
3354/+Fig. 3.4 Myelo- and lyrnphoproliferation occur in old eed mutant mice. (A)
Femur-derived bone rnarrow celis were assayed in methylcellulose for rnyeloid and pre
B lymphoid CFCs. (B) In vitro long-term culture assays of primitive myeloid (LTC-IC)
and lyrnphoid (WW-IC) bone marrow celis. The resuits, mean ± SD, are given as
absolute numbers per femur. (C) CFC generated per LTC-IC at lirniting dilution after 28
days of in vitro culture; includes colony-forrning-unit-granulocyte-macrophage (CfU
GM) and burst-fomiing-unit-erythroid (BFU-E). WW-IC-derived B22O 3 celis (at
limiting dilution) were analyzed by FACS at day 21 of culture. (*), Not deterrnined.
3354/+(Sohd bar) Control group A (n=4); (shaded bar) eecÏ group B (LP) (n5); (dotted
bar) eed3354 group C (MPD) (n=3); (open bar) eed3354 group D (n’1).
Myeloid Lineage
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Fig. 3.5 Monoclonal B-celi tumor in a 3-rnonth-old eed’989’989 mutant mouse. A)
Histological analysis ofa hematoxilin and eosin section ofa thoracic turnor (1.5 grams).
Note the infiltration by mature darkty stained lymphocytes. Magnification lOOx. (B)
Southem blot analysis of genomic DNA isolated from the tumor showing clonai (see
anow) BCR reaffangernent. Note the absence of clonai BCR rean-angernent in bone
rnarrow ceils of this same mouse (BM) and in the spleen and bone maiow of a healthy
control mouse. Membrane was hybridized to a probe colTesponding to the IgH intronic
enhancer iocus capable of detecting both V(D,)J and DJ joints. Exposure time was 84 hr.
(IgI—i9, Innntmoglobulin Fleavy Chain.
eed and Bmil have opposite functions in regulating hemopoietic celi proliferation
Bmil nuli homozygous mice display a severe and progressive reduction in their number
and proliferative potentiai of (mature) bone manow myeloid and pre-B progenitors (van
der Lugt et al., 1994). Interestingly, the eed mutant mice describcd herein have the
opposite hernopoietic phenotype (i.e., a progressive increase in the number and
proliferative potential of several types of bone marrow CFCs). The coexpression of
Bini] and eect in every hemopoietic ceil une tested to date together with their
expresssion in primitive Sca Liii bone mairow cells (Fig. 3.1), suggests that eed and
Bniil may functionally interact to regulate hemopoietic ceil proliferation. To obtain
genetic evidence for a functional collaboration between these two PcG proteins, eed and
Bmi] double mutant mice were generated and their hemopoietic system analyzed.
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eed’989Bmi1 and eed3354Bmi] double mutant mice were severely anemic, and in
vitro colony formation assays ofbone rnarrow progenitors ceils isolated from these mice
gave identical results to those observed with Bini] mice (Fig. 3.6A). Therefore, the loss
of one or two functional alleles of eed did not alter the hemopoietic defects observed at
the mature CFC level in 3mi1 mice. As previously reported, the loss of one allele of
Bmi] resulted in a small reduction in mature rnyeloid CFC and a significant threefold
reduction in pre-B progenitors (Fig. 3.6A; van der Lugt et al., 1994). In contrast, the
number ofpre-B CFC in the bone rnaiow of eed/ Bmi]’ double mutant mice was close
to that found in control littermates. This indicates that the loss of one or two alleles of
eed trans-complemented the deficit at the pre-B CFC level found in Bmi] mutant mice
(n= 7 vs. 13 B,iii1 and eed/ 3miÏ mice analyzed, respectively; Fig. 3.6A). These data
are consistent with a celi-type specific interaction between the two genes and reveal an
unexpected complexity in PcG function in hernopoiesis.
The capacity for eed and Bnii] to functionally interact in the more primitive bone rnarrow
LTC-ICs, and WW-ICs was also evaluated. Since LTC-IC and WW-IC numbers and
proliferative capacity had not been determined previously in Bmi] nnitant mice, we first
completed this evaluation. The results presented in Fig. 3.6B indicate that in 3mi] mice,
the absolute numbers of both primitive rnyeloid (LTC-IC) and lyrnphoid (WW-IC) cell
populations were profoundly reduced to 4% and 1% of wild-type levels, respectively.
Moreover, the proliferative potential of these primitive progenitor ceils was severely
affected. Absolute numbers of LTC-IC-derived CFCs and WW-IC-derived B22O B ceils
anaÏyzed at limiting dilution were reduced 17-fold and 34-fold, respectively, in BmiF
mice as compared with littennate control mice. The pool and proliferative activity of
Bmi] bone marrow primitive precursors progressively decreased with age (data not
shown), and, as reported previously, BiniT mice did not survive beyond 20-25 weeks of
age. Importantly, the numbers and proliferative potential of primitive rnyeloid (LTC-IC)
and lymphoid (WW-IC) cells were not different between eed/BmiT’ double mutant mice
and the single Bmi] mice (Fig. 3.6B).
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In Bmi] heterozygous mice, reduction of Bmi] expression levels neither altered the
number nor the proliferative potential of primitive myeloid ceils (LTC-ICs) but clearly
reduced the proliferative capacity of primitive lymphoid (WW-IC) progenitors (contro!:
2295 B cells/ WW-IC; Biizi1: 275 B cells/WW-IC; fig. 3.6B). This indicates that
heterozygosity for Bmi] limits the proliferative capacity of these progenitor ceils. The
proliferative potential of Biiii1 WW-ICs was partially rescued by the loss of one or
two alleles of eed (from 275 ± 43 to 919 ± 341, for 3mi1’ and eed/ Bmi1’ double
mutant mice, respectively).
Taken together, these resuits indicate that the rnarked reduction of mature bone rnanow
progenitors and differentiated blood ce!ls previously reported in Bmi]-deficient mice
may in fact originate from a major proliferative defect in the pool of primitive rnyeloid
and lymphoid progenitors. In addition, these studies dernonstrated that, aÏthough one
allele ofBmi] is sufficient for the generation of primitive bone marrow celis, both alleles
are required for the proliferation of a group of B-ce!! precursors. furthennore, a
reduction in functional eed trans-cornplements the loss of one allele of Bmil in this
subset of precursors.
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Contro[n=a) 1428*181 2295±880 797*469 17*9
8mi1 868± 326 275 ± 43 3139 ± 2270 16 ±12
8miItn=2i 15*15 67±16 34*7 1 ±0,1
oedi &miL {n=j 22±9 73±11 24±8 1 ±0.3
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Fig. 3.6 Hemopoietic parameters of Bmi] mutant and eed/Bmi] double mutant mice
analyzed at 12-16 weeks of age. (A) Bone malTow, spleen, and thymic cellularity (left)
and bone manow CFC numbers (right) in control (n=9), Bmi] (n=7), Bmi] (n=3),
eed Bmi1 (either eed3354 or eed’989; n3) and eed/ Bini1 (either eecÏ’989 or
eed’989’989; nl3) mutant mice. For clarity, the results for single C3Hf/101 x FVB/N
eed mutant mice were excluded from this table because the data are superimposable to
that of the C3Hf/101 eecÏ mutant animais presented in Fig. 3.2B. (B) Frequency and
proliferative potential of primitive myeloid (LTC-IC) and primitive lymphoid (WW-IC)
bone marrow celis in Bmil versus eed/Bmi] double mutant mice. All results shown in A
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and B represent mean values ± SD. (*), Not determined. NC) Nucleated celis; (HPP
CFC) High proliferative potential-CFC. a Absolute number of B220 cells analyzed by
FACS at day 21 of in vitro culture; reflects the proliferative potential of individual WW
IC• b Absolute number of CFC per LTC-IC; reflects the proliferative potential of
individual LTC-IC. C One eed’989 Bmi] and two eed3354 Bmi1 mutant mice were
included in this calculation because they had very sirnilar phenotypes. d Includes both
eed’989 Bnzii and eed’989’989 Bnu] double mutant mice because they had very
sirnilar phenotypes. e The values conesponding to the Bmi] and eed/BmiÏ groups of
mice are not overlapping but, because of an extreme value obtained in one eed/ Bnii1
mouse (1980 B cells/ WW-IC), they are not statistically different (p<O.07, one-tailed
Students t-test with unequal variance).
ink4a and Hox gene expression are not altered in eed mutant mice
Recent studies revealed a marked increase in the expression levels of the tumor
suppressor genes p]6”4’ and p]94’ along with concomitant down-regulation of cyclin
A and E activity in Bmi]-deficient mouse embryonic fibroblasts and lymphocytes
(Jacobs et al., 1999). To identify candidate downstrearn mediators of eed function,
p16”4” and j9ARF expression was analyzed in bone manow (rnostly rnyeloid), spleen
(mostly B and T cells) and thymus (T celis) of old eed3354 mice and in the B-cell turnor
that developed in the eed’989’989 3-month-old mouse. The results presented in Fig. 3.7
(top) do not show any difference in the expression level 0f]614a/]pÀ1 between the
various mice analyzed (i.e., old eed3354 vs. littenTiate controls vs. young eed’989’989).
This suggests that these two genes do not mediate the hyperproliferative activity of
mutant Eed. Interestingly however, ]6h1<4a and p19Mexpression was undetectable in
the eecl’989’989 mutant mouse B-cell tumor as well as in the human leukemic cell une
controls, likely reflecting inactivation of the ink4a locus, an event observed in several
hemopoietic malignancies (Pinyol et al., 1998; Maloney et al., 1999).
Based on the observation that Hox gene overexpression causes myelo- and
lymphoproliferation (Sauvageau et al., 1997; Thorsteinsdottir et al., 1997; Kroon et al.,
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1998), this group of genes represents another potential mediator of eecÏ function.
However, as shown in Fig. 3.7, the expression levels of Hoxa], Hoxa2, Hoxa6 “not
shown,), Hoxb2, Hoxb3 (‘flOt shown,), Hoxb4, Hoxc4, Hoxd4, Hoxa9,Hoxb9 and HoxalO
in hemopoietic tissues of eed mutant mice (see above) were similar to those of control
sibling 1itternates. This indicates that the increase in the proliferative activity of
hemopoietic celis in eed mutant mice does not involve major changes in Hox gene
expression. Therefore, the hyperproliferative phenotype in eed mutant mice involves a
set ofunknown downstream mediators.
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Fig. 3.7 Expression 0f]6W1<4(1, p19”, and selected Hox genes in various hemopoietic
organs of eed mutant mice together with an mutant mice presenting a
monoclonal B-ce!! lymphoma. Isolation of total RNA from eed mutant hemopoietic
celis is described in Material and Methods. Control (lanes 1-3, 5) and eed3354 (lanes 2-
4, 6) mutant mice were ail 15 months o!d, and control (lane 7) and eed’989’989 (lanes 8,9)
mutant mice were 3 months o!d. Exposure times for Hoxc4, Hoxb4, Hoxa2, Hoxb9, and
Hoxa] was 20 hr; Hoxd4 and Hoxa9, 26 hi (al! on a phospholmager cassette). Exposure
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tirnes forp16”’4’ was 3.5 hi; for pl9’and HoxalO, 77 hi; for Hoxb2, 20 hi; and for fi
Actin, 2 1w (ail at -70 °C). eed’989’989 turnor is described in fig. 3.5. (K562 and HL-60)
Hurnan myeloid celi unes used as positive controls for Hox and negative controls for
]6fNK4a/]ARF expression. (No R.T.) No reverse transcription.
Discussion
This study presents evidence for several critical differences in the function ofthe murine
PcG genes eed and Bniil in hemopoiesis. (1) eed and Bmi] represent functional
antagonists in hemopoietic celi proliferation. Whereas Eed acts as a negative regulator of
hemopoietic progenitor ceil proliferation, Bmil enhances the proliferative activity of
primitive (this study) and more mature (van der Lugt et al., 1994) bone mairow
progenitor ceils. (2) The anti-profiferative function of Eed does not seern to involve Hox
genes or the tumor suppressor locus (3) Double mutant analysis reveals
that Bmi] is epistatic to eed in the control of bone marrow stem celi proliferation. (4)
The genetic interaction between eed and Bmil is celi-type specific because the presence
of one or two mutant eed alleles trans-complernents the Bmil-deficiency in pre-B bone
marrow celis.
Functional antagonism between eec! ami Bmil
Based on hyperproliferation of primitive and mature bone rnarrow progenitors in eed
mutant mice, wild-type eecl functions as an inhibitor of hernopoietic progenitor ceil
proliferation. This stands in sharp contrast to the role of3mi] as a positive regulator of
the proliferative activity ofprogenitor celis. These opposite effects of eed and Bmi] may
be attributed to their involvement in distinct protein complexes. Biochernical studies
indicate that the PcG proteins Bmil, Me118, M33 and Mphl/Rae-28 are constituents ofa
multirneric protein complex A, which localizes to discrete nuclear foci in U-2 OS
osteosarcorna ceils (Aikema et al., 1997; Gunster et al., 1997). Importantly, Eed neither
interacts physically with Brnil nor engages in this protein complex (van Lohuizen et al.,
1998b; Sewait et al., 1998). Instead, Eed forrns a complex B with the PcG proteins
Enxl/EzH2 and Enx2/EzH1, which lacks signs of a discrete subnuclear distribution and
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is found rather uniformly throughout the nucleoplasm of U-2 OS osteosarcorna celis
(van Lohuizen et al., 1998).
In ail cases, the protein interaction domains have been delineated. For example, the
central helix-tum-helix domain of the complex A protein Bmil is required for
interaction with other PcG proteins, such as Meli 8, Mphl/Rae28, and M33 (Gunster et
al., 1997; Aikema et al., 1997; Satijn and Otte, 1999; Satijn et al., 1997). The complex B
protein Eed contains several WD domains, whose integrity is essential for interaction
with the amino termini of the PcG proteins Enxl/EzH2 and Enx2/EzH1 (van Lohuizen
et al., 1998; Denisenko et ai., 1998; Sewalt et al., 1998). Accordingly, the proline
substitution in the second WD motif of the eed3354 nuil allele provides a maxirnally
disruptive effect on protein folding (Schurnacher et al., 1996) and ablates interaction
with Enxl/EzH2 and Enx2/EzH1 (van Lohuizen et al., 1998; Denisenko et al., 1998). In
contrast, the relative confonnational tolerance of an asparagine substitution in the
second WD motif of the eed’989 hypomorphic allele (Schumacher et al., 1998) perniits
interaction with Enxl/EzH2, albeit at a reduced efficiency (van Lohuizen et al., 1998).
Sirnilarly, unlike the eed3354 nuli allele, the eed’989 hypomorphic ailele does not cause
major defects in B-cell proliferation.
These resuits are consistent with a distinct function of the two murine PcG complexes,
which, similar to Drosoph lia ineÏanogaster, may constitute heterogenous regulatory
complexes at various target loci (Sinclair et ai., 1998; DeCamillis et al., 1992; Strutt and
Paro, 1997). Gene dosage effects and haploinsufficiency were reported in mice bearing
one inactivated allele of the complex A Bmi], inell8, M33, Mph]/Rae-28 and complex
B eed PcG genes (van der Lugt et al., 1994; Core et al., 1997; Akasaka et al., 1996;
Takihara et al., 1997), suggesting that a change in the concentration ofone component of
either of these PcG complexes affects the activity of critical reguiators of cellular
proliferation in mice. Therefore, proliferation of hernopoietic cells appears to be
controiled by a stoichiometric relationship between complex A-mediated stimulation and
complex B-mediated inhibition of celI proliferation. Disturbances in this equilibrium, for
example, over-representation of the Bmi 1 -containing stimulatory complex A in eed
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mutant celis, may lead to important proliferative abnonnalities. In fact, the loss of a
single Bmi] or eed allele inhibits and stirnulates the proliferative activity of B-ceil
progenitors, respectiveiy. By virtue of their co-expression during hemopoiesis and
physicai interaction, loss of function of Enx]/EzH2 and/or Enx2/EzHJ shouid therefore
result in dosage-sensitive proliferation defects in bone marrow ceils that are rerniniscent
ofthe eed phenotype.
Eed, a PcG proteïn with tumor suppressing activity
The hyperproliferative defects observed in eed mutant animals together with the
susceptibility of these mice to develop hemopoietic tumors would suggest that Eed has
tumor suppressing activity. Since point mutations at the eed gene locus which account
for the eecl’989 and eed3354 alleles were shown to disnipt its interaction with Enx (see
above), it will be interesting to detennine whether Enx mutant animais also develop
turnors, thereby ascribing the tumor-suppressor function to the Eed-Enx PcG ‘B’
complex. The requirement for exposure to genotoxic agents and the long latency before
tumor development indicate that additional genetic events are required for ‘full
transformation’ ofhemopoietic ceils lacking a functional eed gene.
A genetic hierarchy of PcG function in hemopoiesis
eed and Bmi] function in axial patterning is likely to be governed by a common
regulatory effect on Hox gene expression. For example, a null allele of Bmil displays
posterior homeotic transformations along the anterio-posterior (A!P) axis (van der Lugt
et al., 1994). Several of these skeletal transformations are phenotypically identical to
those observed in a hypornorphic allele of eed (Schumacher et al., 1996). Furthenriore,
consistent with the regulation of a common set of Hox genes, the penetrance ofhomeotic
transfonnations in eed/Bmi] double mutants is significantly increased as compared with
the single mutant phenotypes (A. Schumacher and T. Magnuson, unpubl.). This is
similar to Drosophila meÏanogctster, wherein axial homeotic phenotypes are enhanced in
various double and triple PcG mutant combinations (Soto et al., 1995). Importantly, this
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includes the interaction between esc (extra sex combs) and Psc (Fosterior sex combs),
the fly homologues of eed and Bmi] (Campbell et al., 1995).
In contrast, genetic analysis of eed and Bmil function in hernopoiesis reveals an
unexpected complexity because the eed/Bmi] double mutant phenotype in primitive
bone rnarrow ceils was identical to the Bmi] single mutant phenotype. This suggests that
Bmi] is epistatic to eed in the control of hemopoietic stem celi proliferation.
Altematively, the two genes may flot be coexpressed in the relevant subtypes of bone
marrow progenitors, and hence, epistasis is not tested in the double mutants. WW-ICs
and pre-B lymphoid CFCs as the primary target celis of eed and Bmi] function are
certainly rare and unlikely to be isolated to absolute purity. However, several
observations argue for the coexpression of Bmil and eed in these bone marrow
progenitor ceils. First, eed is expressed in every tissues analyzed thus far (Schumacher et
al., 1996; Denisenko et al., 199$). Second, all 10 hemopoietic cell unes analyzed thus far
reveal coexpression of eed and Bmil (Lessard et al., 199$). Finally, the two genes are
coexpressed at high levels in Sca1 Lin bone marrow cells, which are highly enriched
for stem ceils and primitive progenitors (Morrison and Weissman, 1994). Therefore,
these data provide strong support for the epistasis ofBmi] to eed.
Remarkably, the genetic interaction between eecl and BmiÏ is celi-type specific because
the presence of one or two mutant eed alleles trans-complements the Bmi]-deficiency in
pre-B bone marrow cells. This may reflect differences in genetic interaction between eed
and Bmil as reflected by the lower expression level of Bmil in this cell population.
Altematively, qualitative differences, e.g. a divergent composition of complex A and/or
B, could also account for this phenomenon. Clearly, these resuits reveal an unexpected
complexity in PcG function in hemopoiesis.
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Downstream mediators of eed and Bmil function
The question arises as to whether, sirnilar to axial patteming, eed and Bnii] function in
hemopoiesis involves a common set of downstream mediators. By virtue of their
downreguiation upon differentiation ofprirnary bone marrow celis (Lessard et ai., 1998)
and their weii-documented foie as downstream mediators of PcG function in axial
patterning, Hox genes are perhaps the most likeiy candidates. In particular, they can be
considered as primary effectors of the inhibitory function of eed in hemopoietic celi
proiiferation because overexpression of Hox genes causes hyperproiiferative defects in
mouse bone marrow ceils ($auvageau et ai., 1997; Thorsteinsdottir et al., 1997; Kroon et
al., 1998). $urprisingiy, the expression levels of 11 different Hox genes (including
Hoxb4 and Hoxc4 which show altered anterior expression boundaries in paraxial
mesoderm in eed mutant mice; A. Schumacher and T. Magnuson, unpubi.), were not
detectably altered in hemopoietic tissues of eed mutant animais. This indicates that the
function of eed as an inhibitor of hemopoietic progenitor ceil proiiferation does flot
invoive Hox genes.
Recently, the ink4a locus was identified as the first downstream mediator of PcG
mediated celi proliferation. Removal of ink4a, which encodes the tumor suppressors
p16’4’ and 19ARF aiieviated the lymphoid and neuroiogicai defects seen in Bmi] nuii
mutant animais (Jacobs et ai., 1999). However, given the drarnatic differences in
hemopoietic defects between eecÏ and Bmi] mutants, the ink4a iocus is unlikeiy to be
reguiated by Eed. The j64a and ]9ARF expression ieveis were not aitered in eed
mutant ceils.
These resuits iead to the modei iiiustrated in Figure 3.8. Therein, the function ofthe two
PcG complexes has evolved from a common repressive effect on Hox gene expression in
axial patterning to a more divergent activity in hernopoietic celis. The hemopoietic target
genes involved in the proliferative activity of complex A PcG proteins, including Bmi 1,
seem to inciude the turnor suppressors j61NK4a d ]9ARF In contrast, the complex B
PcG proteins, inciuding Eed, exert their function through the reguiation of other, as yet
unknown, downstream genes. Thus, an intricate equiiibrium between two PcG protein
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complexes governing distinct molecular pathways is critical for hemopoietic ceil
proliferation in mice.
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Fïg. 3.8 Schematic representation of Eed and Brnil mediated effects in embryonic vs.
hernopoietic development in mice. Eed and Brnil PcG proteins synergize to regulate
differentiation of skelettal/bone precursor celis possibly through a common regulatory
effect on Hox gene activity. Conversely, Eed and Brnil have opposing functions in
regulating hemopoietic cdl proliferation in mice that appear to be Hox gene
independent.
Materiais and Methods
Animais
Production of eecÏ’989 hypomorphic and eecÏ3354 nuil mutant mice (1O1/R1 x C3Hf/R1
hybrid background) and Bnii] (129O1aJFVB/N hybrid background) mice have been
described before (Schurnacher et al., 1996; van der Lugt et ai., 1994). Most ofthe mice
were bred at Case Western Reserve University in Cieveland, Ohio and then transported
to and rnaintained in the specific pathogen-free (SPF) animal facility of the Ciinical
Research Institute of Montreal (IRCM). Ail animais were housed in ventiiated
microisolator cages, provided with sterilized food and acidified water, and tested
monthly for the presence of viral, bacteriai, or parasitic pathogens. Selected anirnals
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were sent for complete histopathological studies to rule out the presence of any
pathogen.
Generation of double mutant mice
eed’989 hypornorphic or eed3354 nuli mutant mice (Schurnacher et al., 1996) were
interbred with Bmi] heterozygous mice (van der Lugt et al., 1994) to generate double
homozygous mutant offsprings. Newbom mice were genotyped by PCR and/or Southem
blot analysis. Only —2% of littemiates were of eecÏ’969’989; BnuT genotype. As
expected, none ofthe eed33543354, B111i1 double mutant mice survived to term. Ail other
genotypes were found at the expected Mendelian frequency.
Mice genotyping
Bmi] mutant mice were genotyped by Southeni blot analyses as described (van der Lugt
et al., 1994). The T’°40—*C transition at position 1040 in the eed3354 nuil allele destroys
an Alu] restriction site and allows for genotyping of the mice by Southern blot analysis.
eed’989 hypomorphic mice were genotyped by PCR amplification of D7M1T352. This
microsatellite is polymorphie between the 101/R1 x C3Hf/R1 and 129O1aJFVB/N hybrid
backgrounds and rnaps distal to eecÏ (Schurnacher et al., 1996). In addition, for most of
these mice, the presence of the T1031—*A transversion at position 1031 was confinned by
direct sequencing of PCR-arnplified genomic DNA.
cDNA generation, amplification and analysis
Reverse transcription and amplification of total messenger RNA isolated from purified
bone mairow subpopulations was performed as reported previously (Sauvageau et al.,
1994). In brief, 10 000 bone manow cells purified by cell sorting were pelleted and
lysed in 50 d of 5 M guanidium isothiocyanate solution. Nucleic acids were
precipitated, and cDNA was synthezised with a 60-mer primer containing a 3’ poly
thymidine stretch as described (Brady et al., 1990). A short polyadenosine tau was
added to the 3’ end of the first strand cDNA using terminal deoxynucleotidyltransferase.
Second-strand synthesis and PCR amplification involved the same primer at a higher
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concentration (Sauvageait et al., 1994). Amplified total cDNA was size fractionated on a
1% agarose gel, transferred to nylon membranes, and hybridized. Probes colTesponded
to a 329-hp fragment ofthe human BMI] gene located in the 3’UTR (nucleotides 1938-
224$; accession no. L 13689, #50$); a 1000-bp 3’ fragment of the mouse eed coding
cDNA (nucleotides 1017-2020; accession no. U78103, #696), probe for Hoxb9 was a
250-hp EcoRTIPstI fragment (#639), probe for Hoxal was a SacI/EcoRI fragment of
150-bp (#633), Hoxa6 probe was a 250-bp Sctcl/HiiidIII fragment (#634), Hoxb4 probe
was a EcoRl/PmlI fragment of 485-bp (#405), probe for Hoxb2 was a 260-bp
HincII/FstI fragment (#41 9), Hoxb3 probe was a 3$0-bp EcoRI fragment (#47$), probe
for Hoxc4 was a 212-bp XbaIL7zoI fragment (#214), Hoxd4 probe was a 765—bp
PvuII/HindIII/EcoRI fragment (#770), probes for Hoxa9 and HoxalO corresponded to
full-length cDNAs and probe for Hoxa2 was a 320-hp PstI!HindIII fragment (#650).
Probe specific for p16”’3” colTesponded to exon ÏŒ (nucleotides 5-197; accession no.
AF044335, #775), pJ9Jl’ specific probe corresponded to exon 1f3 (nucleotides 5 1-200;
accession no. L76092, #776) and probe for fi-Actin (#212) xvas isolated as described
(Sauvageau et al., 1994).
In vitro c]onogenic progenitor assays
for myeloid clonogenic progenitor assays, ceils were plated on 35-mm petri dishes
(Corning, Fisher) in a 1.1 ml culture mixture containing 0.8% methylcellulose in alpha
medium (Sigma) supplemented with 10% fetal caif serum (FCS), 5.7% bovine serm
alburnin (B$A), 1 0 M 3-rnercaptoethanol (f3-ME), Ï U/ml recombinant erythropoietin
(Epo), 10% WEHI-conditioned medium (tested to contain 50 ng/rnl of IL-3), 2 mM
glutamine and, 200 rng/ml transfen-in. Colonies were scored on day 12 of incubation as
derived from CfU-GM, BFU-E, or CFU-GEMM according to standard criteria. For
sorne of the experiments, identification of the colony types was confirmed by Wright
staining of cytospins preparations of colonies. for pre-B clonogenic progenitor assays,
celis were plated in 0.8% methylcellulose in alpha medium supplemented with 30% pre
selected fCS (SCT, Vancouver B.C.), Ï0 M 13-ME, and 2 ng/ml ofhuman IL-7. Pre-B
colonies were scored on day 7 of incubation.
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lit vitro long-term culture assays
Myeloid LTC-IC assays were perforrned as described (Lemieux and Eaves, 1996) by
culturing total bone rnanow ceils at limiting di[ution on murine fibroblasts S17 feeder
cdl layers, in 96-well plates, in the presence of alpha medium (Sigma) containing 12.5%
FCS, 12.5% horse senim, i0 M f3-ME, 106 hydrocortisone, 0.016 mM folic acid, 2
mM glutarnine, 0.16 mM inositol, and 50 )lg/ml gentamycin. The clonogenic progenitor
content of the cultures was assayed 4 weeks after initiation. Similarly, lyrnphoid
(Whitlock-Witte) long-terrn cultures were perfonned as described (Whitlock and Witte,
1982) by culturing total bone marrow cells at limiting dilution on a S17 feeder cdl layer
for 3 weeks, in 96-well plates, in RPMI-1640 medium (GIBCO) containing 5 % pre
selected FCS, 50 tM f3-ME and, 50 tg/rnl gentamycin.
Flow cytometry
Flow cytometry ofhemopoietic ceils was performed as described previously (Sauvageau
et al., 1997). Briefly, a single cell suspension ofbone rnarrow was prepared by injecting
phosphate-buffered salt (PBS) solution containing 2% FCS into femurs to flush out cells,
followed by gentle desegregation through a 21 -gauge needle. Ceils were released from
the thymus, spleen, and lyrnph nodes by disruption through a fine nylon mesh. To lyse
erythrocytes, cell suspensions were treated with 0.165 M NH4C1 and washed once. Ceils
were stained with primary antibodies in PBS 2% fCS containing blocking solution for
Fc receptors on ice for 30 mm, washed, and resuspended in PBS 2% FCS containing 1
ug/rnl propidium iodide. flow cytornetric analysis was perfonned using a Coulter
XLTM flow cytometer equipped with a 488-mTl laser beam and fluorescence detectors at
525, 575, 620, and 670 nm. Monoclonal antibodies (Mabs) were titered and used as
described previously (Hough et al., 1994, 1996). FITC-labeled B220, CD43 (57), Gr-1,
and Mac-Ï and PE-labeled B220 antibodies were purchased from Pharrningen. PE- and
FITC-conjugated streptavidin, CD4-FITC, and CD8-PE antibodies were purchased from
GIBCO BRL. Biotinylated-IgM antibodies were from Jackson Laboratories and IgD
FITC from Southem Biotech.
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Chapter 4 summarizes the experimental data obtained so far describing the tumor
suppressive activity of the eed Polvcomb Group (PcG) gene and its ability to suppress
radiation-induced turnorigenesis in mice. Arnelie Faubert, a graduate student in the
laboratory, helped Julie Lessard with the cytofluometric analyses of the turnors (not
shown) and the determination of their clonai composition by Southem biotting (Figures
4.4 and 4.6). This project is now being pursued by Martin Sauvageau, a graduate student
in the laboratory.
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The mouse Polycomb-group (PcG) gene enibiyonic ectodei-m development (eed,) is a
component of the PcGe multimeric protein complex that governs anterior-posterior
patteming ofthe axial skeleton by regulating Hox gene expression 1,2. The mouse gene
encodes a 441-amino-acid protein with five WD motifs which, except foi- the amino
terminus, is highly hornologous to Drosophila ESC (Extra Sex Combs 3 and see fig.
4.1). Beyond its role in embryonic development, eed is also involved in regulating
3354/+hemopoiesis. Heterozygosity for a nuil aÏlele ofeed (eecÏ ) causes marked myelo- and
lympho-proliferative defects in mice (3-fold increase in primitive (LTC-IC and WW-IC)
and 19-fold increase in late (myeloid and pi-e-B CfCs) bone rnarrow progenitor ceil
numbers on average), indicating that eed plays a crucial foie in the negative regulation of
the proliferative capacity ofboth lymphoid and myeloid progenitor ceils (see Chapter 3).
These data indicate that Eed performs important anti-proliferative activity on a subset of
early and late bone marrow progenitors and that ultimately, its absence may lead to tumor
formation.
The hyperproliferative defects observed mostiy in the lyrnphoid B ceil lineage of
heterozygous eed3354 nuil mice would suggest that eed perforrns tumor suppressive
function in hemopoietic cells. To this possibility, a large cohort ofmice homozygous for
1989/1989
a hypomorphic allele of eecÏ (eed ) or heterozygous for a nuli allele of eecl
(eed33541) were given a single dose of ionizing radiation (600 RADs) at 5 weeks of age
and monitored for the development of disease. Hornozygous eed’98911989 mutant mice
developed a high incidence of B- and T-ceii iymphornas with shorter latency when
compared with control littennates (n=7/13 vs n=1/16; 16±4 wks vs 34±0 wks post
irradiation, respectively, Fig. 4.2). Heterozygous eed3354 nuil mice were also more
susceptible to radiation-induced B- and T- celi lymphomas than control littermates
(n=1 1/15 vs n=4/1 5), although after a much longer latency period than homozygous
eed’989”989 mice (27±9 wks vs 16±4 wks, respectively), indicating that eed performs
tumor-suppressive function in lymphoid ceils. Histological analysis of hernatoxyhn and
eosin stained sections confinried the diagnosis of lymplioma in all the tumors recovered
from these animais (data not shown). fiow cytometric analyses performed on
hemopoietic celis derived from the bone manow, thymus, spleen and lymph nodes of
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hypomorphic eed’98971989 animais revealed that 29% of the irradiation-induced
lyrnphomas were of CD4CD$ double positive (DP) origin, whereas 71% ofthe turnors
analyzed conesponded to a CD8 phenotype (Fig. 4.3). Importantly, no B celi and
myeloid tumors were induced by the irradiation treatrnent. Since each developing T- or
3-ceil clone contains unique rearrangements at the T ceil receptor /3 (TcR,6,) and
Iminunoglobin (1g) gene locus, respectively, clonality in these lymphornas was assessed
by the pattem of TC’R/3 and 1cC gene rearrangements by Southem blot analyses.
Irradiation-induced tumors in hypomorphic ceci’ and heterozygous eecÏ3354 mutant
mice were of monoclonal or oligoclonal origin, suggesting that neoplastic transformation
of eed mutant cells arises as a resuit of multiple genetic lesions that collaborate to
generate a malignant clone (Fig. 4.4 and 4.6). In rnost cases, the neoplastic T-cell clones
had aiready infiltrated the spleen and or the bone marrow of the animais, including one
eed 1989/1989 clone (identified as B5 in Fig. 4.4) which presented rearrangement of both
Jfi23 alleles. As expected, ah cecit989”989 tumors presented a germ-line configuration of
the 1g 1cC chain. Although one of the eecÏ’98911989 bone rnairow-derived genornic DNA
samples revealed the over-representation of a B-cell clone (identified as B2), this clone
could flot be detected in the spleen and thymus of this animal. Moreover, cytofluometric
analyses dernonstrated a normal distribution of the B22OCD43, B22OIgM and
IgMIgD B-cell populations in the 3M of this animal (data not shown), potentiaiiy
suggesting aberrant rearrangernent ofthe B-cell receptor (3CR) in these celis.
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Fig. 4.1 Ethylnitrosourea (ENU)- induced point mutations at the eed locus in mouse.
The proline substitution (L196P) in the second WD motif of the 17Rn53354SB nuil ailele
maps to the internai core of the inner end of the beta-propeller blade and is likeiy to
disrupt protein folding. In contrast, the asparagine substitution (1193N) in the second
WD motif of the hypomorphic Ï7Rn5’989 allele maps onto the surface of the beta
propeÏÏer blade near the central cavity and may affect surface interactions without
compromising propeiler packing (Schumacher A. et al., (199$) Genomics 54(1):79-$8).
Eed 1989/1989 Eed
10 20 30
Weeks post-irradiation
Fig. 4.2 Survival curves showing an increased insidence of uTadiation-induced (600
RADs) lymphornas in eecÏ’989’989 and eed3354 mutant mice when compared to control
littermates.
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Fig. 4.3 Representative examples of T-cell lyrnphomas arising in inadiated eed’989’939
mutant mice. Left panel: a T-cell tumor of CD4 CD$ double positive (DP) origin.
Right panel: T-cell lyrnphoma presenting a CD8 phenotype. Abbrev.: 3M, bone
mali-0w; Thy, thymus; SPL, spleen; LN, lyrnph node; PE, phycoerythrin; fITC,
fluorescein isothiocyanate.
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Fig. 4.4 Irradiation-induced lymphomas in eed’989’989 mice are of monoclonal or
oligoclonal origin. Genornic DNA isolated from the hernopoietic organs of control and
eed’989’989 irradiated animais was digested with HindIII (upper panel) or EcoRJiBamH 1
(lower panel) and hybridized to probes capable of detecting realTangements at the T ccii
receptor (TCR) and Immttnoglobuiin (1g) gene locus (J/32B probe, Malissen (1984) CeIl
37: 1101 and kCprobe, Leder (1986) Ccli 45:485, respectively). Abbrev.: S, spleen; T,
thymus; B, bone marrow; N.A., flot analyzed; DP, double positive; i.d., identification.
As revealed by FACS analyses, 36% (n=4/11) of the eed3354 irradiation-induced
lymphomas analyzed expressed phenotypes corresponding to immature cortical
thymocytes, whereas 27% (n=3/l1) of the turnors were of B-ecu origin (Fig. 4.5).
3354/-F . . + +Eed -derived T-ecu lymphornas included CD4 CD8 double positive (DP) tumors
(Fig. 4.5, right panel for representative example) and CD8 single positive (SP) tumors,
expressing variable levels of CD4 (data not shown). One of the monoclonal B-cell
lymphornas that developed in the eed3351 background was strongly positive for the
B220 and IgM surface antigens (Fig. 4.5, left panel) and histological examination of
hernopoietic cells derived from this animal confinried the presence of malignant
lymphoid cells presenting a fragmented nuclei, rerniniscent of a mantie B-cell
lymphoma (MCL) (data not shown). C]onal analysis performed on 3M and thymus-
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derived celis from this animal (identified as 33 in fig. 4.6) revealcd the presence of a
unique reanangernent of the kC chain in those organs as weii as 2 other animais,
identified as B4 and B9 (Fig. 4.6, upper panel). Unique rearrangernents at the f32,6 gene
iocus were observed in at least one of the hemopoietic organs analyzed from three
homozygous eec13354 mice (identified as B2, B3 and 35, Fig. 4.6, iower panel) and two
control iittennates (Al and A2). finally, with the probes used, no clonai reairangement
of the J32,6 and kC genes could be detected in the hemopoietic organs of three eed3354
animais (identified as Bi, 36 and 37).
Ç)
Fig. 4.5 Representative examples of B- and T-ecu abnorrnalities arising in eed3354
irradiated mice, as analyzed by fluorometric activated cell sorting (FACS). Left panel:
B-celi turnor of B22OIgM origin, most iikely of the rnantle ccli type (MCL). Right
panel: CD4CD8 double positive (DP) T-celi lymphoma. Abbrev.: 3M, bone rnarrow;
Thy, thymus; SPL, spleen; LN, lymp node; PE, phycoerythrin; FITC, fluorescein
isothiocyanate; N.A., not analyzed.
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Fig. 4.6 IlTadiation-lnduced lymphomas in eed3354 mice are monoclonal or
oligoclonal. Genomic DNA isolated from the hernopoietic organs of control and
eed3354 inadiated animais was digested with fcoRJJBamHl (upper panel) or HincÏIII
(lower panel) and hybridized to probes capable of detecting rearrangement at the
ImmunogtobuÏin (1g) and T ceÏÏ receptor (TCR) gene locus (kC probe, Leder (1986) CelI
45:485 and, J/32B probe, Malissen (1984) CelI 37: 1101, respectively). Abbrev.: B, bone
man-ow; S, spleen; T, thymus; MCL, mantle ceil lymphoma; N.D., not deterrnined.
The observation that the onset and mean latencies to lymphomagenesis are decreased in
the hypornorphic eed”98911989 background when compared to the heterozygous eed3354
nuli background suggests that eed perforrns tumor-suppressive function in lyrnphoid
celis. To answer this qtiestion, it would be imperative to verify whether the wild-type
ceci allele is lost and/or mutated in heterozygous eed3354 nuIl mice. As point mutations
at the ceci gene locus that account for the eed334 (and eed’989) alfeles disrupt its
interaction with both the Enx and HDAC partners 5,6, co-immunoprecipitation
experiments could be performed in order to verify whether the Eed-EnxÏ and/or the
Eed-HDAC interaction is perturbed in heterozygous eed3354 nuli tumors. Rescue
experiments involving the overexpression of wild-type eed (versus EGfP as a control)
in eed’989989 and eed3354 lymphornas will assess the cellular and molecular
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rnechanisrns ernployed by the PcGe complex to suppress the proliferation of lymphoid
ceils. As the ability E(z) (the fly homologue ofEnx) to methylate lysine 27 ofhistone 3
is dependent on the presence of Esc (Eed) in the compiex , it is plausible that these
include epigenetic modifications of chi-omatin structure, stich as methylation of the coi-e
histones. 0f note, we recently demonstrated a significant decrease in the levels of H3-
K27 rnethylation in ail (n=7/7) eecÏ’98911989-derived T ccli tumors analyzed when
cornpared to that derived from control 1ittenates (ail MMLV-induced T-celi
lyn-iphomas, see Fig. 4.7). Furthennore, it is interesting to note that the chromosornal
region containing the eed locus on hurnan chromosome 11 (1 1q14.2-22.3) is
encompassed by the cyclin Dl (FRADJ) (11q14.2) and Ataxia Telangiectasia Mtitated
(ATM) (1 1q22.3) genes, both of which are regarded as cytogenetic hallmarks of mantie
ccli lyrnphoma (MCL) in humans ( and Fig. 4.8). The presence of tumor suppressor
genes in this region is strongiy suggested by the recmTent deletion of distinct
chromosornal segments at 1 lq in several reported cases of B-cell chronic iyrnphocytic
leukemia (B-CLL), rnantle ccli lymphorna (MCL) and T-cell prolymphocytic leukemia
(T-PLL) (reviewed in 12) As compelling evidence indicates that eed controis the
proliferative potential of Iymphoid progenitor cells in mice by acting as a tumor
suppressor, it is imperative to investigate whether these genes are alielic with eed.
Finally, it will be important to determine whether Enxl and/or Enx2 nuli animais aiso
deveiop tumors, thereby ascribing the tumor-suppressor function to the Eed-Enx PcGe
complex (Fig. 4.9).
CTRL tumors eed’989’989 tumors
l8kDa- i- a—H3-K27-Me
Fig. 4.7 Decreased methylation levels at the lysine 27 (K27) residue ofhistone H3 (H3-
K27) in eed’989’989 MMLV-induced T-cell lymphomas when compared to that isolated
from control littennates. Briefly, 55 ug of proteins from total celiular extracts were
hybridized with an affinity purifled chicken anti-H3-K27-me antibody recognizing
specifically the dirnethylated fomi of H3-K27 (kindiy provided by Dr Yi Zhang,
University ofNorth Carolina).
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Fig. 4.8 Structural aberrations at 11 q are among the most common aberrations invoÏved
in lyrnphoproliferative disorders in humans. The presence of tumor suppressor gene(s)
in this region bas been suspected and may involve eed, which is found at (Ï 1q14.2-22.3)
on the human chromosome 11 (reviewed in Monni 0., (2001) Leuk Lyinphonia 40:259-
66).
PeGe complex
Enx HDAC
EED
PRE TATA
Fig. 4.9 Schematic representation of the Eed-containing PcGe complex in mammalian
ceils. 0f note, DrosophiÏa Eed (Esc) is essential for the ability of the complex to
methylate the lysine 27 residue of histone H3 (through the SET domain-containing Enx
protein), a key event in its ability to induce gene silencing through chromatin
rernodeling (Cao R et al., (2002) Science 298:1039-43). Whether this epigenetic
171
iiiechanisrn underlies the turnor suppressive function of Eed in lymphoid celis is
currently being investigated.
The requirement for exposure to genetoxic agents and the long latency period before
tumor developrnent in eed mutants indicate that additional genetic events are required for
“full transformation” of hemopoietic ceils lacking a functional eed gene. Genetic screens
for modifiers and oncogenic coÏÏaborators of eecÏ function in hemopoiesis and
tumorigenesis are eagerly awaited. A proviral insertional mutagenesis screen in
hypomorphic eect’989’989 neonates, using the Moloney murine leukernia virus (MMLV),
was recently undertaken by myseif and is now pursued by a graduate student in the
laboratory to identify genes that collaborate with eed in tumorigenesis. Proviral
mutagenesis frequently disrupts transcription units by genomic rearrangernent at the
integration site and/or aÏters expression leveÏs of nearby genes due b interference with
regulatory elements. Cloning of collaborating oncogenes will take advantage of the
retroviral tagging ofthe chrornosomal integration site, which can be recovered by inverse
PCR on genomic DNA isolated from these tumors. Initial validation of candidate
oncogenic collaborators and potential modifiers of eed function will be elucidated in
hemopoi etic chimeras and/or transgenic mice.
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Chapter 5 describes a study which established the critical role of the Bmi-] PcG gene
in determining the proliferative capacity of both normal and leukaemic stem ceils.
Importantly, this work xvas the first to provide a molecular basis for the concept that
stem ceil function (whether normal or neoplastic) is regulated by common genetic
deteminants and, potentially, has broad implications in the field of stem ceil biology.
Julie Lessard generated ail the resuits presented in this chapter and wrote the paper
under the supervision ofDr Guy Sacivageau.
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Abstract
An emerging concept in the field of cancer biology is that a rare population of ‘tumour
stem celis’ exists arnong the heterogeneous group of celis that constitute a tumour. This
concept, best described with human leukaemia, indicates that stem ceIl function
(whether normal or neoplastic) might be defined by a common set ofcritical genes. Here
we show that the Polvcomb group gene Bmi-] has a key role in regulating the
proliferative activity of normal stem and progenitor celis. Most importantly, we provide
evidence that the proliferative potential of leukaemic stem and progenitor ceils lacking
Bnti-] is compromised because they eventually undergo proliferation arrest and show
signs of differentiation and apoptosis, leading to transplant failure of the leukaernia.
Complementation studies showed that Bmi-1 completely rescues these proliferative
defects. These studies therefore indicate that Bmi-] has an essential role in regulating the
proliferative activity of both normal and Ieukaemic stem ceils.
Introduction
In humans, the concept of “turnor stem cell” is best described in acute myeloid
leukernias (AMLs) in which the majority ofthe leukaemic cells (blasts) display a limited
proliferative capacity and must therefore be constantly regenerated by the rare
“leukaemic stem ceil” (L-HSC) population, which is itself capable of extensive self
renewal’3 (see also Fig. 5.la). Interestingly, these L-HSCs share phenotypical
sirnilarities (but also some differences, such as CD123 expression4’5) with normal
haematopoietic stem ceils (HSCs)1.
Several arguments suggest that the PoÏycomb Group (PcG) gene 3mi] is a good
candidate for regulating the proliferative activity of both normal and leukaemic HSCs.
First, Bmi-] expression is restricted to primitive bone rnaiow ceils in both hurnans and
mice68 and is expressed in aIl myeloid leukaemias analysed so far6 including the L
HSC-enriched CD34 fraction (Fig. 5.lb). Second, hornozygosity for a nuli allele of
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3mi] causes a profound and progressive failure of the entire haemopoietic system in
mice that is probably responsible for their death in early adulthood or before9. This
progressive and fatal depletion of ail blood ceiis (inciuding primitive progenitors7)
indicates that Bmi-1 is flot required for the generation of HSCs derived from fetal liver
but essentiai for aduit HSCs. Third, in addition to this presumed function in HSCs, Bmi
1 has a critical and dose-dependent role in regulating the proliferative output of primitive
progenitors derived from bone malTow7.
Here we provide evidence demonstrating that 3m i-1 is dispensable for the generation of
stem and progenitor celis derived from fetal liver, but is absolutely necessary for their
ftill proliferative potential. Most interestingly, our studies indicate that this function of
Bmi-1 is presenïed in leukaernic stem and progenitor celis and therefore provide a
molecular basis for the concept that common genetic determinants regulate normal and
letikaemic stem celis.
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Fig. 5.1 Bmi-] is expressed in CD34 leukaemic celis. a, Celitilar hierarchy in hurnan
(xenogenic) acute myeloid leukemia (AML) and phenotypic presentation of the
leukaemic hemopoietic stem celis (L-HSCs). b, Bmi-] is expressed in purified human
CD34 leukaemic celis isolated from AML patients. Proportion of CD34 celis
represented 35% (AMLY), 8% (AML2) and 83% (AML3) of total leukaemic bone
marrow ceils. Bmi-] signal intensity was not significantly different between CD34
celis vs unsorted ceils. Twenty thousand celis were isolated from each leukernia sample
(>98% purity for CD34 upon reanalysis), and their total RNA was reverse-transcribed
and PCR-amplified (see methods). Hurnan HL6O celis were used as a positive control
for Bmi-1 expression. Membranes were hybridized to probes specific for Bini-] and /3—
Actin and exposed for 48 bis on a Phosphohuiager screen. L-CFC, leukaemic colony
forming ceils; SP, side population; NO RT, no reverse transcriptase.
L-Blasts
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Resuits
Function ofBmi-1 ïn stem and progenitor ceils
Bmi-] E14.5 fetal liver celis grown for 4 days in vitro (Fig. 5.2a) present a 27-fold
reduction in their frequency of myeloid progenitors when cornpared to Bmi-J’ controls
(fig. 5.2c, left panel). This progenitor ceil defect was quantitatively and quaiitatively
rescued by the retroviral transduction (94-100% gene transfer) of Bmi-1 in these celis
(see Fig. 5.2c, right panel), indicating that Bmi-] is dispensable for the generation of
rnyeloid progenitors derived from fetal liver but absoÏutely essential for their full
proliferative activity.
On the basis ofthese resuits, it can be infelTed that a sirnilar situation might occur at the
long-terrn repopulating ccli (LTRC) level. An inability ofbone rnarrow and E14.5 fetal
liver-derived Bmi-I ceils to contribute to long-term haernatopoiesis was recently
shown in reconstitution experiments, suggesting that 3mi-1 plays a key role in self
renewal/proliferation of primitive haematopoietic cells24. Sirniiarly, an experirnent
performed by our group (with the same group of ceÏÏs as described in fig. 5.2c,
transplanted at about one LTRC per sublethally inadiated recipient) confirmed the
presence of roughly normal numbers of cells with long-term repopulating potential in
the fetal liver of Bmi-T’ mice but the detection of these cells, at 16 weeks after
transplantation, was strictly dependent on the retroviral expression of Bmi-] (Fig. 5.2d,
three of three recipients were reconstituted with Bmi-1-transduced ceils, whereas no
reconstitution was observed in five of five recipients of a sirnilar number of ceils
transduced with enhanced green fluorescent protein (EGFP)). As rnight be expected
from previous experiments in wÏiich near-lirniting numbers of stem celis are
transplanted, the proportion ofEGFP-expressing lyrnphoid and rnyeloid ceils was at best
5.6% in the peripheral blood ofthese mice (nos 53-55 in Fig. 5.2d). The long-term (16
weeks) and pluripotent potential ofthese ceils confirrned that the rescue was occurring at
the HSC level.
180
Together, these complementation studies conflrmed the critical function of Bmi—l once
stem and progenitor ceils have reached a given developmental stage. Considering the
striking parallel between the organization of normal and leukaernic haematopoiesis and
the knowledge that Bmi-] is expressed in ail primary leukaemia and leukaernic ce!! unes
ana!ysed so far (see introduction and Fig. 5.lb), we sought to investigate the importance
ofBmi-] in the biology of !eukaemic stem and progenitor celis.
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Fig. 5.2 Bmi-] regctlates the proliferative potential ofembryonic day (E) 14.5 fetal liver
(fL)-derived haematopoietic celis. a, Overview of the experimental strategy. Ctrl,
control; IL, interleukin. b, Western blot analysis of total celi extracts isolated from fetal
liver ceils engineered to express Bmi-1 (lane 3) or not (lane 2). Lane 1, transcribed and
translated (TNT) Brni-1 protein. c, BI?li-] and Bmi-] fetal liver celis engineered to
express EGfP or Bmi-]-EGFP were assayed for their content in colony-forrning celis
(CfC). HPP-CFC and LPP-CfC indicate CFC with high and Ïow proliferative potential.
d, Southem blot analysis to detect the integrated provintses in DNA (digested with
KpnI) from the bone marrow of recipients of Bnii-1 fetal liver celis transduced with
Bmi-1 (lanes 1-3) or with EGFP only (lanes 4-8). kb, kilobases.
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Generatîon of leukemia in Biizi-T’ and Bmi-1 FL celis
To detennine whether Bmi-] might also be essential in leukaernic haematopoiesis as it is
in the normal situation, we first investigated whether stem or progenitor celis lacking
Bmi-1 could be transformed by a set of complernentary oncogenes, and whether these
Ieukaemic ceïls could self-renew and proliferate sufficiently to induce AML in mice. To
achieve this, 3mi-] fetai liver ceils were infected with a retrovirus containing both the
Hoxa9 and Meis]ct genes, and transduced celis were transplanted into sublethally
irradiated syngeneic hosts (Fig. 5.3a). The selection of the Hoxa9 and Meisi
collaborating oncogenes was based on several criteria: first, these genes generate a well
characterized rnyeioid leukaemia in mice that dispiays a sirnilar cellular hierarchy
(nameÏy L-HSCs and “mature” blasts) to that observed in human patients’°; second,
these two oncogenes are sufficient to induce full transformation of primary
haernatopoietic ceils without the need for additional genetic events’°; third, the HSCs, or
a close progeny, are the target for the transformation induced by these genes (ref 10 and
U. Thorsteinsdottir, P. Austin and G. Sauvageau, unpublished data); and last, the Hoxa9
oncogene is involved in rnyeloid leukaemia in humans11”2.
Regardless ofthe genotype (that or Bnii-]j, ail recipients ofHoxa9-Meisl-
transduced fetal liver celis developed AML within a similar Iatency period (Fig. 5.3b).
The simultaneous overexpression of Bmi-1 did not accelerate the occurrence of the
leukaernia in ail groups anaiysed, nor did it change their phenotype or clinical
presentation (except for one pararneter; see below and Fig. 5.3e-d). The ieukaemic mice
from ail groups had a very similar and aggressive disease (see Fig. 5.3e-d for a detaiied
description). When analysed by fluorescence-activated ccli sorting (FACS), the
leukaemic blasts were strongly positive (more than 96%) for the Mac-1 myeioid ccli
surface antigen and 13-33% co-expressed Gr-1 (data not shown).
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Although the Bmi-1 status of the transformed fetal liver ceils did not affect the
phenotypical and clinical characteristics of the leukaernias, the presence of 3m i-J
seemed to be important for the capacity of large numbers of leukaemic cells to
accurnulate in the peripheral blood (Fig. 5.3d, group A versus group B, eighth column).
This phenotype was dependent on Bmi-1 because it was cornplemented by the retroviral
introduction of Bmi-J in Binj-J fetal liver ceils (Fig. 5.3d, group A versus group D,
eight column).
A northem blot analysis of total RNA isolated from the leukaemic ceils confirmed high
expression levels of retrovirally derived mRNAs (data not shown). DNA analysis of
proviral integration sites in both wild-type and B,nj-J leukaernic celis demonstrated
that the Hoxa9-Meisl—induced AMLs were derived from two to four Jeukaemic clones
(data not shown). Because a leukaemic rnouse contains at least iO leukaernic celis, this
indicates that 3,nj_] leukaemic celis displayed a substantial proliferative capacity in
vivo. However, the lower leukaemic ccli numbers in the peripheral blood of recipients of
3mj_J ceils (Fig. 5.3d, group B) could indicate a progressive exhaustion ofthe Bmi-1
L-HSCs.
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CTRL A9M(5/5) A 34±5 0.4±0.1 yes 80±12 22±25
A9M + Bmi-1 (3/3) C 36±5 0.4±0.2 yes 84±6 46±40
Bmi-1A9M(10/10) B 37±8 0.3±0.1 yes 91±1 1±1
A9M+Bmi-1 (5/5) D 31±11 0.3±0.1 yes 86±14 28±21
Fig. 5.3 Bmi-l is dispensable for the generation of AML in primary recipients. a,
Summary of the experirnental strategy and retroviruses used. Ctri, control; fL, fetal
livei-; LTR, long tel-minai repeat. b, Survival grapli ofmice reconstituted with control or
Bnîi-] E14.5 fetal liver celis engineered to express either Hoxa9-Meisl (A9M) or
EGfP. e, Cytoiogical preparations of peripheral biood leukocytes (PBL), bone rnarrow
(3M) and liver (Li) of representative ieukaemic mice from each group shown in b. il,
Major characteristics of the leukaemia that occurred in each cohort. * Mean + SD;
organs infiltrated were lung, liver, kidney; n = 200 cells counted from three
representative mice. WBCs, white blood celis.
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Bmi-T AMLs do flot repopulate secondary recipients
b evaiuate a possible exhaustion of Bmi-i L-FISCs, a dose of Ieukaemic ceils
derived froin the bone rnarrow of three different primary recipients from group A
(control Hoxa9-Meisl) and group B (Bini-T Hoxa9-Meis]) were transplanted into
syngeneic hosts (n 5 secondary recipients per primary leukaernic mouse). Mice were
then rnonitored over tirne for the deveÏopment of AML. StrikingÏy, Bnzi-] seerned to be
essential for the maintenance of Hoxa9-Meis] L-HSCs in vivo because the leukaemias
generated in Bnii-] celis were not maintained on transplantation into secondary hosts
(Fig. 5.4a, group B). However, animais bearing control Hoxa9-Meisl transpianted
turnours developed AML within 30 + 25 days after transplantation (Fig. 5.4a-b, group
A). Clonai analyses of proviral integration sites indicated these leukaernias originated
from severaÏ clones (Fig. 5.4c, and data not shown).
As mentioned above, none of the secondary recipients of 3mi-1 Hoxa9-Meisl
leukaemic bone marrow celis developed AML (Fig. 5.4a) and no leukaemic ceils were
detected in long-teini recipients analysed at 4 and 11 rnonths after transplantation (Fig.
5.4b-c, and data not shown, respectively).
This difference in the “transplantability” between Bini-i and control AIVILs is
particulariy significant considering that ail (n = 3) of the secondary recipients receiving
as few as 1 000 ieukaemic ceils from the control “group A” developed AML within 27 +
9 days of transplantation (data not shown). In ail cases, the invasive behaviour of the
control Hoxa9-Meisl tumours was reproduced after transplantation, and the morphology
and phenotype of the ieukaemias were indistinguishable (data not shown). Interestingly,
leukaemias developing in two of three primary recipients of Bmi-T’ Hoxa9-Meisl fetal
liver ceils co-infected with Bmi-] (group D) were transfelTed to secondary recipients
within a sirnilar tirnefrarne than controi AMLs (group A) (data not shown). This
suggests that the transplantation of the leukaemic phenotype is dependent on the
continuous expression ofBmi-1.
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Fig. 5.4 Bmi-1 is essential for the “transplantability” of AML into secondary hosts. a,
Survival graph of secondary recipients of control (Ctrl) and Bmi-1 leukaemic ceÏls (see
Fig. 5.3). b, Characterization of secondary recipients shown in a. Abbreviations and
details are as in Fig. 5.3d. FL, fetal liver; NED, no evidence ofdisease. c, Southem blot
analyses of DNA isolated from the bone manow of primary and secondary recipients
detailed in Fig. 5.3d and 5.4b. 2°: Secondary recipients. Top panel versus middle and
lower panels show EcoRI versus KpnI restriction, respectively. The probe was Hoxa9.
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The hands enclosed in the dotted box in the top panel correspond to a specific fragment
of proviral Hoxa9-derived DNA that does not represent clonality (inappropriate
activity?). GPE A9M, viral producei-s of Hoxa9-Meis] retrovirus; Neg. Ctrl, GPE ceils
only.
In vitro properties ofB,iti-T” leukaemic celis
To explain the apparent exhaustion of the 3ini-1 Ïeukaemic clones in vivo, we
rnonitored their survival and growth characteristics in vitro. After 10 days of growth, the
celluÏarity of cultures initiated with 31?li-] leukaemic celis was decreased 15 (±4)-foÏd
relative to controis (namely flj_]+/+; data not shown). Supporting these findings, a
direct comparison between control and Bini-1 ieukaernic cells indicated that the latter
had the foïlowing properties: first, they displayed accumulation in Gi (Fig. 5.5a-b) and
reduction in S-phase (Fig. 5.5c); second, they underwent much greater morphological
changes consistent with differentiation to butyrate-positive adherent layer-forrning
macrophages; third, they showed an increased proportion of apoptotic cells (Fig. 5.5d);
and last, they were less efficient in generating leukaernic colony-fonuing ceils (Fig.
5.5e).
Derivatïon of clones fiom Bmi-T” AMLs
To investigate further the impairment in proliferation of Bini-1 leukaemic blasts,
attempts were made to derive highly proliferative clones (HPCs) from cultures initiated
with Bnzi-] and Bnzj-1 leukaemic celis. Only 1% of colonies from the Bmi-1
cultures could generate more than 1010 ceils tour minimal definition of HPC), whereas
HPCs couid be derived at a frequency of 24% in control cultures (Fig. 5.5 f). In contrast
to controis, ail B,,ii-1 HPCs initiaÏiy presented the same characteristics as those
described in the previous section for leukaemic bone maiow cells (namely reduced
proliferation, monocytic differentiation and increased apoptotic index). However, within
about 2 weeks of culture, the 3ini-J HPCs were sirnilar to controls (Fig. 5.5g-j).
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Karyotype analysis (G-banding) perfonned on several independent control (group A, n =
3) and Bmj_] (group B, n = 8) HPCs revealed a near-diploid content (containing 38-40
chromosomes) and the absence of reculTent structurai chromosomai abeiiati ons,
indicating that the derivation of Bmi-F” HPCs in vitro involved neither overt genomic
instability nor recurrent chrornosornai lesions (data flot shown). When anaiysed by
FACS, about 100% of celis from HPCs from both groups A (n = 12) and B (n = 13)
expressed the myeÏoid antigen Mac-1, whereas the expression ofGr-1 varied extensiveiy
(data not shown). Clonai analysis perforrned on several ofthe control (n 37) and Bmi
1 (n = 25) HPCs revealed the presence of several integrations of an intact Hoxa9-
IRES-Meisï provircis, where IRES stands for internai ribosorne entry site (Fig. 5.6a, and
data flot shown).
The low frequency (1%) of clonai derivation from Bnti-T’ AMLs suggested either that
there was a rnarked decrease in their generation in vivo and/or that genetic or epigenetic
events were required for their emergence (clonai evolution). On the basis that the Ink4a-
Arfiocus is a criticai genuine target in vivo for 3m i-J in the regulation of haematopoietic
ceil proiiferation’3, and increased pl9’ levels induce a p53-rnediated checkpoint
response in Gi (refs 14,15), we verified whether inactivation of Cdkn2a (161NK4a)
Cdkn2b (19F) and other reguiator(s) of the GI ceil cycle checkpoint was present in
Bmi-T” Hoxa9-Meisl HPCs. Most of the control Hoxct9-Meisl (group A) HPCs
analysed presented normal levels of most of the GI cyclin-dependent kinase inhibitors
(CKIs) tested, including 19ARF 57K1P2 27KinI and p2l (Fig. 5.6b, left panel). In
sharp contrast, rnost of the Bmi-T’ HPCs (group B) anaiysed showed low levels or
complete loss of expression ofseveral ofthese CKIs (n = 11 of 14 HPCs; Fig. 5.6b, right
panel, and data not shown). Together with the initiai deiay (2 weeks) in proliferation of
each of these Bmi-T’ HPCs (sec above), these resuits indicate that clonai evolution,
through epigenetic or genetic loss ofCKI expression, rnight represent the “driving force”
that aiiowed the derivation of HPCs from 3mi-J AMLs in vitro.
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Fig. 5.5 Cliaracterization ofcontro! and 3ini-]’ leukaernic ceils in vitro. a-c, Ce!! cycle
analysis performed as described22. Ctrl, control. d, Apoptotic index determined by the
percentage of PI-positive/annexinV-positive cel!s. e, Abso!ute number of !eukaernic
colony-forrning ce!!s (CFCs) per femur in primary recipients. f, Percentage of CFCs able
to generate HPCs. g, Wright staining of representative HPCs from f. h, i, Ce!! cycle
ana!ysis (as in a and b) of exponentia!ly growing HPCs. j, Proportion of cel!s in S-phase
in exponentially growing HPCs. for c-f and j, resuits are presented as means ± s.d.
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Fig. 5.6 Loss of expression of several CKIs in Bmi-] Hoxa9-Meis HPCs. a, Southem
blot analyses of Hoxa9-Ivfeisl proviral integration sites in genomic DNA isolated from
control (Ctrl) and Bini-] HPCs. Restriction digest, neg. control and probe are as
described in Fig. 5.4c. Letters a-d in the top panel indicate four different clones from the
saine prirnary recipient. The Ïeukaemogenic potential of several clones was evaÏuated.
Below each clone: number of cells transplanted (Tx) per recipient, the occurrence of
AML reported and the number of mice transplanted (parentheses) and the tirne to
clinical leukaemia. b, Western blot analyses showing the protein expression levels of
several CKIs in control and Bini-] HPCs.
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Bmi-T” IIPCs are weakly leukaemogenic
The ability of these HPCs to induce ieukaemia lit vivo was investigated by transpianting
between 106 and 8 x 106 cells per clone into sublethaliy ilTadiated syngeneic recipients
(fig. 5.7a). Strikingiy, ail recipients of control Hoxa9-Meisl HPCs (n = 6, one to four
mice per group) succumbed to AML within 16 ± 6 days of transplantation. However, ail
of the HPCs that could be derived from Bmi-T’ Hoxa9-Meis] AMLs either did not
induce AML (6 of 12; fig. 5.6a and 5.7b) or induced the disease after a significant delay
(see below). DNA analysis of proviral integration sites from selected HPCs indicated
that clones such as 68.2 or 65.3-65.5, which represented dominant leukaemic clones in
primary recipients, failed to induce AML in vivo, whereas clones 65.1 and 65.2 (see
asterisk in fig. 5.6a), which couid transmit AI\4L to secondary recipients after long
iatencies (66-67 days), had the same retrovirai integration profile as clones 65.3-65.5
(see filled circles in Fig. 5.6a), which could not.
Rescue ofBmi-T”HPCs AML-induciiig capacity
To distinguish between clonal evolution and selection as the mechanism responsible for
leukaernic progression in certain 3iiii-] HPCs, we engineered retroviral expression of
Bnzi-1 or EGFP (control) in three HPCs (two non-leukaemic identified as HPC-63.5 and
HPC-65.4, and one poorly leukaemic identified as HPC-63.2 in fig. 5.7c; sec also Fig.
5.6a-b) and transplanted these celis immediately after gene transfer, at a dose of 3.5 x
106 ceils, into irradiated syngeneic recipients (n = 2 or 3 mice per group, except HPC
63.2 plus EGFP (n 1)). The three clones engineered to express Bmi-1 readily induced
AIVIL within short iatencies, whereas no leukaernias were detected untii day 85 in
recipients of similar numbers of celis from the same clones infected with the control
EGfP virus (fig. 5.7c). The leukaemias generated by the three HPCs expressing Bmi-]
were highly polyclonal (see clonality in lanes 5-17 in fig. 5.7d) and contained an intact
3m i-1 provinis. The contribution of these Bmi-1 clones expressing Bmi-Ï to AML
(chimaerisrn) was evaluated by FACS analysis for EGFP expression (the Bmi-1 virus
contains an EGfF reporter gene) (Fig. 5.7d) and by Southem blot analysis, by assessing
the ratio of the inactivated Bmi-] alleie (donor-derived) relative to the wiid-type 3m i-J
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allele (host-derived) in various haematopoietic organs of the leukaemic animais (Fig.
5.7d, bottom panel). Donor-derived ceils colTesponded to 25%-95% of the total
haernatopoietic celi population, confirming infiltration of the neoplastic ceils into ail of
these organs (Fig. 5.7d). The dernonstration ifiat Bmï-] was sufficient to fuiiy rescue the
leukaemogenic potential of Bnii-]’ HPCs further suggests that clonai evolution, rather
than selection, is the underlying mechanism responsible for ieukaemic progression in
Bmi-] HPCs.
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Fig. 5.7 Bmi-] rescues the weak leukaemogenic potential of Bnii-] HPCs. a,
Experimental procedures. 3M, bone malTow; CFC, colony-forrning ceils. b, c, Survival
graph ofrecipients of selected HPCs (see Fig. 5.6) transduced (c) or not (b) with Bmi-]
EGfF or EGfP. il, Southem blot analyses showing the polyclonality ofthe leukaemias.
Upper panel: genomic DNA isolated from the BM (B), spleen (S), thymus (T) and/or
lymph nodes (L) was digested with EcoRI; the probe used was EGFP (see Fig. 5.3a).
Lower panel: genomic DNA was hybridized to a DNA probe specific for Bmi-] to assess
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chimaerism. Time to leukaemia and proportion of EGFP-expressing ceils present in the
haematopoietic organs ofthe ieukaemic animais are shown below.
Discussion
In summary, the findings reported here reinforce the notion of a structure in Ieukaemic
hierarchy where “sternness” would be conferred by the continuai expression of Bnïi-Ï
(see Fig. 5.8). Irnportantly, it was possible under conditions of stimulation with higli
concentrations of growth factors in vitro to generate non-Ieukaemogenic 3nzi-J clones
with an impaired expression 0f19A1 and y6TNK4a both ofwhich are known functional
targets ofBmi-1 (ref.13). Retroviral introduction of3mi-1 into these clones deficient in
1 9ARF and 1 6INK4a (n = 3) readily rescued their tumorigenic properties, suggesting that
Bmi-1 has one or more additional ftmctions in L-HSCs besides repression ofthese CKIs.
The expression of cuiientiy known regulators of earÏy haematopoiesis (such as taÏ-]/SCL
(ref.16) and Hoxb4 (ref. 17)) vas not aitered by the status of Bmi-] in leukaernic and
non-leukaemic clones (See Fig. 5.9).
The apparent difficuities of bypassing the requirement for Bmi-1 in leukaemic
stem/progenitor ceils in vivo suggests that adroit molecular targeting of Bmi-1 in
leukaemic stem/progenitor ceils rnight have potent and specific therapeutic effects.
Interestingly, BMI-1 expression was recentiy reported in several cases of human non
small-celi lung cancer18, breast cancer ccii unes’9 and immortaiized mammary epithelial
celis (MECs)’9. It will therefore be interesting to determine whether the findings
reported here might also extend to other types of “cancer stem celis”.
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Proliferative Potentïal
EI45FL Mature
Genesis of HSC
HB?
HSCs
_______
Bmi-1 Bmi-1
independent 4 dependent
L-HSC 4, L-Blasts
Fig. 5.8 Bmi-1 regulates the proliferative capacity of stem and progenitor colis, whether
normal or leukaemic. This also indicates that Bmi-] is dispensable for the genesis ofFL
(E14.5) HSCs and foi- their leukaemic transformation. HSC, haematopoietic stem ceil;
L-HSC, leukaemic haematopoietic stem ccli; L-blasts, leukaernic blasts; FL, fetal liver.
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fig. 5.9 Expression of selected genes in 3mi-] and 3ini-1 Hoxa9-Ivfeisl highly
proliferative clones overexpressing or not Bmi-]. Ceil unes were also included as
specificity control for hybridization. Total RNA isolated from each sample was reverse
transcribed and PCR-amplified (see rnethods). Membranes were hybridized to probes
specific for SCL, MLL, LMO2, HoxalO, Hoxb4, Hoxa9, Hoxa5, —Actin and GATA-2
(not shown) and exposed for 36-48 hrs on a PhospholiTiager screen. Note that GATA-2
expression was undetectable in HPCs.
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Methoils
Mice and genotyping
The B,ni-]’ mice (129O1aJFVB/N hybrid background) used in these studies9 had been
backcrossed 10-12 times in the C5731/6J background.
Retroviral generation, infection and transplantation of E14.5 fetal liver and boue
marrow ceils
Details of the construction of the MSC V-Hoxa9-IRES-Meisl a bicistronic retroviral
vector and the MSCV-Bmi-]-pgk-EGFP vector are available from the authors on
request. Production of vesicular stomatitis virus-pseudotyped retroviruses, infection of
haematopoietic celis and transplantation into mice were done as described20.
Methylcellulose cultures, flow cytometry and ceil cycle analyses
102127These assays were perfomed essentially as descnbed
Generation, amplification and analysis of complementary DNA
Semi-quantitative PCR with reverse transcription was performed with a previously
described rnethod that amplifies ail the cDNAs derived from as few as 1-1 000 ceils23.
The amplified (total) cDNAs were then transferred to a nylon membrane and hybridized
to specific probes as indicated. See Table IV for a detailed description of each probe
used.
Southern, northern and western analyses
Ah ofthese were essentially donc as described’°’22. Information on the antibodies used
in these studies is available from the authors on request.
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hi vitro generation of HPCs
Myeioid progenitors derived fiom methylcellulose cultures of leukaemic boue rnaiow
celis isolated from prirnary recipients (n = 3 for wild-type and 5 for Biiii-1 ieukaemic
mice) were plucked on day 6 and expended in vitro in liquid culture media containing
DMEM (Invitrogen), 15% fetal caifserurn (pre-selected, Invitrogen), 6 ng½il Interleukin
(IL)-3, 10 ng½Tli IL-6, 100 ng/rnl Steel factor, 100 ng/ml IL-11 (ail generated and titrated
at LRCM from COS ceii supernatants) and 1x10-5 M f3-Mercaptoethanol. Clones that
could generate more than lOlo progeny celis are referred to as highly proliferative clones
(HPCs).
Table IV
Generation of gene-specific probes.
fig. Probes Enzymes fragments Bank Number Accession; Nucleic acids
2,9 hHOXB4 SaÏUPmÏI 40$bp 178 Af307160; 1512-1920
4, 6, 9 mffoxa9 PstT/HindllI 243 bp 321 A3005457; 1267-1510
9 hHOXAJO ApaI 247bp 84 Af040714; 603-$50
9 hHOXA5 SacIL/HindIII 230 bp 185 as described’7
1,9 hBMI-] EcoRV/fcoRI 3lObp 508 L136$9; 193$-224$
9 hLMO2 BcimHl 476bp 1587 X61118; 1037-1513
9 inSCL PstL/HindIII 437 bp 1590 U01530; 6272-6709
9 ÏiGATA-2 EcoPJ 252bp 1589 M6$$91;1463-1715
9 hMLL XbaUSincïI 936bp 1586 L04284; 10974-11910
1, 9 fi-A ctin PstI 1.8 kb 212 as described35
2,7 EGFP EcoRUHindIII 719bp 719 U76561;289-1008
7 ,nBmi-1 SacI 1.3 kb 675 as described’’
Received 30 January; accepted 5 March 2003; doi: 10.1038!naflire0 1572. Published online 20 April 2003.
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CHAPITRE 6
Identification ofNovel Co-factors ofBmi-l in Hemopoietic Stem Cetis
Julie Lessard, Sherry Niessen, Simon Girard and Guy Sauvageau
(Ongoing studies)
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Chapter 6 summarizes the resuits of a yeast-two-hybrid screen which was aimed at
identifying HSC-specific partners foi- the Bmi-1 protein. Julie Lessard conducted the
screen which led to the identification of 13 Bmil-interactive clones, representing $
different gene products. She is responsibe for the resuits presented in Figures 6.1 to 6.3,
6.7 and 6.11 to 6.16. Sherry Niessen, a graduate student in the laboratory, is working at
elucidating the functional interaction between Brni-1 and one of these molecules,
narnely E4f-1. She is responsible foi- the resuits presented in Figures 6.5, 6.6., and the
generation of the E4F-1 deletion mutants presented in Figure 6.8. Simon Girard, a
technical assistant on the laboratory, is working at investigating the role of BHP-1, a
novel gene product identified in the screen and its biochemical and functional interaction
with Bmi-1. He generated the resuits presented in Figures 6.4, 6.9 and 6.10 under the
supervision ofJulie Lessard and Sherry Niessen.
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Bmi-I, which is essential for the proliferation (seif-renewal) of embryonic and aduit
hemopoietic stem ceils (HSCs, see Chapters 3 and 4) participates in the formation of a
multirneric complex with other PcG proteins including Mphl/HPH1, Mph2/HPH2, M33,
RING1A, RING1B MPc2, MPc3 and Mci-1$ ‘ The RING domain ofBmi-1 (together
with its nuclear localization signal (NLS)) is essentiai for its proliferative/oncogenic
function, whereas homeotic transformations of skeletai structures require the HTHTHT
region of the protein 6,7 Direct interactions between Bmi-1 (or DrosophiÏct Psc) and
other PcG proteins have been examinated mainly through the use of yeast-two-hybrid
(Y-2-H) screens. Drosophitct Pc interacts with Psc through an extended HTHTHT region
which is also required for its interaction with Ph . Mammalian Bmi-1 interacts through
its RING dornain with the RING finger-containing Mci-1$, RinglA and RinglB
proteins 2,4,5 and through its HTHTHT region with the MPh1 and MPh2 proteins 2,4
Irnportantly, these interactions are evolutionary conserved, as the human HPHY and
HPH2 gene products (homologues of Drosophila Ph and mouse MphI/Mph2) also
interact with Bmi-13. The association of Bmi-1 with M33 is mediated through a region
encompassing both its RING and HTHTHT domains 2
We have previously reported a curious dissociation between the expression profile of
Bmi-Ï (rnostly restricted to primitive human CD34CD71CD45 and mouse Sca-1 Lhï
bone marrow celis) and that of other gene products with which Bmi-1 norrnally interacts
(mostiy expressed in mature bone manow ceiis, sec Chapter 2), Therefore, we
postulated that the function ofBmi-1 in primitive bone rnarrow ceils is rnediated through
its interaction with yet unidentified proteins. To identify such gene products (in
particuiar those involved in its recruitment to relevant DNA target loci), a yeast-two
hybrid screen was perfonned (MatchMaker III, Clontech) using the full-length Bmi-1
coding sequence (CD$) as a bait in a yeast expression library (1.2 x 106 clones screened)
made from week 14-1$ hurnan fetal livers (Clontech) enriched for primitive
stemlprogenitor ceils (sec Fig. 6.1 for details on the experimental procedure). The Bmi-1
bait vector did not resuit in non-specific activation of any of the 3 yeast reporter genes
(histidine, adenine and LacZ, data not shown). A total of 13 clones, which represented $
different Brni-1-interacting factors, were identified (Fig. 6.2). Two of those encoded
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novel gene products and were named BHIP-l and BHIP-2 for Bmi-1 Hemopoietic
Interacting Protein-1 and 2. Four of the clones corresponded to three different fiagments
ofthe human vacuolar protein sorting 11 (hVPSY1) gene product, a RllG/Zinc finger
domain-containing protein. The remaining 4 clones identified included: the PcG Bmi-1-
interacting protein HPHY, two pRb-interacting proteins (Trip23O and E4F-1), the RED
protein (also kriown as 1K factor) and the HtATPase (n=3 clones out of 13).
A list of criteria was established to prioritize the study of proteins that specifically
interacted Brni-1 in primitive bone mairow (3M) celis. These included: (i) confirmed
interaction with Bmi-1 in yeast; (ii) coexpression with Bmi-] in primitive 3M celis; (iii)
known DNA-binding activity; (iv) proof of interaction and/or colocalization with Bmi- 1
in mammalian cells and, (y) potential to participate in chromatin remodeling and/or to
possess trans-repressing activity. Based on these criteria, the E4F-1 and BHIP-1 gene
products were selected.
The studies presented in this Chapter will extend our initial efforts to characterize the
Brni-1-containing complex present in primitive bone rnarrow ceils. This is most
important considering the unique and essential role played by Bmi-1 in early
hemopoiesis, together with the inability ofthis protein to intrinsically bind DNA (Bmi-1
DNA-tethering proteins must be present in primitive cells). Below, I will provide a
short description of the proteins identified in the screen, together with some of the work
that bas been accomplished tbus far.
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Fig. 6.1 Yeast transformation and screening protocol. Abbrev.: Trp, tryptophane; Leu,
leucine; Ade, adenine; His, histidine; 3-AT, 3-amino-1,2,4-trazole; a competitive
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Fig.6.2 Bmi-l-interacting clones identified in our yeast-two-hybrid (Y2H) screen. The
protein interaction domain(s), DNA binding and/or repressive functions for each of the
clones is indicated if known. Abbrev.: Zn, zinc finger dornain; KRAB, kruppel
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associated box; RED, dornain ricli in arginine (R) , glutamic acid (E) and aspartic acid
(D) residues; Rb, retinoblastoma protein; TR, thyroid hormone receptor; PEST, a
sequence rich in proline, aspartate or glutamate, serine, and tbreonine residues found in
many unstable proteins.
E4F-1, a potential mediator of Bmï-1 function in HSCs?
E4F-l (p190E4F) is an ubiquitously expressed GLI-Kruppel-related zinc finger
phosphoprotein with 86% sequence identity to the murine nuclear factor oAP3 . E4F-1
was initiaily cloned as a transcriptional repressor of the E4 adenoviral gene through the
direct recognition ofa specific promoter element (5’-RTGACGTC/AAY-Y sites) 9-11
response to adenovirus E1A, E4F-l becornes hyperphosphorylated and undergoes a
reduction in both DNA binding and transcriptional repressor activities 9,12 possibly to
permit activation of (adeno) viral genes during eariy infection. Aithough cellular target
genes for E4F-1 remain to be identified, overexpression ofE4F-1 in prirnary fibroblasts
inhibits ceil cycle progression and cdl growth 11-14 This inhibitory activity of E4F-l
correlates with the post-transcriptional elevation ofseveraI ceil cycle reguiatory proteins,
including the CDK inhibitors p2l and 7fK1P1 cyclin E, and cyclin Bi, with reduced
Cdk2, Cdk4/6, and Cdc2 kinase activities and with the down-regulation of cycÏin A2
gene expression 11,12,15 E4F-1-induced ccli cycle alTest is enhanced by its interaction
with the p53 transcription factor and hypophosphorylated pRb 13,14 Although cyctin A2
expression is down-regulated by E4F-l, it is likely that other cell cycle regulatory
molecules are reguiated by E4F-1, as ectopic expression 0f120E41 can induce ceil cycle
arrest at the G1-S and G2-M transitions, even when cyclin A mRNA and protein levels
are not reduced 12,15
A recent study demonstrated that E4F-1 fornis a ternary complex together with 14ARF
and p53 and enhances p14-induced G2 cdl cycle a;Test in a p53-dependent manner
16 These findings suggest that the interaction ofBmi-l with this trirneric complex is part
of a network regulating cellular proliferation that is disnipted in cancer and following
viral infection.
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Using serni-quantitative RT-PCR studies, we showed that, together with Bini-], j20E4
is preferentially expressed in primitive subsets of mouse bone marrow ceils (Fig. 6.3).
E4F-1 specifically associates with Bmi-1 in yeast (confirmation tests, see Fig. 6.4). Co
immunoprecipitation experiments demonstrated a specific association between Bmi- 1
and E4F-l in hurnan 293T ceils. Using a monoclonal antibody against Bmi-1, we
showed that both an overexpressed HA-tagged version ofthe E4F-1 clone identified in
our Y-2-H screen (Fig. 6.5) and the endogeneous E4F-l protein (Fig. 6.6) can be
coirnmunoprecipitated together with endogenous Brni-1 in these ceils. 0f note, recent
experiments revealed that the interaction is cytoplasmic-specific (data not shown). Pull
down experiments using in vitro transcribed and translated (TNT) 35S-labeled proteins
indicate that Bmi-1 and E4F-1 directÏy associate (Fig. 6.7). A panel ofBmi-1 and E4F-1
deletion mutants (subcloned in yeast and retroviral (MSCV)) expression vectors) xvas
used to rnap the minimal interaction domains between Brni-l and E4F-l in yeast (Fig.
6.8). For Bmi-1, these included: (1) deletion of the RING finger domain (n.t. 52-167);
(2) deletion of the HTHTHT domain (n.t.493-659); (3) deletion of the C-terminal PEST
dornain (n.t. 706-975), and (4) an inactive Rll’JG finger mutant of Bmi-1 corresponding
to two cycteine to phenylalanine substitutions (C—*F, Fig. 6.9). For E4F-1, these
included: (1) a C-terminal deletion including the zinc-fingers 3 to 6 (n.t. 473-783); (2) a
N-terminal deletion including the zinc fingers 1 and 2 (n.t. 1-471); (3) a specific deletion
ofthe zinc fingers 1 and 2 (n.t. 194-240), and (4) a specific deletion ofthe zinc fingers 3
to 6 (n.t. 437-567, Fig. 6.10). These studies identified the HTHTHT domain of Bmi-1
and the zinc finger domains 3 to 6 ofp120’4’ as being required for their interaction (Fig.
6.9-6.10). The functionality (i.e. proper folding) of the Bmi-1 deletion mutants was
assessed by confirming their ability to interact with other known Bmi-1 interacting
partners (HPH1 and RINGYB; Fig. 6.9) and that of E4F-1 by perfonriing gel-shifts
experiments using an E4F-1 specific DNA probe (data not shown). The presence of a
E4F-l DNA response element at position -1687 to -1658 bp on the human p]4
promoter leads to the hypothesis that down-regulation of 14A1 levels, through the
interaction with E4F-1, may be essential for Bmi-1 function in HSCs. Trans-repression
assays using a panel of 14A promoter deletion mutants failed to demonstrate an
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ability of E4F-1 to modulate 14ARF levels in 293T cells (data not shown). Most
irnportantly, we recently demonstrated that E4F- 1 cytoplasmic levels progressively
increase in prirnary murine ernbryonic fibroblasts (MEfs) undergoing senescence. This
is rnost interesting considering that the E4F-1-Bmi-1 interaction is cytoplasmic-specific
(see above) and the aging of primary human fibroNasts is accornpanied by decreased
Bini-] expression (both at the RNA and protein level) and accumulation 0f16tNK4a and
y4ARF (171$ and see Chapter I for details).
The detailed analysis 0fpy20E4F function in regulating hemopoietic ceil proliferation and
senecence is now being pursued by Sherry Niessen, a PhD student in the Iaboratory.
BM populations
hE4f-1
RED protein
Bntt-1
B-Actiit
Fig. 6.3 20E4’ and RED protein are co-expressed together with 3m i-1 in primitive
bone rnarrow cells and hemopoietic ccli unes. Ten thousand ceils were isolated from
each subpopulation (>98% purity upon reanalysis), and their total RNA was reverse
transcribed and PCR-amplified as described (see Material and Methods, Chapter3).
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Cocktail of lineage-specific (Lin) monoclonal antibodies (MoAbs) contained B220 (B
lymphocytes), Gr-l (granulocytes), and Mac-1 (granulocyte-macrophages). From
primitive to mature subpopulations: Sca-1 Lin subpopuation (lane 2); Sca-F Lin
subpopulation (Ïane 3). Exposure times are as follow: j20t’4E (22 hrs), REDprotein (12
hrs), Bmi-] (20 hrs) on Phosphor-Imager screen. f3-Actin (25 min at _700).
-Trp -Leu -Leu -Trp -Ade -lis + 3-AT
3 7
Fig. 6.4 Brni-1 specifically associates with E4F-1 in yeast. AHYO9 yeast were co
transfected with GAL4-DNA binding (pGBKT7) and GAL4-transactivation domain
(pGADT7 or pACT2) expression vectors encoding Bmi-1, E4F-1, RING1B (positive
control) and Large T antigen or Lamin C (both negative controls) and grown on
selection media (left panel), depleted in the amino acids (a.a.) tryptophane (Trp) and
leucine (Leu), allowing the growth of any yeast co-transformant and (right panel),
depleted in the a.a. adenine (Ade), histidine (Ris), Trp and Leu, and allowing the growth
of yeast interactors only. pCL1 is used as a positive control as it encodes a functional
GAL4 protein. Abbrev.: 3-AT, 3 -amino- 1 ,2,4-triazole.
1. pGBKT7-Eui1 + pGADT7
2. pCBKT7-1?miI + pACT2-L-H-I
3. pGBKT7-Bmil + pGADT7-Largc’ T
4. pGBKT7-Bnzil + pGAD7’7-RINGIB
5. pACT2-E4f-1 + pCBKT7
6. pACT2-E3I.-! + pCBKT7-BniI
7. pACT2-E3f-1 + pGÀDT7-LambzC
8. pCL1
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Transfection + Bnii-1 Transfection Hoxb4 Ring E4F MSCV
Hoxb4 Ring E4F MSCV
— 20$ kDa à — 208 kDa
— 131 kDa — 131 kDa
14f-i — 14f-i
:
Ring1B—’ Rïng1B
— 43kDa — 43kDa
tP a—Bmi-i IP a-Brni-1
Western Œ—FIA Western Œ-HA
Fig. 6.5 Bmi-i and E4F-1 specifically coimmunoprecipitate in human 293T ceils. 293T
colis were transfected with 20 ig of either HA-Hoxb4 (negative control), HA-R1NGYB
(positive control), a HA-tagged version ofthe C-terminal E4F-1 fragment clone isolated
in the screen with (left panel) or without (right panel) Brni-i. Immunoprecipitations
were perfonned overnight on total cellular extracts using a monoclonal anti-Brni-1 (f6)
antibody. Western blots were revealed using a monoclonal anti-HA antibody (clone
12CA5, Boehringher). Abbrev.: IF, immunoprecipitation; MSCV, empty MSCV
retroviral vector; HA, peptide epitope derived from the hemaggiutin protein.
IP E4f-I Serum Ringi Bmil Brnil Hoxb4 Scrum Brnil Hoxb4
Transfection MSCV MSCV Ringi E4F-1 MSCV Hoxb4 NISCV MSCV Hoxb4
* —
E4f-I— —l34kD 14f-1-—i -134kD
Western Œ_PI2OE3F Western api 20E4F’
Fig. 6.6 liTirnunoprecipitation of an endogenous Brni-1 and E4F-1 complex in hurnan
colis. 293T celis were transfected with 20 tig of ernpty MSCV retroviral vector or
M$CV-HA-RING1B (positive control), HA-E4f-1 or HA-Hoxb4 (negative control).
Immunoprecipitations were perfomied ovemight using rabbit anti-E4f-1 serum, rabbit
pro-immune serum, a mouse monoclonal anti-Brni-1 or anti-HA antibodies (same
isotype). Samples were separated by SDS-PAGE and blots were revealed using the anti
E4F-1 serum. Two different exposure times are shown: loft panel, 15 secondes; and
right panel, 2 minutes. (*), Background; MSCV, empty retroviral vector.
Bmil — s . —
RinglB —
Lamin-C —
Fig. 6.7 Direct physical association between Bmi-1 and E4F-1. In vitro transcribed
translated 35S-labeled proteins were irnmunoprecipitated for 2 hrs in ELB binding buffer
with a monoclonal anti-Brni 1 (F6) antibody, washed and separated by SD$-PAGE.
Abbrev.: IP, immunoprecipitation.
Bmi-1 Deletion Mutants E4F-1 Deletion Mutants
BrniJ
WiIUIype
NLS
++ I,
RING IITIITIIT l’EST
RING 168 492 660 708 975
I-- I
372 436 568 783
FI-2 iic5ic,ii.
1 193 241 436 568
I ICi IC,Ihl I
I 193 241 436 568 783
Fig. 6.8 Mapping the minimal interaction dornains of E4F-1 and Bmi-1 using a panel
of deletion mutants. See text for details. (*), inactivating point mutations (cysteine to
phenylalanine substitutions) in the RING finger dornain of Bmi-1. Abbrev.: HTHTHT,
helix-tur-helix-turn-helix dornain; C2H2, zinc finger domain ofthe C2H2 subtype.
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Interaction in Yeast
RingJB HPHJ E4F-J
NLS
__________ __________
Bmi-1 I I RING ImITUT f PEST + + +
1 51 168 492 660 705 975
NLS
Bmi-1 I ItI lEST + -AHTH I SI 169 492 660 7U5 975
NLS
ARING
fl1Tu1t51 + +
I 51 168 492 660 705 975
NLS
Bmi-J RING IITIITIIT f + + +APEST I 51 168 192 660 705
Fïg. 6.9 The HTHTHT domain of Brni-1 is essential for its interaction with E4F-1 in
yeast. AH1O9 yeast were co-transfonned with expression vectors encoding the different
Bmi-1 deletion mutants (as described in text) together with either full-Ïength E4F-1,
RinglB (a known interactor of Bmi-1 through its RING linger dornain) or HPH1 (a
known interactor of Brni-1 through its HTRTHT domain) and their growth assessed in
selection media depleted in the arnino acids TRP, Leu, Ade and His in presence of3-AT
(see below).
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Fig. 6.10 A dornain comprising the zinc finger 3 to 6 of E4F-1 is essential for its
ability to interact with Brni-1. Ai-1109 yeast were co-ttansformed with expression
vectors encoding the different E4F-Ï deletion mutants (as described in text) together
with full-length Brni-1 and their growth assessed in selection media depleted in the
arnino acids TRP, Leu, Ade and His in presence of3-AT (see below).
E4F-1
Fig. 6.11 Schematic representation of our cuiTent working model. Bmi-1 associates
with E4F-1 and modulates its ability to repress transcription of ceil cycle regulatory
genes.
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BHIP-1: a novel Bmi-1 interacting pattner in FISCs
Bmi-1 Hernopoietic Interacting Protein-1 (BHIP-1) is a novel gene product identified in
our screen which, together with 3mi], is preferentialiy expressed in the stem/progenitor
ccli cornpartment of mouse bone marrow celis (data flot shown). BHJP-1 expression (2
transcripts) was aiso obseiwed in ail the mouse aduit tissues anaiyzed thus far, inciuding
the bone marrow, spleen and thymus (data not shown). BHIP-1 is evolutionariiy
conserved, as homologues have been identified in several species including mouse and
human. 0f note, BHIP-1 (1059 a.a) does not encode any conserved protein-interaction
motif, but contains two PEST domains ta motif found in many short-iived eukaryotic
proteins that piays a role in their degradation, see Fig. 6.12). Yeast-two-hybrid assays
using a panei of positive and negative controls (as presented in Fig. 6.4 for E4F-l)
confirrned the specificity of the interaction between Bmi-1 and BHIP-1 (data not
shown). Simon Girard, a research assistant in the laboratory, is pursuing the project. He
recentiy cloned the human fuii-length BHIP-1 cDNA (3179 bp) from K562 cells and
developed a polyclonal rabbit antisera to BHIP-1, which recognizes a single protein of
approximateiy about 155 kDa in both mouse and human celis. He aiso demonstrated that
a monocional antibody against endogenous Bmi- 1 specifically co-immunoprecipitates a
fuii-lenght fLAG-tagged form ofBHIP-1 as weli as endogenous BHIP-1 in human 293T
celis (data not shown). The function of BHIP-1 in the hemopoietic system is being
investigated using a conditional allele ofBHIP-1 in the mouse.
1
51
101
151
201
251
301
351
401
451
501
551
601
651
701
751
801
851
901
951
1001
1051 AFPACKVEf*
GSEFGSPGLL
IVKGQRSLHH
CLEETGELLL
TFGDWAQPAP
PSPFELLEPP
PKS S FWKLVR
SWDDRLRRLI
PLSRGPVPAK
AGPGEKVVRV
RSKESVGSRD
TPRELRKDPK
SGFPPVANGP
EKALELPLAA
TVTTPTVTTP
LRGPRARRSA
QE RAGGLGAE
HDPLPDPLKV
SRAAAPKATP
PKTATRGPSG
VRALCYVI SG
HTW YAETHAR
TYVLEELERG IRSWDVDPGV
RGDNLETLVL LNPSDKSLYD
QTGGFS PHHF LQVLKDRE I R
AVPGLQGA LR LQLRLNP FAQ
TSGGFLRLGR PCCYI FPGGL
HLDRVDAVLV THPGADSLPG
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LfPGCTPPAC LLDGLVRLQH
SSKREGLLAT HPRPGQERPG
?SVSRTQPRE VRRAASSVPN
RSPPSLRCGE ASPPSAACGS
SSIPRPRTPS PESHRSPAEG
SLPAEVGSPH STEVDESLSV
SPHDVDLCLV SPCEFEHRKA
ETPPTSVSES LPTI.,SDSDPV
PPPLPDPSSI CMVDPEMLPP
VWKTKGLA GGDRASRPLS
SASSRPGVSA TPPKSPVYLD
QDQRKEEGMR AVLDALLASK
HQALGITVLG SNSMVSMQDD
fig.6.12 Amino acids sequence of the human BHIP-1 protein. The protein sequence
was obtained from Genbank (1059 a.a, accession XP038599). Putative nttclear
localization signais (NLS) are underlined. The colored boxes represent the putative
PEST domains identified by the PESTfind progiam (http://vienna.at.embnet.or2). The
first amino acid of the yeast-two-hybrid clone (arginine (R) residue), clone 60.9) is in
purpie.
Bmi-1 ïnteracts with the thyroid hormone receptor (TR) coactivator protein
Trip23O
Trip23O is a specific coactivator ofthe thyroid honnone receptor (TR) that is negatively
regulated by interacting with the retinoblastoma turnor-suppressor (pRB) protein (19, Fig.
6.13 for schematic representation). Thyroid hormone receptor (TR) bound to thyroid
hormone (T3)-responsive elernents in the absence of ligand decreases transcription, due
to its interaction with the nuclear co-repressors NcoR and SMRT 20,21 Ligand-dependent
activation of TR resuits in the replacement of the corepressor by a coactivator complex
including pCIP/SRC1/NcoA-1/pCAF and CBP/p300 (reviewed in 2223 Trip23O, which
is predominantly a cytoplasmic protein, is such an activator that becomes
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MAAVAGSGAA AAPSSLLLW
CNLDEQLKVF VSRHSATFSS
ELRNLLLDPA SHKLLVLAGL
DILATTPPPV QPFILTITCP
LPNSEGLCEF LEYVAESLEP
GDAAFFAVNG FTVLVNGGSN
LNSLLRRKLA ERSEVAAGGG
GEDEAELALS LLAQLGITPL
PSAGAERTLA SVCALLVWHP
LRFLREPWT PQDLEGPGRA
VARKEPARAE APRKTEKEAK
LKKTNAQAAP_KPRKAPSTSH
PASQLVATPS LELGPIPAGE
SERLSLSFLR GGEAGPDASP
SFEQVL?PSA PTSEAGLSLP
VPMAPAPASP GSSNDSSARS
PLAPGAADSD EDTEG FGVPR
KTARQTENVS RTRKPLARPN
ARSEPSEKGG RAPLSRKSST
LAYLPSGSSA HLVDEEFFQR
QHWDRDLQVT LI PTFDSVAI’I
phosphorylated and transiocates to the nucieus in presence of T3 to potentiate
21$
transcription of T3-responsive genes 24 The association of Bmi-1 with a TR-specific
coactivator molecule is most interesting considering that TR bas a role in regulating such
diverse cellular processes as proliferation, differentiation, and programrned ccli death.
We first confinned the specificity of the interaction between Bmi-l and Trip23O in a
yeast-two-hybrid assay (data not shown). Expression studies perfonned on purified
subpopulation of murine bone marrow celis reveaied that Trip23O is expressed at very
low levels in mouse bone manow ceils (either in total or purified primitive (Sca-1 Liiï)
and mature (Sca-F Lin) populations, Fig. 6.14). A polyclonal antisenim to Trip23O
(raised against a.a. 1099-1372 ofTrip230, obtained from Dr Yumay Chen, Texas) was
used in coimmunoprecipitation experirnents to characterize the interaction between Bmi
1 and Trip23O in human 293T ceils (data not shown). A monoclonal antibody directed
against endogenous Bmi- 1 specificaiiy imrnunoprecipitated an overexpressed FLAG
tagged version ofTrip230 (the partial cDNA isolated in the screen) in these ceils, as weli
as FLAG-Ringlb (a PcG protein; positive control) but not FLAG-Hoxb4 (negative
control, data flot shown). Using the anti-Trip23O antiserum, the presence of an
endogenous E4F-1-Brni-1 complex was also demonstrated in the hurnan K562
hemopoietic ccli une (data not shown). We decided to hand these resuits to our
coliaborator, Dr Maarten van Lohuizen, at The Netherlands Cancer Institute, The
Netherlands.
TRI P230
1468 1978 a.a.
I I I Y2H clone 33.6
pRb-interactiiig TR-interacting
domain domain
1099 1255 1754 1867 1978a.a
I I I I Hurnan Trip23O
Fig. 6.13 Schematic representations of the human Trip23O protein and the Trip23O
clone identified in our yeast-two-hybrid screen. The clone 33.6 corresponds to the
amino acids 146$ to 197$ of human Trip23O (accession AF007217) and encodes the
thyroid hormone receptor (TR)-interacting domain. Abbrev.: Y-2-H, yeast-two-hybrid;
pRb, retinoblastoma protein; a. a., ami no acids.
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Fig.6.14 Tnj230 is expressed at low levels in purified subpopulations of murine bone
marrow celis. Note tint Trp23O expression is very high in the HL-60 and K562
hemopoietic ccli unes. Exposure tirne, Tnji23O, 23.5 hrs; fi-A ctin, 1 1m Sec Fig. 6.3 (this
Chapter) for a detaiied description of the purified subpopulations and experimentai
procedure.
iluman Vacuolar protein sorting 11 (hVPS11) specifically associates with Bmi-1 in
yeast.
1 4AAYLQWRRF VFFDKELVKE PLSNDGAAPG ATPASGSAAS KFLCLPPGIT
51 VCDSGRGSLV FGDMEGQIWF LPRSLQLTGF QAYKLRVTHL YQLKQHNILA
101 SVCEDEEQIN PLVKIWNLEK RDGGNPLCTR IFPAIPGTEP TWSCLTVHE
151 NLNFMAIGFT DGSVTLNKGD ITRDRHSKTQ ILHKGNYPVT GLAFRQAGKT
201 THLFWTTEN VQSYIVSGKD YPRVELDTHG CGLRCSALSD PSQDLQFIVA
251 GDECVYLYQP DERGPCFAFE GHKLIAHWFR GYLIIVSRDR IWSPKSEFTS
301 RDSQSSDKQI LNIYDLCNKF IAYSTVFEDV VDVLAEWGSL YVLTRDGRVH
351 ALQEKDTQTK LEMLFKKNLF EMAINTjAKSQ HLDSDGLAQI FMQYGDHLYS
401 KGNHDGAVQQ YIRTIGKLEP SYVIRKFLDA QRIHNLTAYL QTLHRQSLAN
451 ADHTTLLLNC YTKLKDSSKL EEFIKKKSES EVHFDVETAI KVLRQAGYYS
501 HALYLAENHA HHEWYLKIQL EDIlJYQEAL RYIGKLPFEQ AESNMKRYGK
551 ILNHHIPEQT TQLLKGLCTD YRPSLEGRSD REAPGCRANS EEFIPIFANN
601 PRELKAFLEH MSEVQPDSPQ GIYDTLLELR LQNWAHEKDP QVKEKLHAEA
651 ISLLKSGRFC DVFDKALVLC QNHDFQDGVL YLYEQGKLJQ QINHYHMQHE
701 QYRQVISVCE RHGEQDPSLW EQALSYFARK EEDCKEYVAA VLKHIENKNL
751 MPPLLWQTL AHNSTATLSV IRDYLVQKLQ KQSQQIAQDE LRVRRYREET
801 TRIRQEIQEL KASPKIFQKT KCSICNSALE LPSVHFLCGH SFHQHCFESY
851 SESDADbPTd LPENRKVMDM IRAQEQKRDL HDQFQHQLRC SNDSFSVIAD
901 YFGRGVFNKL TLLTDPPTAR LTSSLEAGLQ RDLLMHSRRG T*
Fig. 6.15 Arnino acid sequence of the human Vacuolar protein sorting 11 (hVPS1 1)
protein. The hurnan protein contains 941 a.a (accession number Q9H270). fle first
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arnino acid encoded by the yeast-two-hybrid clones 41.7 and 53.7 (identical clones) is in
pink, that of clone 42.7 is in grey and that of clone 43.7 is in yellow. The green colored
boxes correspond to the cysteine (C) and histidine (H) residues involved in coordinating
the C-terminal R1NG/zinc finger domain.
BHIP-2: a KRAB and Zinc finger domain-containing protein that associates with
Bmi-1 in yeast.
The KRAB domain (or Kruppel-associated box), which is present in about a third of zinc
finger proteins containing C2H2 fingers, is found to be involved in lirotein-protein
interactions. This domain is generally encoded by two exons, colTesponding to the
KRAB-A and KRAB-B subdornains.
The C2H2 zinc finger is the classical zinc finger domain. The two conserved cysteines
and histidines co-ordinate a zinc ion. The following pattem describes the zinc finger. #-
X-C-X(1-5)-C-X3-#-X5-#-X2-H-X(3-6)-[H/CJ, where X can be any amino acid, and
numbers in brackets indicate the number ofresidues. The positions marked # are those
that are important for the stable fold of the zinc finger. The final position can be either
an histidine (H) or cysteine (C). The C2H2 zinc finger is composed of two short beta
strands followed by an alpha helix. The amino terminal part of the helix binds the major
groove in DNA binding zinc fingers.
1 METQAIDLVSQ EPQALLDSAL LSKVPAFSDK DSLGDEMLAA ALLKAKSQEL
51 VTFEDVAVYF IRKEWKRLEP AQRDLYR]DVM LENYGNVFSL DRETRTENDQ
101 EISEDTRSHG VLLGRFQKDI SQGLKFKEAY EREVSLKRPL GNSPGERLNR
151 KMPDFGQVTV EEKLTPRGER SEKYNDFGNS FTVNSNLISH QRLPVGDRPH
201 KCDECSKSFN RTSDLIQHQR IHTGEKPYEC NECKAFSQS SHLIQHQRIH
251 TGEKPYECSD CGKTFSCSSA LILHRRIHTG EKPYECNECG KTFSWSSTLT
301 HHQRIHTGEK PYACNECGKA FSRSSTLIHH QRIHTEALPT FVTLIRLLPS
351 VDPIVTNEAA FPAESLATIF ALIWRLFCVH SLMFKKV*
Fig. 6.16 Amino acid sequence ofthe human Zinc finger protein 3 (ZNF3) protein. The
hurnan protein contains 387 amino acids (accession number NPO6O 185). The KRAB
box is underlined in yellow. The four zinc finger domains (C2H2 type) ai-e underlined.
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The conserved cysteines (C) and histidines (H) residues that co-ordinate the zinc ions
are in green. The glycine residue in pink is the first amino acid of the yeast-two-hybrid
clone identified in our screen (clone 46.7). 0f note, no mouse homologue for ZNF3 has
been identified thus far.
222
Referen ces
1. Alkerna,M.J. et al. IvIPc2, a new murine hornolog of the Drosophita polycomb
protein is a member of the mouse polycomb transcriptional repressor complex. I
Mol. Biol. 273, 993-1003 (1997).
2. Alkema,M.J. et ctl. Identification of BmiI-interacting proteins as constituents of a
multimeric mammalian polycomb complex. Genes Dcv. 11, 226-240 (1997).
3. Gunster,M.J. et al. Identification and characterization of interactions between the
vertebrate polycornb-group protein BMI1 and human homologs of polyhomeotic.
Mol. Ccli Bio!. 17, 2326-2335 (1997).
4. Hernenway,C.S., Halligan,B.W. & Levy,L.S. The Brni-1 oncoprotein interacts with
dinG and MPh2: the role of RING finger domains. Oncogene 16, 2541-2547
(199$).
5. Satijn,D.P. & Otte,A.P. RING 1 interacts with multiple Polycomb-group proteins
and displays turnorigenic activity. Mol. Cet! Bio!. 19, 57-6$ (1999).
6. Cohen,K.J., Hanna,J.S., Prescott,J.E. & Dang,C.V. Transforniation by the Brni-1
oncoprotein correlates with its subnuclear localization but not its transcriptional
suppression activity. Moi. Ce!! Bio!. 16, 5527-5535 (1996).
7. Alkema,M.J., Jacobs,H., van Lohuizen,M. & Berns,A. Pertubation of B and T ceil
development and predisposition to lymphomagenesis in Enitt Binil transgenic mice
require the Bmil RING finger. Oncogene 15, $99-910 (1997).
$. Kyba,M. & Brock,H.W. The Drosophila polycomb group protein Psc contacts ph
and Pc through specific conserved domains. Moi. Ccii Bio!. 1$, 2712-2720 (199$).
223
9. Fernandes,E.R. & Rooney,R.J. The adenovirus E1A-regulated transcription factor
E4F is generated from the human homolog of nuclear factor phiAP3. Mol. Ccli
Biol. 17, 1890-1903 (1997).
10. Rooney,R.J., Rothammer,K. & Fernandes,E.R. Mutational analysis of p50E4f
suggests that DNA binding activity is mediated through an alternative structure in
a zinc finger domain that is regulated by phosphorylation. Niicteic AcicÏs Res. 26,
1681-168$ (1998).
11. fajas,L. et aï. Cyclin A is a mediator ofpl2OE4F-dependent ceil cycle alTest in
Gi. Mol. CeliBiol. 21, 2956-2966 (2001).
12. Fernandes,E.R., Zhang,J.Y. & Rooney,R.J. Adenovirus E1A-regulated
transcription factor p120E4f inhibits celi growth and induces the stabilization of
the cdk inhibitor p21WAFY. Mot. Ccli Biol. 18, 459-467 (1998).
13. Sandy,P. et aï. p53 is involved in the p120E4f-rnediated growth arrest. Oncogeiie
19, 188-199 (2000).
14. Fajas,L. et aï. pRB binds to and modulates the transrepressing activity ofthe E1A-
regulated transcription factor p120E4F. Froc. Nati. Acad. Sci. U. S. A 97, 773$-
7743 (2000).
15. Rooney,RJ. Ceil cycle attenuation by p120E4F is accornpanied by increased
mitotic dysfunction. Ceti Growth Differ. 12, 505-5 16 (2001).
16. Rizos,H. et aï. Association ofpl4ARF with the p12OE4F transcriptional repressor
enhances celi cycle inhibition. I Biol. Chem. 278, 498 1-4989 (2003).
17. Itahana,K. et aï. Control of the replicative life span of hurnan fibroblasts by p16
and the polycornb protein Bmi-l. Moi. Ccli Bioï. 23, 389-401 (2003).
224
18. Dimri,G.P. et aï. The Bmi-1 oncogene induces telomerase activity and
immortalizes human mammary epithelial ceils. Cancer Res. 62, 4736-4745 (2002).
19. Chang,K.H. et cil. A thyroid hormone receptor coactivator negatively regulated by
the retinoblastoma protein. Froc. NatÏ. AcacÏ. Sci. U. S. A 94, 9040-9045 (1997).
20. Lee,J.W., Choi,H.S., Gyuris,J., Brent,R. & Moore,D.D. Two classes of proteins
dependent on either the presence or absence of thyroid hormone for interaction
with the thyroid hormone receptor. Mol. Endocrinoï. 9, 243 -254 (1995).
21. Horlein,A.J. et al. Ligand-independent repression by the thyroid hormone receptor
rnediated by a nuclear receptor co-repressor. Nature 377, 397-404 (1995).
22. Torchia,J., Glass,C. & Rosenfeld,M.G. Co-activators and co-repressors in the
integration oftranscriptional responses. Cttrr. Opin. Ccii Biol. 10, 373-383 (1998).
23. Shibata,H. et aï. Role of co-activators and co-repressors in the mechanism of
steroid/thyroid receptor action. Recent Prog. Horin. Res. 52, 141-164 (1997).
24. Chen,Y., Chen,P.L, Chen,C.F., Sharp,Z.D. & Lee,W.H. Thyroid hormone, T3-
dependent phosphorylation and transiocation of Trip23O from the Golgi complex
to the nucleus. Froc. Natï. Acacï. Sci. U. S. A 96, 4443-4448 (1999).
CHAPITRE 7
Conclusions, Perspectives and Future Directions
226
Chapter 7 is a discussion of flic relevance of die findings presented in this thesis and
adresses potenflai future studies that could be performedto further understand die mies
ofBnd-1 and eed in die regulation of normai and leukemic hemopoiesis.
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“Epigenetics” and the regulation of hemopoiesis
The unique hierarchical and unidirectional nature of the hemopoietic system makes it a
powerful mode! system to study the molecular mechanisms involved in the regulation of
ceil fate. Everyday, billions of mature blood ce!! elements must be replenished from a
rare population of highly primitive multipotent hernopoietic stem ceils (HSCs) capable
of extensive se!f-renewal. The processes of Ïineage commitment and ensuing
differentiationlproliferation outcomes of the gradually maturing b!ood-forming units
along a paiticular lineage pathway are tightly regu!ated both at the extracellular and
intracellular !evels. Amongst the intrinsic influences, chromatin stntcture appears to
contain the molecular imprint underlying the epigenetic inheritance of lineage/cel!-type
specific transcription programs. Modification of the protruding histone tails —by the
addition of methyl, acetyl or phosphate groups- is known to alter chromatin structure,
which in tum influences the activity of neighboring genes. While the consequences of
individual histone modifications have begun to be addressed, the great challenge now
resides in deciphering how a sequentia! and possibly combinatoria! network of such
modifications —known as the histone code- can direct gene expression, either in a
synergistic or antagonistic fashion.
Epïgenetic regulation of celi fate by the Polycomb group (PcG) genes
The Fotycomb ‘PcG and the Trithorax (TrvG,) group genes are part of a widety
conserved epigenetic ce!!ular memory system responsib!e for regulating ce!! fate in
several developrnental systems 1,2 (see also Chapter 1). Based on biochemical
characteristics, at least two distinct types of PcG complexes with different
properties/functions can be distinguished both in Drosophila and mammals (see Chapter
1) 3-11 The Extra Sex Combs (Esc) and Enhancer of Zeste (E(z)) PcG proteins forrn the
core of an evolutionary conserved PcG complex that appears to be invo!ved in making
the “pigenetic mark” necessary for the establishment and memory trace of the suent
state and is therefore referred to as “PcGe” The rnechanisms by which the PcGe
complexes find their way onto chromatin and convey epigenetic iiiheritance are being
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unraveled. Biochernical evidence links PcGe complexes to histone deacetylases
(HDACs), although the data gathered to date suggests that the interaction may be
transient or that biochemically distincts PcGe complexes may exist 7j1,12 Further
insights into the mechanisms underlying PcGe silencing came from the recent finding
that E(z)/EZH2 displays methyltransferase activity towards lysine (K) 9 and K27 of
histone H3 (with a strong preference for the latter), a modification that might contribute
to the stabiÏity of the PcGe complex and its spi-eading to neighboring target loci,
particularly in the early stages of assembly at Folvcontb response elements (PREs)
11,13,14 Experiments perforrned in the fly demonstrated that the trimethylation mark at
K27 is lost well before the binding of the PcGe Iroteins and revealed the presence of
PcGe complexes at sorne transcriptionally active PoÏycomb response elements (PREs) 1)
Thus, the trirnethyl mark could represent the distinction between the mere recruitment of
the PcGe complex (which may be constitutive) and its ability to trigger the suent state.
ImportantÏy, the trimethyl K9 and dimethyl K27 on histone H3 appear to be a specific
mark for PcG chromatin, as this pattem is highly enriched at PcG target sites in polytene
chromosomes and poorly represented in regions of constitutive heterochromatin 13
Notably, H3-K27 methylation is found in a variety of multi-cellular organisms including
hurnan, chicken, and DrosophiÏct, but bas not been observed in the budding yeast
Saccharoinyces cerevisiae 12 were orthologs of Eed and E(z) are absent. Deciphering
the “histone code” accountable for PcGe complex recruitment will be instrumental in
understanding how defined chromatin states are self-propagated through DNA
replication and mitosis and will assess whether PcGe-mediated histone H3 methylation
and/or deacetylation constitute an “ancient” molecular mechanism of gene silencing in
the metazoan era.
The second type of PcG complexes appears to be required for stable maintenance
(PcGm) of gene silencing and is exemplified by Polycomb repressive complex 1
(PRC1), a MDa complex purified from Drosophila embryos 3,16 While its in vivo
mode of action remains elusive, the PRCY complex, which is widely conserved, harbors
the capacity to counteract SWIISNf chromatin remodeling complexes and stabilize a
repressive chromatin structure in vitro. While a recent study stiggested that the
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association of PRC1-like (PcGm) complexes with the SuV39HY histone
methyltransferase enzyme (specific for H3-K9) may be involved in its ability to silence
gene expression 17 PcGrn complexes appeau to recognize a pue-existent epigenetic
repressional state generated by EZH2-containing PcGe complexes 11• Accordingly,
elegant experirnents in the fly revealed that the establishment of heritable PcG silencing
early in development requires a transient interaction between the PcGe and PcGm
complexes 14 It will be important to verify whether this transitory interaction between
the complexes is evolutionarily conseuved and takes place in othet cellular and
developmental contexts.
PcG function in regulating hemopoiesis: a role for the Itox cluster genes?
Although Hox genes are best known for their role in the specification of the antero
posterior (AIP) skeletal axis during embryonic development, it is flOW becoming clear
that Hox genes also play a part in determining ccli fate in several other tissues, including
blood (reviewed in 18l9) By analogy to their role in skeletal development, the studies
presented in Chapter 2 raise the possibility that the FcG complexes might be involved in
regulating hemopoiesis through the transcriptional silencing ofthe Hox cluster genes. In
sharp contrast to the expression of HoxA and B cluster genes which is highest in the
most primitive bone rnarrow celis, differentiation of primary human bone marrow ceils
is accompanied by a marked up-regulation in PcG gene expression levels including
M33, MEL-]8, HPH] and ENX-1/EZH2. Only BMI-] exhibits a different pattern of
expression with high levels in primitive CD34 celis and very low levels in mature
CD34 cells (see below). These data are consistent with a role for the PcG complexes in
regulating the differentiation and/or proliferation of human bone marrow ceils by
silencing Hox gene expression 20 Similarly, the Met-18, Bmi-1, M33 and Mphl/Rae-28
FcG genes were shown to be rapidly activated upon antigenic stimulation of lymphoid B
cells and are considered as immediate early genes. This contrast with the ubiquitous
expression of the PcG genes in Di-osophita syncytial blastoderms (reviewed j 21) and
might represent a critical rnechanism of PcG function in aduit hemopoiesis. Interestingly
however, no evidence for Hox gene misexpression in the hemopoietic tissue of PcG
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mutant mice bas been reported yet, even though such a role bas been suspected 10,22
Extensive analyses of Hox gene expression levels in highly purified subpopulations of
hemopoietic celis isolated from PcG mutant mice is awaited in order to resolve this
issue.
Irnportantly, the above findings raise the intriguing possibility that the heterogeneity in
PcG complex composition contributes to the establishment of Ïineage/cell-type specific
transcription programs in differentiating bone rnaiow ceils. In this view, PcG gene
function in aduit hemopoiesis would resuit, at least in part, from temporal and ceil-type
specific expression of the PcG genes 20,23-26 their modifications at the post-translational
level 9,27,28 their subcellular distribution 27,29,30 the competition between PcG sub-family
members with highly homologous protein interacting motifs (sec Chapter 2 and 6) and
their physical association with co-regulatory molecules displaying intrinsic enzymatic
properties 17,31,32 Furtherrnore, owing to the apparent absence of DNA-binding activity
amongst the PcG machinery, the selective recruitment of PcG complexes to relevant
target loci in hemopoietic celis relies on sequence-specific tethering molecules (sec
Chapter 6), their ability to recognize definite repressive “histone codes” 17,31 their
interaction with components of the general transcriptional machinery 15,33 and chromatin
condensation proteins Boundary elements that establish “nuclear domains” of
transcriptional regulation through modulation of the chrornatin environment most likely
also impact on PcG gene function in regulating hemopoiesis 36,37V
The proliferation of hemopoietic progenïtor ceils is regulated by the combined
action ofEed and Bmï-1-containing PcG protein complexes
The murine Folvcomb Group (PcG) proteins Eed and Bmi-1 govern axial patterning
during embryonic development by segment-specific repression of Hox gene expression
38-41 The two proteins engage in biochemically distinct multimeric complexes that are
known to functionally interact to render the regulatory regions of Hox and other
downstream target genes inaccessible to transcriptional activators (42 Chapter 1 and S.
Paylor and A. Schumacher, unpublished). The finding that eed and Bmi-1 are co
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expressed in both murine Sca-lLiif and human CD34CD45CD7l primitive bone
marrow celis 10,20 lead us to propose that Eed and Bmi-l rnight sirnilarly interact to
regulate some critical aspects ofliemopoietic ceil developrnent. In the studies reported in
Chapter 3, evidence is presented that is consistent with an antagonistic function of eecl
and Bmi-] in hemopoietic celi proliferation. Heterozygosity for an eed null allele in mice
causes rnarked myelo- and lympho-proliferative defects (3-fold increase in primitive
(LTC-IC and WW-IC) and 19-fold increase in late (myeloid and pre-3-CFC) bone
marrow progenitor ceil numbers on average), indicating that eecl is involved in the
negative regulation ofthe pool size ofboth lymphoid and myeloid progenitor celis. This
antiproliferative function of eed does not appear to be mediated by the Hox genes or the
Ink4a-Aijtumor suppressor locus, as the expression ofthese genes was not altered in eecÏ
mutants. Conversely, a loss-of-function allele of Bmi-1 causes a profound decrease in
the numbers and proliferative potential of both highly primitive myeloid (LTC-IC) and
lyrnphoid (WW-IC) bone rnalTow ceils (4% and 1% of wild-type levels, respectiveiy).
Moreover, the absolute number of mature B22O B ceils generated per WW-IC at
lirniting dilution was reduced 8-fold Bnj]1 mice relative to control animais,
indicating that Brni-] is haplo-insufficient for the proliferative potential of this subset of
B celi precursors. In order to verify whether Eed and Brni-1 functionally interact to
regulate hemopoietic celi proliferation, inter-cross experiments between ceci and Bmi-1
mutant mice were perforrned. EecÏ/Bnii-1 double mutant mice were severely
pancytopenic and their number of early (WW-IC and LTC-IC) and late (myeloid and
pre-B CfC) bone man-ow progenitor celis were identical to those of 3nii-1 mice,
indicating that Bmi-1 is epistatic to eed in the control of primitive bone maiow celi
proliferation. However, the genetic interaction between the two genes is ceil-type
specific as the loss of one or two functional alleles of eed trans-complements the Bmi-1
deficiency in pre-B bone marrow celis. Thus, the ftinction of the two types of PcG
complexes seems to have evolved from a common repressive effect on Hox gene
expression in axial patterning to a more divergent activity in hemopoietic cells. Whereas
the PcGm complex is involved in enhancing the proliferation of 3M progenitor celis, the
PcGe complex is a negative regulator of 3M progenitor cell proliferation. Ongoing
experirnents suggest that the latter displays tumor suppressive function in hemopoietic
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celis, possibly through an epigenetic mechanism involving H3-K27 methylation (see
Chapter 4). Therefore, we believe that proper level of proliferation of several subsets of
hernopoietic ceils is regulated by the relative contribution ofEed (repressive) and Bmi-1
(enhancing)-containing PcG gene complexes.
Bmi-1 as a regulator of embryonic and aduit FISC function
During mouse ontogeny, the first bloods ceils, embryonic (or primitive) erythrocytes,
arise within the blood islands of the extraembryonic yolk sac at embryonic day 7.5
(E7.5). By 11.5, hernopoiesis shifts to the fetal liver (FL), where aduit (or definitive) red
celis, as well as ceils ofother hernopoietic lineages, first appear. The site of origin ofthe
hemopoietic stem ceils (HSCs) bas been less certain. Whereas it was previously
accepted that HSCs and progenitors migrate from the yolk sac to the fetal liver during
development, more recent studies relying on ce!! transplantation to reconstitute
hernopoiesis in aduit recipients assign an intraembryonic source for definitive (adult)
hemopoiesis within the intraernbryonic para-aortic splanchnoplecira (PS) and aortic
gonadal-mesonephros (AGM) regions . HSCs arising in these areas are believed to
migrate to and colonize the fetal liver and spleen, where they continue to differentiate
into recognizable hernopoietic precursors. After birth, definitive hernopoiesis is
primarily confined to bone marrow, and in sorne pathological conditions, also to
extramedullary sites such as the spleen, the liver and occasionally the lung and brain.
The presence of multipotential progenitors in the blood of ElO embryos suggests that
migration and colonization are mediated via the circulation “e. A unique origin ofHSCs
is challenged by recent evidence demonstrating long-term repopulation by yolk sac
(extra-ernbryonic) progenitors as assayed by reconstittLtion of fetal recipient animaIs
Hence, the origin of aduit hemopoietic celis (and in particular definitive HSCs) within
the specific vascular regions of the mammalian embryo body rernains highly
speculative. Nevertheless, the development of a stable functioning hemopoietic system
reflexes complex processes involving cellular differentiation, as well as temporal and
spatial control of migration, horning, self-renewal/proli feration and survival of HSCs.
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During ernbryonic (FL) and aduit (°‘° and sec Chapter 2) hemopoiesis, expression of
the Bmi-1 gene is highly enriched in stem and multipotent progenitor celis, consistent
with a role for this gene in regulating HSC function. In the studies presented in Chapter
3, we showed, using a knock-out allele of the Bmi-] gene and techniques of limiting
dilution analysis, that Bmi-1 is absolutely essentiai for the identity and function of aduit
hemopoietic stem and progenitor celis. In Chapter 5, we next examined the
consequences of Bmi— 1 inactivation on embryonic (FL) stem and multipotent progenitor
ccli function, using hemopoietic chimeras generated from 3mi-] E 14.5 fetal liver (FL)
derived celis engineered to overexpress either Bnii-1 or the EGfP gene. First, these
studies demonstrated that the absolute number and proliferative potential of myeloid
progenitors derived from Bi i-1’ E14.5 fetal liver (fL) celis is significantly impaired
relative to controis. This progenitor ccli defect was quantitatively and qualitatively
rescued by the retroviraÏ transduction Bmi-1 in these ceils, indicating that Bmi-] is
dispensable for the generation of fetal liver-derived myeloid progenitors, but absolutely
essential for their full proliferative activity. Similarly, transplantation studies performed
at limiting dilution in sub-lethally iiradiated recipients confirmed the presence of similar
numbers of ceils with long-terni repopuiating potential (LRC) in E14.5 Bmi-T” fetal
livers relative to controls. Irnportantly, the detection ofthe 3iizi-] FL-derived HSCs, at
16 weeks post-transpÏantation, was strictÏy dependent on the retroviral expression of
Bmi-1, indicating that Bmi-] is dispensable for the genesis of fetal iiver-derived HSCs,
but absolutely required for their proliferative capacity. The long-term (16 wks) and
pluripotent potcntial of these ceils confirrned that the rescue was occuiring at the HSC
levei . Clarke and cou. aiso demonstrated recentiy an inability of bone marrow (BM)
and E14.5 FL-derived Bmi-T’ cells to contribute to long-tenn hemopoiesis in
reconstitution (FL and BM) as well as competitive (fL) experiments, suggesting a ccli
autonomous impairment of their self-renewal/proliferation potential 0f note, the
proliferative defect in progenitors derived from Bnii-T’ E14.5 fetal livers (FLs) vas
much less pronounced than that observed in the bone marrow, suggesting a progressive
impairnient of the proliferative potential of hemopoietic celis lacking this gene (10 and
Chapter 5). The apparent progressive instabiiity of the HSC phenotype in the absence of
Bmi-1 may reflect complex epigenetic regulatory circttits established in a context
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dependent manner during hemopoiesis. Because our resuits are derived from the analysis
of transplantation chimeras, we infer that the fetal liver and bone marrow HSC defects
are ceil-autonornous and hernopoietic celi specific. Our findings, however, do not
exciude additional functions ofBmi-1 specific to cefls ofthe microenvironment, as these
would not be detected in our assays.
The transcriptional machinery governing hemopoietic stem celi biology is undoubtedly
very complex. Genes involved in regLlÏatmg HSC function in early embryogenesis
include: ScL/tal-] 48 (stem celi leukemia hemopoietic transcription factor), GAlA-2 ‘
and Rbtn2 50 (also known as Lino-2 or ttg-2), which are essential foi- primitive and
definitive hemopoiesis and AML-Ï 51,52 (aÏso known as RUNX]/cBFA2 ancÏ PEBP2B),
that is specifically required for definitive hemopoiesis. In the aduit hemopoietic system,
HSC horneostasis is maintained, at least in part, by the TEL/ETV6 Hoxa9 and
Hoxb4 genes. Examination of the contribution of these genetic axes to Bmi-1 ‘s
function in regulating the proliferation of embryonic and aduit HSCs is eargeÏy awaited.
Using a conditional gene targeting approach, Orkin and colleagues recently established
that SC’Ll/tal—l is critical for the genesis of HSCs, but its continued expression is
dispensable for HSC function s. Our studies now suggest that Bmi-] is dispensable for
the identity of fetal liver-derived embryonic HSCs, but absolutely reqttired for their in
vivo proliferative capacity. Thus, we propose that two distinctive classes of hemopoietic
“stem ceil” regulatory factors exist: those required for HSC genesis, and those required
for later HSC properties, such as long-terni repopulating activity and multipotency.
The studies presented in Chapters 2 and 3 reported an inquisitive dissociation between
the expression profile of Bmi-] (mostly restricted to primitive human CD34CD7F
CD45and mouse Sca-l Lin bone manow celis), and that of other kiiown gene products
with which Bmi-1 interacts (mostly expressed in the mature compartment of bone
marrow celis). Therefore, we postulated that Bmi-1 function in early hemopoietic ceils is
rnediated through its interaction with yet unidentified proteins. Chapter 6 summarizes
the results of a yeast-two-hybrid screen which led to the identification of 8 Bmi-l
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interacting factors in human stem and progenitor celis. These included: (1) p12OE4, a
known inhibitor of cellular proliferation and growth which seems to functional!y interact
with Bmi-1 in the regulation of ceil proliferation and senescence; (2) Trip23O, a
coactivator of the thyroid hormone receptor (TR) that is inhibited through its interaction
with pRb; (3) HPH1, a PcG protein already known to interact with Bmi-l and (4) 2
nove! gene products that were named BHIP-1 and BHIP-2 for Bmi-Ï Hemopoietic
Interacting Proteins I and 2. Characterizing the Bmi-l-containing complex(es) in early
hernopoietic cells is most important considering the inability of this protein to
intrinsically bind DNA and its essential rote in regulating the proliferation of stem and
progenitor ceils.
Bmi-1 determines the proliferative activity of normal and leukemic hemopoietic
stem ceils
Compelling evidence indicates striking similarities in the organization of the cellular
hierarchy of normal and neoplastic tissues , i.e. a rare stem cdl population with
extensive se!f-renewal capacity resuits in mature celis representing the bu!k of the
resulting tissue. Based on this, a cuiTent hypothesis suggests that genes essential for the
integrity of normal stem celis are also required for “cancer stem cells”.
The similarity in the hierarchical organization of cancerous and normal tissues is best
characterized in the hemopoietic system. In humans, evidence suggests that acute
myeloid leukemias (AMLs) originate from a population of primitive celis including
hemopoietic stem ceils (HSC5) 5961• Most immature-looking leukemic cel!s (blasts)
dispÏay a Jirnited proliferative capacity and therefore must be constantÏy repÏenished by
the rare “leukemic stem ceils” (L-HSCs) capable of extensive self-renewa!
Interestingly, these L-HSCs are morphological!y indistinguishable froni mature
leukemic blasts, btit they display surface antigens similar to norma! HSCs. In the study
presented in Chapter 5, we focused on the functional characterization of Bmi-], a gene
which appears to qualify as a new member of genetic detenninants required for the
maintenance ofboth normal and neoplastic “stem cells” in the hemopoietic tissue.
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Several arguments suggest that the PoÏyconib Group (PcG) gene Bmi-1 represents a
good candidate for regulating the proliferative activity of both normai and leukemic
HSCs. First, Bmi-1 regulates the expression of Hox genes which influence the expansion
of HSCs and leads to their transformation when overexpressed 55,6264• Second, 3mi]
expression is restricted to primitive bone marrow celis in both humans and mice (see
100Chapters 2 and 3) and is expressed in ail myeloid leukemias anaÏyzed to date (
Chapters 2, 3 and 5). Third, homozygosity for a nul! allele ofBnzi-] causes a profound
decrease in the numbers and the proliferative potential ofboth primitive myeloid (LTC
IC) and lymphoid (WW-IC) progenitor celïs (4% and 1% of wild-type levels,
respectively, (b and Chapter 3) as well as aduit HSCs (Chapter 5). Fourth, although not
investigated in stem ceils, genetic ablation ofthe INK4a/ARf locus dramatically reduced
the proliferative defects observed in 3m i-Y deficient ceiis, indicating that INK4a/ARf is
a critical in vivo downstream target for Bmi-1 in the regulation of hemopoietic celi
proliferation 65 This is potentially important considering that recent evidence indicated
that FISCs’ homeostasis/quiescence is maintained, at least in part, by a dominant
antiproliferative tone mediated by critical molecular checkpoints in the ccii cycle
machinery 66,67
In the studies presented in Chapter 5, we show that Bmi-] is a significant detenninant of
the proliferative activity of normai and leukemic stem and progenitor ceils. Although
Bmi-] is dispensable for the initiai establishment of Hoxct9-Meis]-induced AML,
replicative exhaustion of3nii-] L-HSCs is reached upon transplantation into secondary
recipients, leading to rapid proliferative arrest, differentiation, apoptosis of the leukemic
bÏasts and resumption to normal host hemopoiesis. However, through high in vitro
selective pressure which induced epigenetic aiterations of critical regulators of
proliferation (including both 19A11 and rare immortalized Bnii—T’ highiy
proliferative clones (HPCs) could be derived from 3mi-] AMLs (at a frequency of 1%
vs 24% without selection in control AMLs). When assessed in vivo, some of these Bmi
T” HPCs, initially non-leukemogenic, eventually acquired the capacity to induce AML,
pointing to clonai evolution rather than selection, as the underlying mechanism
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responsible for leukemic progression in certain Bmi-T’ HPCs. RetroviraÏ introduction of
Bmi—1 in these “immortal” but non-leukemic 3,,ii-] HPCs could induce AML within
similar latency periods than HPCs derived from control AMLs. The highly polyclonal
nature and short latencies of these leukernias indicated that Bnti-1 is sufficient to fully
restore the leukernogenic potential of these clones. This demonstrates that Bmi-]’s
function in L-HSCs involves more than cellular proliferation, which was apparently
sirnilar between the several selected RPCs derived from control and B,iij-] AMLs .
Importantly, epigenetic and genetic abrogation of cDKN2A ]61m\4tl,) and cDKN2B
(p]91?)
are common lesions associated with poor prognosis in several human leukemias
and mouse leukernia models 6$-72 The observation that the leukemogenic potential of
Bmi-T’ clones correlated with the loss of expression ofp]6’4a and p19” underscores
the importance of investigating whethei- these CKIs represent downstream regulators of
Bmi-] function in normal and neoplastic HSCs. However, the inability of a several Bini
P clones, which lacked expression of both py6INK4a and p19’ (and other CKIs), to
induce AI\4L when transplanted indicates that Bmi-]’s function in leukemic stem ceits
involves additional targets . Together, our studies indicate that Bmi-1 is dispensable for
the generation of normal and leukemic fetal liver-derived HSCs, but is absolutely
necessary for their full proliferative potential.
Although it has been assumed that cancer may arise from a seemingly endless
combination of genetic and epigenetic alterations, our observations suggest that
leukernic transformation occurs when a limited number of critical molecular events
converge. One such event causes deregulated ceil proliferation (or i mmortalization),
which, together with the necessary compensatory suppression of apoptosis needed to
support it, provides a minimal platforrn necessary to support further neoplastic
progression. The challenge is to identify and to understand the molecular anatorny of
such pivotai steps in turnor progression and to develop therapies that directly attack
these points of convergence. The crucial role played by a single molecule, Bmi-1, in
niaintaining leukemic stem ceil pool kinetics in vivo suggests that Bmi-1 is involved in a
pathway that is critical in integrating such processes. Thus, adroit targeting of its
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components should have potent and specific therapeutic consequences. Among other
consequences, transgenic systems that allow for induction and reversion of gene
expression will be invaluable in testing the requirement for sustained Bmi-1 activity in
the in vivo maintenance of L-HSCs. Such a system would also enable investigation of
the leukemogenic potential of other types of complementary oncogenes in the absence of
Bmi—]. The recent demonstration that continuous expression of the offending oncogene
is required to maintain the tumor phenotype, despite the accumulation of spontaneous
secondary mutations in other oncogenes and tcimor suppressor genes, emphasizes the
importance ofsuch future studies in the elaboration ofnovel therapeutic strategies 7376rn
Bmi-1: a common regulator of stem ccli function?
Recent studies impÏicated the Notch , Vint 80,81 and Shh 82-84 signaling pathways in
promoting stem ccli seif-renewal in a variety of different epithelia in addition to HSCs.
In particular, mutations ofthese pathways have been associated with a number ofhuman
neoplasia, including colon carcinoma and epiderniaÏ tumors (Vint) 86,
medulloblastoma 87 and basal cail carcinoma (Shh) , and T-cell leukemias (Notch) .
Supporting a potential role for 3mi] in regulating the self-renewal/proliferation of stem
ceÏls others than the FISCs, severe skeletal and neuronal deveÏopmental defects were
reported in the Bmi-] knockout mouse °. Moreover, as mentioned in Chapter 5, the
overexpression of Bnii-1 was observed in several cases of human non-small cdl lung
cancer
90, breast cancer cell unes 91 as well as irnmortalized mammary epithelial celis
(MECs) 91 High-level DNA amplifications and gains of the region encompassing the
human B,ni-] gene locus (lOpl3) have also been reported in several cases of head and
neck carcinomas 92•
In summary, with the research described in this thesis, we established that the Folcomb
Group (FcG) genes are expressed in the hemopoietic system and play a central role in
regulating hemopoietic cell proliferation. Secondly, we were able to identify the Bini-]
gene as a master regulator of FISC proliferation in both embryonic and aduit
hemopoiesis. Most importantly, we found that Bmi-] function is preserved in leukernic
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hernopoietic stem celis (L-HSCs), providing the first molecular basis for the concept that
stem celi function (whether normal or neoplastic) is regulated by a common set
ofgenetic determinants. These above findings have broad implications in the fields
of stem ceil biology and cancer.
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